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Toll-like receptors (TLRs) play key roles in innate immunity. The hallmark of 
TLR signaling is the activation of distinct patterns of immune-related gene expression 
and optimization of innate immune response. The specificity is achieved by: (i) 
recognition and differentiation of different pathogen associated molecular patterns 
(PAMPs) by different TLRs and (ii) recruitment of distinct Toll/Interleukin-1 receptor 
(TIR) domain-containing adaptor proteins (via the dimerization of TIR domains) after 
ligation of PAMPs to respective TLRs. This leads to the activation of different 
downstream signal transduction pathways. Sterile alpha and Armadillo motif 
containing protein (SARM) is the most recently described TIR domain-containing 
adaptor protein. SARM homologs from different organisms share common domain 
architecture of two SAM motifs, an ARM motif and a TIR domain. All the individual 
domains of SARM are well-known for their ability to promote protein-protein 
interaction. Unlike other TIR domain-containing adaptors, the role of SARM remains 
unclear albeit its crucial contribution in C. elegans host defense against infection. Our 
investigation of proteins in the horseshoe crab, Carcinoscopius rotundicauda, that are 
responsive to Pseudomonas aeruginosa infection led to the isolation of an EST clone 
homologous to human SARM. Sequence alignment of CrSARM cDNA showed that it 
is highly homologous to SARM from other organisms, especially those from the 
arthropods. Although not ubiquitously expressed, CrSARM transcripts were detected 
in various tissues including the amebocytes and hepatopancreas (immune-responsive), 
heart and muscle. Transcript profiling indicated that CrSARM expression is induced 
rapidly in response to P. aeruginosa infection, hence its involvement in innate 
immunity. Yeast two hybrid screening identified the potential interaction partners of 
CrSARM to be: CaMKI, SUMO-1, HAX-1, proteasome-α subunit, and Hsp40. We 
 v
propose that CrSARM participates in calcium-dependent signaling cascade leading to 
the activation of p38 kinase and/or HAX-1 mediated signaling pathway that controls 
cytoskeletal remodeling and/or apoptosis. Activation of p38, apoptosis and 
cytoskeleton remodeling have been demonstrated to play significant roles in innate 
immunity. Further studies on CrSARM will give insights on this TIR domain-
containing protein, as well as its implications in TLR signaling.  
 
 vi
List of Tables 
Table 1.1 Ligands of mammalian TLRs .................................................................................... 8 
Table 1.2 ARM motif proteins have diverse origins and functions ......................................... 17 
Table 1.3 Example of interaction partners of SAM motif-containing proteins ....................... 18 
Table 1.4 Innate immune molecules of the horseshoe crab ..................................................... 24 
Table 2.1 PCR amplification for cloning of bait fragments to pGBKT7................................. 55 
Table 3.1 SARM homologs that were used for phylogenetic analysis .................................... 69 
Table 3.2 Transformation efficiency of the yeast amebocyte 3 hpi cDNA library .................. 76 
Table 3.3 pGBKT7-bait constructs .......................................................................................... 77 
Table 3.4 Testing the baits for toxicity .................................................................................... 80 
Table 3.5 Screening of amebocyte 3 hpi cDNA library by the yeast mating method.............. 81 
Table 3.6 List of putative interaction candidates of CrSARM................................................. 88 
 
 vii
List of Figures 
Figure 1.1 Mannan binding lectin recognizes equatorial 3-hydroxyl and 4-hydroxyl sugars.... 4 
Figure 1.2 Drosophila Toll signaling pathway .......................................................................... 6 
Figure 1.3 Predicted three dimensional structure of TLR.......................................................... 7 
Figure 1.4 TLRs differentially use TIR domain-containing adaptors...................................... 11 
Figure 1.5 MyD88-dependent signaling pathway.................................................................... 13 
Figure 1.6 Schematic diagram of the domain organization of SARM..................................... 15 
Figure 1.7 Three-dimensional structure of ARM repeat motif of importin-α and β-catenin... 16 
Figure 1.8 Horseshoe crab mounts a powerful immune response against P. aeruginosa........ 22 
Figure 1.9 Amebocyte mediated immune responses against Gram-negative bacteria............. 23 
Figure 2.1 Supression subtraction cDNA hybridization .......................................................... 35 
Figure 2.2 Screening of the phage cDNA library .................................................................... 36 
Figure 2.3 Conversion of λTriplEx2 phagemid to pTriplEx2 plasmid. ................................... 41 
Figure 2.4 Principle of GAL4-based yeast two hybrid system ................................................ 48 
Figure 2.5 Overview of yeast two hybrid screening assay for identification of putative 
interaction partners of CrSARM .......................................................................... 49 
Figure 2.6 Schematic diagram of cDNA constructs of the baits.............................................. 53 
Figure 3.1 EST clone AmeR209 is homologous to SARMs from other organisms ................ 63 
Figure 3.2 3’end of CrSARM was obtained from phage cDNA library screening.................. 65 
Figure 3.3 Cloning of 5’-end cDNA of CrSARM ................................................................... 67 
Figure 3.4 CrSARM has a standard modular structure of the vertebrate SARM..................... 68 
Figure 3.5 CrSARM has high homology to the orthologs ....................................................... 70 
 viii
Figure 3.6 Phylogenetic tree of CrSARM and SARM from other........................................... 71 
Figure 3.7 Expression of CrSARM in different tissues ........................................................... 72 
Figure 3.8 Transcription profile of CrSARM upon Pseudomonas infection ........................... 73 
Figure 3.9 The synthesis of double stranded cDNA for the yeast library construction ........... 75 
Figure 3.10 PCR amplification of cDNAs encoding the baits ................................................. 77 
Figure 3.11 Expression of BD-bait fusion proteins in Y187 yeast .......................................... 78 
Figure 3.12 Checking for transcriptional activity of pGBKT7-ARM...................................... 79 
Figure 3.13 Screening of the amebocyte 3 hpi cDNA library by yeast mating ....................... 82 
Figure 3.14 Analysis of interaction specificity by yeast co-transformation ............................ 85 
Figure 4.1 CrSARM regulates Ca2+-dependent activation of p38/JNK kinases in response to 
pathogen infection via the interactions with CaMKI and SUMO-1..................... 97 
 ix
List of Abbreviations 
aa Amino acid  
AD Transcription activation domain 
ARM Armadillo 
ASK1 Apoptosis signal regulated kinase1 
BD DNA-binding domain 
BSA Bovine serum albumin 
CaMKII Calcium-calmodulin-dependent protein kinase II  
CDD Conserved domain database 
CFU Colony forming unit 
dATP Deoxyadenosine triphosphate 
dCTP Deoxycytosine triphosphate 
dGTP Deoxyguanosine triphosphate 
dNTP Deoxynucleoside triphosphate 
dTTP Deoxythymidine triphosphate 
DEPC Diethylpyrocarbonate 
DMSO Dimethyl sulfoxide 
DO Drop out 
EDTA Ethylenediaminetetraacetic acid 
EST Express sequence tag 
H Hour 
hpi Hour post infection  
IKK Inhibitory κB kinase 
IL Interleukin 
IOD Intergrated optical density  
IRF3 Interferon regulatory factor-3 
IPTG Isopropyl-1-thio-β-D-galactopyranoside  
IRAK IL-1 receptor-associated kinase 
LB Luria-Bertani 
LPS Lipopolysaccharide 
LRR Leucine rich repeat 
Mal MyD88-adaptor-like 
MAPK Mitogen-activated protein kinase 
MBL Mannan-binding lectin 
MMLV Moloney Murine Leukemia Virus 
NF-κB  Nuclear factor-κB 
OD Optical density 
ORF Open reading frame 
QDO Quadruple drop out 
PAMP Pathogen-associated molecular pattern 
PBS Phosphate-buffered saline 
PCR Polymerase chain reaction 
PMSF Phenylmethylsulphonylfluoride 
PRR Pattern recognition receptors 
RACE Rapid amplification of cDNA ends 
RbL3 Ribosomal protein L3 
 x
SAM Sterile-α 
SARM SAM and ARM-containing protein  
SDS Sodium Dodecyl Sulfate 
TAK1 Transforming growth factor-β-activating kinase 
TBK1 TANK binding kinase-1 
TICAM-1 TIR-containing adaptor molecule-1  
TIR Toll/Interleukin-1 receptor 
TIRAP TIR domain-containing adaptor protein 
TLR Toll-like receptor 
TNF Tumour necrosis factor  
TRAM Trif-related adaptor molecule  
TRAP-6 Tumour necrosis factor receptor-associated factor-6  
TRIF TIR domain-containing adaptor inducting interferon-β  
TIR-1 Toll and interleukin 1 receptor domain protein 
TSA Tryptone soy agar 
TSB Tryptone soy broth 





List of primers 
 
Name Sequence (5’ to 3’) 
 
Purpose 
CrSARM GENE SPECIFIC PRIMERS 
TIR-5RACE CCACAGACCTCTTCCAGTTGGTC
TTCCG 
Reverse primer for 5’RACE of CrSARM  
TIR-17-F1  CTGAAGTCAGACAGAAG Forward primer for sequencing of 
5’RACE product 




AGACGTAGAGAGGCTCGAAGC Forward primer for accessing tissue 
distribution and transcription profile of 
CrSARM  
TIR-R1 TGTTCCCAGGGTCTTTCTTGT Reverse primer for accessing tissue 
distribution and transcription profile of 
CrSARM 
CrSARM GENE SPECIFIC PRIMERS WITH RESTRICTION SITES 
ARM-F-Nde CATATGAATAGAGCTTACGTTGT
GGA 
Forward primer for cloning CrSARM-
AST and ARM domain into pGBKT7 
ARM-R-Bam GGATCCTTAAGCTACTAAAGTAG
TGATA 
Reverse primer for cloning CrSARM-












Forward primer for cloning CrSARM-
ORF  into pGBKT7 
SARM-R-Bam GGATCCTTAAAGTTCCACCGAAC
AAG 
Reverse primer for cloning CrSARM-








Reverse primer for cloning TIR domain  
into pGBKT7 




TGTTTCTTCAGAGGACCCA Forward primer for positive control of 
RT-PCR to analyze expression and 
transcription profile of CrSARM 
RiboR:  
 
CACCAAGAAGTTGCCTCG Reverse primer for positive control of 
RT-PCR to analyze expression and 
transcription profile of CrSARM 
VECTOR OR ANCHOR PRIMERS 
5’-RACE CDS 
primer 
(T)25VN Reverse primer for synthesis of 5’-
RACE-ready cDNA 













Forward primer for RACE-PCR 
amplification of 5’-end of CrSARM 
CDS III primer ATTCTAGAGGCCGAGGCGGCCGA
CATG-d(T)30VN 















Reverse primer for colony screening of 
pGADT7-cDNA clones 
T7 ATACGACTCACTATAGGG Sequencing primer 
 
The coding for degenerate bases are: N = A, C, G, or T; V = A, G, or C 
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Chapter 1 Introduction 
1.  
1.1 The innate immunity  
 
Innate immunity is the host defense mechanism that is evolutionarily 
conserved in all metazoans. It serves as the powerful first-line defense against a wide 
variety of pathogens in both invertebrates, in which innate immunity is the exclusive 
host defense system, and vertebrates, which are also armed with the adaptive 
immunity. Indeed, it takes three to five days for the adaptive immune system to 
produce sufficient number of effector cells from the extremely diverse reservoir of 
naïve lymphocytes through the process of clonal selection and amplification. The 
delay in the generation of the adaptive immune responses would give the pathogens 
enough time to invade the host. Fortunately, upon the recognition of invading 
pathogens by the germ-line encoded receptors, the innate immune system rapidly 
mounts various responses including phagocytosis; synthesis and release of 
antimicrobial peptides; production of reactive oxygen and nitrogen; and activation of 
the alternative complement pathway to contain the proliferation of the infective 
pathogen until the adaptive immunity is ready to execute effective immune responses 
(Janeway and Medzhitov, 2002; Medzhitov and Janeway, 2000).  
Not only providing immediately available defense mechanisms, in the 
vertebrates, the innate immune system also control and instruct the adaptive immune 
responses through the regulation of the expression of co-stimulators, chemokines, and 
cytokines upon pathogen infection (Fearon and Locksley, 1996; Janeway and 
Medzhitov, 2002). For example, the activation of T cells requires two signals 
presented on the surface of the antigen-presenting cells: (1) a peptide, which can be of 
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either self- or non-self origin, bound to MHC class II molecule; and (2) the presence 
of co-stimulatory molecules CD80 and CD86. The expression of CD80 and CDE86, 
however, can only be induced upon the recognition of infectious microbes by the 
receptor of the innate immune system (Banchereau and Steinman, 1998). This 
mechanism helps to avoid the generation of adaptive immune responses against the 
host itself once the self-antigen is presented on the surface of the antigen-presenting 
cells.  
1.1.1 Basic paradigm of innate immunity: the recognition of 
pathogen associated molecular patterns (PAMP) by pattern 
recognition receptors (PRRs) 
 
The first step in innate immune responses is the recognition of microbial 
components by the germ-line encoded receptors, called pattern recognition receptors 
(PRR) (Medzhitov and Janeway, 2000). In contrast to the amazing diversity of the T 
and B-cell receptors of adaptive immunity, which are generated by somatic 
recombination and hypermutation, the repertoire of PRRs is much more restricted due 
to the limited number of genes encoded in the genome of every organism. To 
overcome this limitation, the PRRs have evolved to recognize invariant molecular 
motifs common for the large groups of microorganisms, called pathogen-associated 
molecular patterns (PAMPs), rather than detect every possible antigen like the 
receptors of the adaptive immunity. Medzhitov and Janeway (Medzhitov and 
Janeway, 2000) have defined the common properties shared by all PAMPs to be: (1) 
expressed exclusively by the microbes but not the host, allowing the discrimination 
between self and non-self; (2) fundamental for the survival of microbes to prevent the 
generation of mutants that can escape the detection by PRRs; and (3) highly 
conserved in the entire array of microorganisms, and thus serves as indicators of the 
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classes of microbes. This feature not only allows the detection of a wide variety of 
microorganisms by a restricted repertoire of PRRs but also ensures that the innate 
immune system mounts the most appropriate responses at the critical time of 
infection. Examples of PAMPs are lipopolysaccharide (LPS) of the Gram-negative 
bacteria, lipoteichoic acid of Gram-positive bacteria; zymosan, mannan and β-glucan 
of fungi (Aderem and Ulevitch, 2000). 
The introduction of PRR-PAMP paradigm has a great implication to the field 
of innate immunity since, for the first time, it provides a logical explanation of how 
this ancient host defense system is able to recognize virtually all microorganisms and 
to optimize the defense responses depending to the type of invading microbes.  
1.1.2 Activation of intracellular signaling by PRRs 
 
PRRs can be divided into three functional classes: opsonizing, endocytic and 
signaling (Medzhitov and Janeway, 2000). Opsonizing PRRs are plasma proteins that 
can bind to PAMPs on the surface of pathogens and activate the complement system 
and phagocytes to clear the invading microbes from the circulation. An example of a 
PRR belonging to this class of PRRs is mannan-binding lectin (MBL), a secretory 
product of the liver that can recognize equatorial 3-hydroxyl and 4-hydroxyl groups 
on the terminal sugar of the carbohydrates on the cell wall of gram-positive, gram 
negative, yeast, some viruses and parasites (Holmskov et al., 2003). The ligation of 
MBL to its correspondent PAMP leads to the activation of MBL-associated proteases 
1 and 2 (MASP-1 and -2), ultimately resulting in the activation of lectin-dependent 
complement cascade (Epstein et al., 1996).  
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Figure 1.1 Mannan binding lectin recognizes equatorial 3-hydroxyl and 4-hydroxyl 
sugars. Figure is adapted from (Ng, 2005) 
 
 
Members of the second group of PRRs are those expressed on the surface of 
phagocytes and mediate the endocytosis of the pathogens. Scavenger receptors, 
mannose receptors and β-glucan receptors of the macrophages are among the 
members of the endocytic PRR group (Mukhopadhyay and Gordon, 2004). The 
binding of these receptors to microbial ligands initiates the killing of the pathogen by 
phagocytosis. Phagocytosis also results in the generation of pathogen-derived peptides 
that can be presented on the surface of the macrophage by the major 
histocompatibility-complex for the activation of cells of the adaptive immune system 
(Fraser et al., 1998; Thomas et al., 2000).  
Signaling PRRs are referred to those receptors that recognize PAMPs and 
activate intracellular signaling pathways resulting in the activation of immune-related 
genes. Toll-like receptors (TLRs), the best-characterized member of this group of 
PRRs, play the key role in the detection and elimination of pathogens. Signaling 
pathways activated by TLRs are conserved from invertebrates to vertebrates. Within 
the scope of this thesis, the following sections will focus on the significance of TLR-
mediated signaling pathways to the host defense against infection. 
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1.2 Toll-like receptor signaling  
1.2.1 Toll-like receptors and their ligands 
 
Toll of Drosophila is the first member of Toll-like receptor family that was 
identified. At first, Toll was only known as a transmembrane receptor that functions 
in the establishment of dorsoventral polarity in the fly during embryogenesis 
(Hashimoto et al., 1988). Latter, the involvement of Toll in the innate immune 
responses was proposed based on the similarity between Toll and the mammalian 
interleukin-1 (IL-1) receptor. Indeed, genetic analysis of Toll revealed that its 
cytoplasmic domain is highly similar to that of IL-1 receptor. This motif was hence 
defined as Toll/IL-1 receptor (TIR) domain. In addition, signaling transductions 
induced by both receptors ultimately result in the activation of the same transcription 
factor, nuclear factor (NF)-κB, that is known to be involved in the regulation of many 
immune related genes (Belvin and Anderson, 1996). The role of Toll in host defense 
was experimentally confirmed by Lemaitre et al (Lemaitre et al., 1996) who showed 
that flies harboring a mutation in the toll gene were more susceptible to fungal 
infection. Subsequently, Toll was reported to be essential in immune response against 
Gram-positive bacteria (Rutschmann et al., 2002). However, not as expected, 
microbial component is not the direct ligand of Drosophila Toll. Rather, Toll was 
shown to recognize Späetzle, an endogenous protein that is cleaved from the precursor 
protein pro-Späetzle, upon infection by Gram-positive bacteria or fungi (Levashina et 
al., 1999). Molecular mechanism responsible for the cleavage of Späetzle, however, 
remains unclear. It was reported that peptidoglycan recognition protein PGRP-SA 
(Werner et al., 2000) and a serine protease encoded by Persephone gene (Ligoxygakis 
et al., 2002) are involved in the activation of Toll in response to the invasion of gram-
positive bacteria and fungi, respectively. The former is a PRR that recognizes Gram-
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positive lysine-type peptidoglycan whereas the latter does not contain any pattern 
recognition motif (Figure 1.2). 
 
Figure 1.2 Drosophila Toll signaling pathway  
Toll signaling pathway is essential for immune responses against Gram-positive bacterial and 
fungal infection in Drosophila. Gram-positive bacterial or fungi challenges initiate 
protease cascades leading to the cleavage of pro-Späetzle to Späetzle, which then 
binds and triggers the recruitment of DmMyD88 to TIR domain of Toll. The death 
domain of DmMyD88, on the other hand, interacts with the death domains of Tube 
and Pelle, which possesses a serine-threonine kinase domain. The formation of this 
receptor-adaptor complex induces signal transduction that leads to the dissociation of 
the ankyrin-repeat inhibitory protein, Cactus, a homolog of mammalian IκB, from the 
Dorsal-related immunity factor (Dorsal/Dif), which is a homolog of mammalian NF-
κB. Nuclear translocation of the Dorsal-related immunity factor ultimately results in 
the activation of antimicrobial proteins. Figure is adapted from Takeda and Akira 
(Takeda and Akira, 2005) 
 
Since the elucidation of the role of Drosophila Toll in innate immunity, 11 
homologs of Toll, which are collectively named as Toll-like receptors (TLRs), have 
been identified in mammals (Takeda and Akira, 2005, and Table 1.1). The presence of 
a TLR in horseshoe crab, Tachypleus tridentatus, was reported recently by Inamori et 
al (Inamori et al., 2004). In our lab, the TIR domain of Carcinoscopius rotundicauda 
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has been recently cloned (Loh et al, unpublished). Members of TLR family share a 
common structural feature with a transmembrane portion that is flanked with an 
extracellular region containing leucine-rich repeat (LRR) motif and an intracellular 
region which contains a TIR domain9 (Figure 1.3). 
 
Figure 1.3 Predicted three dimensional structure of TLR.  
Each TLR is a transmembrane protein with the extracellular LRR motif responsible 
for ligand binding and the intracellular TIR domain for signal transduction, which are 
in grey and cyan, respectively. Mammalian TLRs have large insertions at position 10 
or 15 within the LRRs that may provide the binding site for PAMPs. LRR-NT & -CT: 
N- and C-terminal flanking regions of the LRR motif, respectively. Figure is adapted 
from Bell et al (Bell et al., 2003). 
 
LRR domain of TLRs, which contains up to 25 tandem repeats of a conserved 
leucine-rich repeat sequence of 24-29 amino acids, is responsible for ligand binding. 
Based on the three dimensional structures of other LRR-containing proteins, it was 
predicted that LRR motif of the TLR form a horseshoe structure with the concave 
surface is likely to be involved in ligand binding. Unlike Drosophila Toll, 
extracellular domains of individual mammalian TLRs can directly recognize specific 
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pathogen-associated molecular patterns from bacteria, fungi, virus, and protozoa 
(Akira and Takeda, 2004,  and Table 1.1). This difference was proposed to be related to 
the presence of large insertions at residue 10 or 15 within the LRRs of mammalian 
TLRs that are absent from LRRs of Toll. It was hypothesized that these insertions 
provided the binding sites for the PRRs of mammalian TLRs (Bell et al., 2003, and 
Figure 1.3).  
Table 1.1 Ligands of mammalian TLRs 
 
The preparation of ligands marked with star (*) may be contaminated with LPS. Further 
investigation is thus needed to confirm the connection between these ligands with TLRs. 
Table is adapted from Akira and Takeda (Akira and Takeda, 2004)  
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While the extracellular domain of TLRs functions in the detection of 
pathogens, the TIR domain at their cytoplasmic tail mediates signal transduction 
across the plasma membrane to the downstream components of TLR signaling 
pathway within the cell. TIR domain is a protein motif of approximately 200 amino 
acids with relatively low sequence homology (20 – 30 %). However, within the TIR 
domain, there are three highly conserved regions, named boxes 1, 2 and 3. These 
boxes play a critical role in mediating the interaction between the TIR domains of two 
TLRs or of the TLRs and their respective downstream adaptive proteins (Slack et al., 
2000). Homodimerization of TLR4 and heterodimerization between TLR2 with either 
TLR1 and TLR6 that are mediated by the interaction of TIR domains of the TLRs are 
crucial for the recruitment of downstream adaptor proteins. For other TLRs, however, 
there is no evidence of dimerization of the receptor in response to ligand binding. The 
recruitment of adaptor molecule just downstream of TLR to the activated TLR is also 
based on the interaction between the TIR domains present in both molecules. In 
addition to the TLRs and IL-1 receptors, these cytoplasmic adaptor proteins form the 
third group of proteins that possess TIR domain (Akira, 2000). They are thus 
collectively referred as TIR domain-containing adaptors.  
Research has shown that, depending on the nature of microbial challenge, 
different TLRs are stimulated to recruit the respective TIR domain-containing adaptor 
molecule, leading to the activation of distinct sets of genes. For example, the 
stimulation of TLR3 and TLR4 lead to the activation of genes under the control of the 
transcription factor interferon regulatory factor-3 (IRF-3) whereas activation of TLR2, 
TLR7, and TLR9 result in the induction of genes under control of transcription factor 
NF-κB. In addition to IRF-3, signal transduction mediated by TLR4 can activate NF-
κB through two distinct mechanisms (Figure 1.4). Therefore, it was proposed that 
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differential usage of the TIR domain-containing adaptors by TLRs allows the 
induction of appropriate immune responses against a particular pathogen (O'Neill et 
al., 2003). This will be elaborated further in the following sections.  
1.2.2 TIR domain-containing adaptors  
 
The TIR domain-containing adaptor family is referred to as a group of 
cytoplasmic proteins with the presence of the signature TIR domain in their structure. 
To date, five members of this protein family have been described:  
(a) MyD88, the product of the myeloid differentiation primary response gene 88  
(b) TIR domain-containing adaptor protein (TIRAP) that is also known as 
MyD88-adaptor-like (Mal) 
(c) TIR domain-containing adaptor inducting interferon-β (TRIF) or TIR-
containing adaptor molecule-1 (TICAM-1) 
(d) TRIF-related adaptor molecule (TRAM) or TICAM-2 
(e) Sterile alpha and Armadillo motif-containing protein (SARM).  
Except for MyD88, which is a “universal” adaptor recruited by all TLR 
homologs apart from TLR3, other TIR domain-containing adaptors are involved in the 
distinct TLR mediated signaling pathways (Takeda and Akira, 2005, and Figure 1.4). 
The functions of each TIR domain-containing adaptor in TLR signaling in response to 
infection and inflammation are being uncovered as a result of extensive research on 
TLR signaling, especially those based on mice that are deficient in individual or 
combination of the adaptor molecules. The following sections will review current 






Figure 1.4 TLRs differentially use TIR domain-containing adaptors  
Five TIR domain-containing adaptors, MyD88, TIRAP, TRAM, TRIF and SARM, are 
differently used by TLRs in order to mediate distinct gene expression profile according to the 
nature of immune challenge. Refer to the text for detail description of the pathways. Figure is 
adapted with modification from Takeda and Akira (Takeda and Akira, 2005). AP-1, activator 
protein 1; IKK, inhibitory κB kinase; IRAK, IL-1 receptor-associated kinase; IRF-3, 
interferon regulatory factor-3; MKK, mitogen-activated kinase kinase; NF-κB, nuclear factor-
κB; SARM, SAM and ARM-containing protein; TIRAP, TIR domain-containing adaptor 
protein; TAK1, transforming growth factor-β-activating kinase; TBK1, TANK-binding 
kinase-1;TLR, Toll-like receptor; TRAM, TRIF-related adaptor molecule; TRAP-6, receptor-




MyD88 is the first TIR domain-containing adaptor protein to be discovered 
and is also the most extensively studied. In addition to the C-terminal TIR domain, 
MyD88 harbors a death domain at its N-terminus. Researches have shown that all 
TLRs except for TLR3 are able to recruit MyD88 to their cytoplasmic TIR domain, 
leading to the activation of a signaling pathway that is analogous to IL-1 receptor-
mediated pathway (Janssens and Beyaert, 2002). Following the engagement of 
MyD88 to TLR, MyD88 recruits IL-1 receptor-associated kinase-4 (IRAK-4) via the 
interaction of the death domains of both molecules. IRAK-4 then mediates the 
phosphorylation of IRAK-1, which then recruits and activates tumour necrosis factor 
(TNF) receptor-associated factor-6 (TRAP-6). Signaling downstream of TRAP-6 
finally results in the activation and nuclear translocation of AP-1 and NF-κB 
transcription factors through the activation of p38 and c-Jun N-terminal kinase (JNK) 
and the inhibitory κB kinase (IKK) complex (McGettrick and O'Neill, 2004, and 
Figure 1.5). This MyD88 dependent signaling cascade is thus important for the 
production of inflammatory cytokines, whose expression is controlled by NF-κB and 
AP-1 transcription factor, such as interleukin (IL)-1, IL-6, IL-8, and TNF-α. In 
addition, the activation of p38 kinase by TLR can induce phagocytosis of the invading 
microbes probably through upregulating the expression of scavenger receptors (Doyle 














Figure 1.5 MyD88-dependent signaling pathway  
 TLRs except for TLR3 recruit MyD88 to activate the transcription factor NF-κB and 
MAPK signaling cascade that leading to the phosphorylation of p38 and JNK. The 
detail of this MyD88-dependent signaling pathway can be found in the text. Figure is 




TIRAP/Mal was identified as a result of the database search for proteins which 
are structurally related to MyD88. Using mice deficient in either Mal or MyD88, 
researcher found that TIRAP and MyD88 work together to mediate signal 
transduction within the TLR2- and TLR4- signaling pathways (Horng et al., 2002; 
Yamamoto et al., 2002a). Subsequently, Dunne et al (Dunne et al., 2003) reported that 
these two adaptors can physically interact with each other and individually interact 




TRIF was described by Yamamoto et al (Yamamoto et al., 2002b) and 
Oshiumi et al (Oshiumi et al., 2003a), who named it as TICAM-1, as the TIR-
containing adaptor molecule that is responsible for the MyD88-independent 
activations of IRF3 and NF-κB by TLR3. Indeed, TRIF was found to associate with 
TLR3 in coimmunoprecipitation (Yamamoto et al., 2002b) and yeast two hybrid 
studies (Oshiumi et al., 2003a). Mutagenesis of the gene encoding TRIF inhibits the 
activation of IRF3, and thus the induction IFN-β and IFN-inducible promoters, and 
NF-κB by TLR3 (Hoebe et al., 2003; Yamamoto et al., 2003a). In addition, TRIF was 
found to be involved in the MyD88-independent delay activation of NF-κB (Kawai et 
al., 2001) and the activation of IRF3 (Hoebe et al., 2003) by LPS, the ligand of the 
TLR4. TRIF-dependent activations of IRF3 and NF-κB were found to be associated 
with the recruitment of IKKs including TBK1 and IKKi/IKKε complex and TRAP-6 
to the N-terminal of TRIF, respectively (Sato et al., 2003). In brief, TRIF is engaged 
in two distinct signaling pathways that are mediated by TLR-4 or TLR-3: one leading 
to the activation of IRF-3 transcription factor; and the other resulting in MyD88-
independent activation of NF-κB.  
(c) TRAM 
 
Although TRIF was found to be a component of TLR4 signaling pathway that 
activates IRF3, its interaction with TLR4 was not observed (Yamamoto et al., 2002b). 
The discovery of TRAM provided insights to the missing link between TLR4 and 
TRIF. Indeed, TRAM was demonstrated to function in the activation of IRF3 and 
TRIF-dependent activation of NF-κB by acting as a bridge between TLR4 and TRIF 
(Fitzgerald et al., 2003; Oshiumi et al., 2003b; Yamamoto et al., 2003b). 
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(d) SARM 
Although sterile alpha and Armadillo motif containing protein (SARM) was 
first described in human in 2001 (Mink et al., 2001), it has just been included into the 
TIR domain-containing adaptor family upon the discovery of a TIR domain within 
this molecule (O'Neill et al., 2003). SARM is an evolutionary conserved protein. 
Homologs of human SARM have been found in mouse, zebra fish, Drosophila, and C. 
elegans (Couillault et al., 2004; Jault et al., 2004; Meijer et al., 2004; Mink et al., 
2001).  Although varied in length, SARM homologs share a common domain 
architecture of an N-terminal Armadillo repeat (ARM) motif, followed by two sterile 
alpha (SAM) motifs, and a TIR domain located just C-terminal to SAM motifs 
(Couillault et al., 2004). The domain organization of SARM is shown in Figure 1.6. 
Interestingly, all three protein domains made of SARM function in the mediation of 
protein-protein interaction.  
 
Figure 1.6 Schematic diagram of the domain organization of SARM  
Figure is not to scale. ARM = Armadillo motif, SAM = Sterile alpha motif, TIR = 
Toll/Interleukin-1 domain. 
 
The Armadillo motif is characterized by the tandem repeats of a conserved 42 
amino-acid-long sequence (Peifer et al., 1994). Each repeat folds into three α helices. 
Bundles of helices of the multiple repeats composing ARM motif in turn, fold further, 
creating a regular structure of a right-handed superhelix (Coates, 2003). This is clearly 
demonstrated by the crystal structures of β-catenin (Huber et al., 1997) and importin-
α (Conti and Kuriyan, 2000), which contain 12 and 10 tandem ARM repeats, 
respectively (Figure 1.7). ARM motif is found in proteins from wide variety of 
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eukaryotes ranging from uni- to multi-cellular animal. Examples of such proteins are 
listed in Table 1.2. ARM repeat-containing proteins have diverse functions including 
regulation of cytoskeleton; transportation of proteins between the cytosol and the 
nucleus; acting as the guanine nucleotide exchange factor; controlling of gene 
expression; and signaling (Table 1.2). The versatile functions of ARM repeat-
containing proteins are explained by the fact that the superhelix structure of ARM 
motif provides surface for multiple protein interactions, promoting complex formation 
(Conti and Kuriyan, 2000; Huber et al., 1997). For example, the interaction of ARM 
repeats of β-catenin with cadherin is involved in the regulation of cytoskeletal 
functions (Aberle et al., 1994) while the recognition of nuclear localization signals by 
the ARM motif of the importin-α is essential for the transport of proteins through the 
nuclear pores (Conti and Izaurralde, 2001).  
 
Figure 1.7 Three-dimensional structure of ARM repeat motif of importin-α and β-
catenin. 
The ARM repeat-motifs of Saccharomyces cerevisiae importin-α and mouse β-catenin have 
superhelix three dimensional structure. The three helices, termed H1, H2 and H3, of each 
ARM repeat are colored in green, red and yellow, respectively. Importin-α is shown as 
complex with the nuclear localization signal (NLS) of nucleoplasmin. Figure is adapted from 
Andrade et al (Andrade et al., 2001).  
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Table 1.2 ARM motif proteins have diverse origins and functions 
 
 
Examples of ARM motif-containing protein families. Each ARM repeat is represented by one 
green box. Known functions of each protein are listed in the right with those functions 
associated with ARM motif written in blue and those are not are in red. Table is adapted from 
Coates (Coates, 2003) 
 
The sterile alpha (SAM) domain is a conserved domain of approximately 70 
amino acids (Ponting, 1995) that is present in almost 1000 proteins from a wide 
variety of eukaryotes and even some bacteria (Schultz et al., 1998). The functions of 
SAM domain-harboring proteins are extremely diverse, ranging from 
transcriptional/translational regulation, apoptosis to signal transduction (Kim and 
Bowie, 2003 and Table 1.3). The hallmark of this huge group of proteins is their 
ability to form polymeric complexes via: (1) the oligomerization of SAM domains of 
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the same type of protein as in the case of transcriptional repressor TEL (Kim et al., 
2001); (2) the polymerization of SAM domains of different types of proteins for 
example the complex of Mae (modulator of the activity of Ets), and transcriptional 
regulators Yan and Pnt is formed due to the interaction between SAM domains of 
each of the proteins; (3) the interaction with proteins do not contain SAM domain 
such as those listed in Table 1.3.  
Table 1.3 Example of interaction partners of SAM motif-containing proteins  
 
 
SAM domain-containing proteins bind variety of proteins and performed diverse 
functions. Table is adapted from Kim and Bowie (Kim and Bowie, 2003) 
 
TIR domain, as described previously, is a conserved ~ 200 residue-long 
protein motif that is found in three protein families that play a role in immune 
response, namely IL-1 receptor family, Toll-like receptor family, and TIR domain-
containing protein family. Interactions between the TIR domains of TLRs or between 
TIR domains of TLRs and the downstream TIR domain-containing adapters are 
critical for signal transduction leading to the activation of immune-related genes.  
The conservation of SARM across the animal kingdom and the fact that 
mutation in the gene encoding the SARM homolog in Drosophila was lethal (Mink et 
al., 2001) suggest functional significance of this protein. However, unlike the other 
four TIR domain-containing adaptor proteins, the role of SARM in TLR signaling 
remains to be determined. Nevertheless, research in C. elegans strongly demonstrated 
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that SARM is essential for innate immune response against microbial infection 
(Couillault et al., 2004; Liberati et al., 2004). Both Couillault et al (Couillault et al., 
2004) and Liberati et al (Liberati et al., 2004) reported that RNA-interference 
suppression of tir-1 gene, which encodes TIR-1, the SARM homolog of C. elegans 
rendered the worm more sensitive to bacterial and fungal infection. Although the 
exact causes are still unknown, the increased susceptibility was speculated to be 
partially related to the reduction in the expression of NLP-31 antimicrobial peptide 
(Couillault et al., 2004) and/or the inhibition of activation of p38 mitogen activated 
protein kinase (MAPK) PMK-1 (Liberati et al., 2004). The linkage between TIR-1 
with the p38 MAP kinase was also recently reported by Chuang and Bargamann 
(Chuang and Bargmann, 2005). The authors demonstrated that TIR-1 physically 
interacted with the C. elegans calcium-calmodulin-dependent protein kinase II 
(CaMKII), UNC-3, and probably its downstream target, the MAP kinase kinase 
kinase NSY-1, to regulate the expression of odorant receptors during the 
differentiation of olfactory neurons. NSY-1 is the homolog of mammalian apoptosis 
signal regulated kinase1 (ASK1) that is known to be able to activate p38 and JNK. As 
a result, it was hypothesized that the role of TIR-1 in neuronal development is to 
mediate signal transduction through the Ca+2/MAPK cascade, which finally leads to 
the activation of the p38/JNK kinases. Nevertheless, further efforts should be 
undertaken to determine the implication of this signaling pathway in innate immunity. 
In addition, the unique combination of three protein-protein interaction modules in 
SARM suggests that it may be engaged in the more complicated signaling pathways 
that are distinct from that mediated by other TIR-containing adaptors.  
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1.3 Horseshoe crab is an excellent model for innate immunity 
research 
Invertebrates serve as good models for the study of innate immunity for 
following reasons. First of all, the invertebrates rely solely on the innate immune 
system for protection against pathogen invasion. In the absence of adaptive immunity, 
the interpretation of experimental results is uninterrupted since the influence from the 
adaptive immune system to the innate immune responses is totally absent. Secondly, 
due to the evolutionary conservation of innate immune-related molecules, knowledge 
of the innate immunity in the invertebrates is very useful for the understanding of 
molecular mechanisms underlying the innate immune responses in the vertebrates.  
Over the last two decades, a wide variety of invertebrates have been used for 
the studies of the innate immunity, examples of which are the threadworm, 
Caenorhabditis elegans; the tobacco hornworm, Manduca sexta; the silkworm 
Bombyx mori; the fruit fly, Drosophila melanogaster; the mosquito, Anopheles 
gambiae; the horseshoe crabs, Tachypleus tridentatus, Limulus polyphemus and 
Carcinoscorpius rotundicauda; and the Pacific oysters, Crassostrea gigas. Amongst 
these species, the Drosophila and C. elegans are the animal models of choice due to 
the availability of genome sequences that allows the high throughput genomic and 
proteomic analysis and ease of genetic manipulation (Royet, 2004). Indeed, studies in 
these organisms have greatly contributed to the understanding of innate immunity, 
especially the discovery of Toll and Toll signaling pathway in Drosophila. Horseshoe 
crab, however, is also a good model for innate immune study since it has much larger 
volume of blood and bigger tissues compared with most of other invertebrate models, 
allowing convenient physiological and molecular manipulations. In addition, this 
organism habours a very sophisticated innate immune system that ensures its survival 
for over 200 million years. This point will be elaborated further.  
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Horseshoe crab is a “living fossil” 
The horseshoe crab belongs to the order Xiphosura that has more than 500 
million year of evolutionary history. Evolution leading to the formation of modern 
horseshoe crab took place for about 200 million years from the Silurian period (~ 420 
million years ago) to the Jurassic period (~ 200 million years ago). After that, it has 
remained largely unchanged until now (Stormer, 1952). Due to its long history of 
evolution, horseshoe crab is often referred as a “living fossil”. Today, there are four 
species of horseshoe crabs in different habitats around the world: Limulus polyphemus 
in the East coast of USA; Tachypleus tridentatus in China and Japan and Tachypleus 
gigas and Carcinoscorpius rotundicauda in South Asia (Ding et al., 2005).  
Horseshoe crab possesses a powerful innate immune system 
In order to survive for more than 200 million years, the horseshoe crab has 
developed a powerful innate immune system to combat the pathogenic 
microorganisms, especially Gram-negative bacteria, the main infective agents in the 
marine environment. Indeed, Ng et al (Ng et al., 2004) demonstrated that the 
horseshoe crab, C. rotundicauda, survived an infection of 2 x 106 CFU of 
Pseudomonas aeruginosa / 100 g of body weight, a dose that was shown to be lethal 
to mice. The immune response was so fast and efficient that majority of the bacteria 
were cleared from the plasma after three hours of infection and the rest was 
completely removed finally (Figure 1.8) 
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Figure 1.8 Horseshoe crab mounts a powerful immune response against P. aeruginosa 
Horseshoe crabs were infected with a sublethal (2 x 106 CFU / 100 g of body weight) and a 
lethal dose (2 x 108 CFU / 100 g of body weight) of .P. aeruginosa. At different time points, 
crabs were bled and the hemolymph was plated onto TSA (dotted lines) and Pseudomonas 
selective cetrimide (bold lines) agar media to determine level of viable bacteria for the level 
of live bacteria.  The significance difference between certain time point to the previous one 
indicates by the asterisk. One, two and three asterisk, represent significant differences with 
P<0.05, P<0.01 and P<0.001, respectively. Figure is adapted from Ng et al (Ng et al., 2004) 
 
Research over the last 20 years has revealed that this organism harbours a 
large repertoire of firstline defense molecules  including antimicrobial peptides, 
lectins, clotting factors, serine proteases, and protease inhibitors (Iwanaga, 2002; Ng 
et al., 2004; Yau et al., 2001; Zhu et al., 2005, and Table 1.4). Most of these proteins 
are identified either in the hemolymph or in the granules of the amebocyte, which is 
the major type of blood cells in the horseshoe crab. Many of these firstline defense 
molecules are involved in the Gram-negative endotoxin (LPS)-induced coagulation 
cascade leading to the formation of the clots, into which the intruders are entrapped 
and thus destroyed. The gelation of the blood starts with the activation of the protease 
cascade by the LPS, ultimately leading to the cleavage of coagulogen into coagulin, 
which are crosslinked to form the clot (Ding et al., 1993; Iwanaga and Kawabata, 
1998). Pathogen killing is also achieved by the release of many potent antimicrobial 
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peptides from the amebocytes into the hemolymph (Iwanaga, 2002 and Figure 1.9). 
Recently, Ding et al (Ding et al., 2005) reported that not only the firstline defense 
proteins are essential for in immune responses against Gram-negative bacteria in the 
horseshoe crab, proteins functioning in apoptosis,stress responses and cell signaling 
are also involved. In addition, Ariki et al (Ariki et al., 2004) reported that factor C, in 
addition to play a role in coagulation, also serve as a PRR for Gram-negative bacteria 
endotoxin through the interaction with lipid A of the LPS. The presence of such broad 
spectrum of immune responsive molecules suggests that the molecular mechanisms of 
innate immune responses in the horseshoe crab are more complicated than what has 
been known so far. The existence of effector mechanisms other than what have been 
identified as well as cellular signaling pathways that are critical for innate immunity 
in the horseshoe crab remain to be uncovered and exploited.  
 
Figure 1.9 Amebocyte mediated immune responses against Gram-negative bacteria.  
Upon contact with Gram-negative bacteria, amebocytes are degranulated, releasing into the 
hemolymph the contents of the large and the small granules, majority of which are 
antimicrobial peptides and clotting factors. Invading bacteria are trapped in the clots that are 
formed as the result of a cascade activated by Factor C upon its binding to the endotoxin and 
killed by the antimicrobial peptides. The figure is adapted from Iwanaga and Kawabata 
(Iwanaga and Kawabata, 1998) 
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Table 1.4 Innate immune molecules of the horseshoe crab  
Proteins and peptides  Mass (kDa)  Function/specificity  Localization  
Coagulation factors     
Factor C 123  Serine protease  L-granule  
Factor B 64  Serine protease  L-granule  
Factor G 110  Serine protease  L-granule  
Proclotting enzyme 54  Serine protease  L-granule  
Coagulogen 20  Gelation  L-granule  
Protease inhibitors     
LICI-1 (Limulus intracellular 
coagulation inhibitor) 48  Serpin/factor C  L-granule  
LICI-2 42  Serpin/clotting enzyme  L-granule  
LICI-3 53  Serpin/factor G  L-granule  
Trypsin inhibitor 6.8  Kunitz-type  ND  
Limulus trypsin inhibitor 16  New type  ND  
Limulus endotoxin-binding 
protein-protease inhibitor 
12  New type  L-granule  
Limulus cystatin 12.6  Cystatin family 2  L-granule  
α2-Macroglobulin 180  Complement  Plasma & L-granule  
Chymotrypsin inhibitor 10  ND Plasma  
Antimicrobial substances     
Anti-LPS factor 12  GNB L-granule  
Tachyplesins 2.3  GNB, GPB, Fungus  S-granule  
Polyphemusins 2.3  GNB, GPB, Fungus S-granule  
Big defensin 8.6  GNB, GPB, Fungus L & S-granule  
Tachycitin 8.3  GNB, GPB, Fungus S-granule  
Tachystatins 6.5  GNB, GPB, Fungus S-granule  
Factor D 42  GNB  L-granule  
Lectins     
Tachylectin-1 27  LPS (KDO), LTA  L-granule  
Tachylectin-2 27  GlcNAc, LTA  L-granule  
Tachylectin-3 15  LPS (O-antigen)  L-granule  
Tachylectin-4 470  LPS (O-antigen), LTA  ND  
Tachylectin-5 380-440  N-acetyl group  Plasma  
Limunectin 54  PC  L-granule  
Limulus18-kDa agglutination-
aggregation factor 
18  Hemocyte aggregation  L-granule  
Limulin 300  Hemolytic/PC, PE, SA, 
KDO  
Plasma  
Limulus C-reactive protein (CRP) 300  PC, PE  Plasma  
Tachypleus CRP-1 300  PE  Plasma  
Tachypleus CRP-2 330  Hemolytic/PE, SA  Plasma  
Tachypleus CRP-3 340  Hemolytic/SA, KDO  Plasma  
Polyphemin ND  LTA, GlcNAc  Plasma  
Tachypleus tridentatus agglutinin ND  SA, GlcNAc, GalNAc  Plasma  
Liphemin 400-500  SA  Hemolymph  
Carcinoscorpin 420  SA, KDO  Hemolymph  
galactose-binding protein 40  Gal  Hemolymph  
Protein A binding protein 40  Protein A  Hemolymph  
(1 → 3)β-D-glucan binding 
protein 168  Pachyman, cardlan  Hemocyte  
Others     
Transglutaminase (TGase) 86  Cross-linking  Cytosol  
8.6 kDa protein 8.6  TGase substrate  L-granule  
Pro-rich proteins (Proxins) 80  TGase substrate  L-granule  
Limulus kexin 70  Precursor processing  ND  
Hemocyanin  3600  O2 transporter/ 
Phenoloxidase  
Plasma  
Toll-like receptor (tToll) 110  ND Hemocyte  
L 11  Unknown  L-granule  
L4 11  Unknown  L-granule  
GNB, Gram-negative bacteria; GPB, Gram-positive bacteria; LPS, lipopolysaccharide; KDO, 2-keto-3-
deoxyoctonic acid; PC, phosphorylcholine; PE, phosphorylethanolamine; SA, sialic acid;, LTA, lipoteichoic acid; 
ND, not determined. Talbe is adapted from Iwanaga and Lee (Iwanaga and Lee, 2005).  
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1.4 Aims and rationale of the project 
The aim for the first part of this project was to identify proteins of the 
horseshoe crab, C. rotundicauda, that are differentially expressed in response to         
P. aeruginosa infection. With the isolation of the EST clone that is homologous to 
human SARM, a potential TIR domain-containing adaptor protein of the TLR 
signaling pathways, subsequent study focussed on the cloning and functional 
characterization of C. rotundicauda SARM, CrSARM.  
P. aeruginosa is a ubiquitous Gram-negative bacterium that can be found 
(Hardalo and Edberg, 1997), in the coastal marine environment, the natural habitat of 
C. rotundicauda the animal model used in this project. P. aeruginosa has a wide 
range of host, from plants, insects to mammals. In addition, this bacterium has 
developed multi-resistance against various antibiotics (Stover et al., 2000). Altogether, 
these factors make P. aeruginosa the major cause of nosocomial infection and a 
significant opportunistic human pathogen. Study of the regulation of the expression of 
immune-related genes in response to P. aeruginosa infection, is thus beneficial not 
only for the understanding of the host-pathogen interactions but also for theurapeutic 
intervention.  
Since the discovery of human SARM in 2001 (Mink et al., 2001) and 
subsequent identification of its homologs in other organisms including Drosophila, 
zebra fish and C. elegans (Couillault et al., 2004; Liberati et al., 2004; Meijer et al., 
2004; Mink et al., 2001), the function of this signaling molecule has remained largely 
unknown. The study of SARM has been restricted to TIR-1, SARM homolog of C. 
elegans, which was demonstrated to be essential for immune response against 
bacterial and fungal infections (Couillault et al., 2004; Liberati et al., 2004) in 
addition to its role in neuronal development in the worm (Chuang and Bargmann, 
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2005). The immune-related signaling pathway that TIR-1 is involved in, however, is 
still undefined except for the fact that this molecule works upstream of the p38 kinase 
(Liberati et al., 2004). Our work on CrSARM, would thus provide insights into the 
biological relevance of this novel signaling protein, especially in the context of innate 
immunity against P. aeruginosa infection. In addition, the findings of this project 
would enrich the limited information about intracellular signaling that allows this 
“living fossil” to mount a very powerful frontline immune response against P. 
aeruginosa infection (Ng et al., 2004). Last but not least, we aim to contribute to the 
current knowledge on the TLR signaling, the crucial component of infection, host-
pathogen interaction and the resulting immune response.  
With the limitation of literature support, our approach to functionally 
characterize CrSARM was, firstly, to search for its interaction partners since the 
success of this would allow the speculation of potential signaling pathways that 
CrSARM is involved in. Further experiments were then designed accordingly to 
validate these hypotheses. To this end, the spatiotemporal expression of CrSARM 
under various hours post-infection by P. aeruginosa was investigated. Subsequently, 
yeast-2-hybrid screens were carried out to determine the interaction partners of 
CrSARM. The putative partners of CrSARM yielded very exciting possible 
explanations on the molecular mechanisms of signaling action of SARM in general. 
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Horseshoe crabs, C. rotundicauda, were collected from the Kranji estuary of 
Singapore. The specimens were washed to remove mud and acclimated overnight in 
30% (v/v) sea water/fresh water before being used for experiments.  
Bacteria strains used for infection experiments was P. aeruginosa ATCC 
27853. Escherichia coli XL1-Blue was used as host bacteria for propagation of the 
phage cDNA library. E. coli BM25.8, which expresses Cre recombinase, was used as 
the host bacteria to facilitate the conversion of λTriplEx2 phagemid to pTriplEx2 
plasmid. 
2.1.2 Biochemicals and enzymes   
Glutathione SepharoseTM 4B, Protein A Sepharose 4 Fast Flow, Redivue [32P]-
dCTP, [35S]-methionine, Hybond-N+ nylon membrane, and Hybond PDVF membrane 
were products of GH Healthcare.  Deoxyadenosine triphosphate (dATP), 
deoxyguanosine triphosphate (dGTP), deoxycytosine triphosphate (dCTP) and 
deoxythymidine triphosphate (dTTP) were from Promega. X-α-gal was from BD 
Biosciences Clontech. Colony/Plaque ScreenTM nylon membrane was a product of 
Perkin-Elmer. Isopropyl-1-thio-β-D-galactopyranoside (IPTG) was from Biorad. 
Zymolyase was from Seikagaku Corporation. All restriction enzymes were from New 
England Biolabs or Fermentas. Mouse monoclonal anti-HA antibody and Complete 
Cocktail Inhibitors were from Roche.  SuperSignal® West Pico Chemiluminescent 
Substrate was from Pierce. Mouse monoclonal anti-c-myc antibody was a product of 
Invitrogen. Phenylmethylsufonylfluoride (PMSF), bovine serum albumin fraction V, 
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calf thymus DNA, Ficoll 400 were from Sigma.  Super RX X-ray film was from Fuji. 
Common chemicals were from Sigma and Merk.  
2.1.3 Medium and agar   
Luria Bertani (LB) broth was prepared with 1.0 % sodium chloride, 1 % (w/v) 
Tryptone (Difco) and 0.5 % (w/v) Yeast extract (Difco) at pH 7.0.  For LB agar, 1.5 
% (w/v) agar (Difco) was added.   
Tryptone soy broth (TSB) was made by dissolving premix formula (Oxoid) 
consisting of 0.5 % (w/v) sodium chloride, 1.7% (w/v) pancreatic digest of casein, 0.3 
% (w/v) papain digest of soybean meal, 0.25 % (w/v) di-potassium hydrogen 
phosphate and 0.25 % (w/v) glucose to 3 % (w/v) with deionised water.  1.5 % (w/v) 
agar (Difco) was added for preparation of tryptic soy agar (TSA). 
SD medium was prepared with 0.67 % (w/v) yeast nitrogen base without amino 
acid (Difco), 2 % (w/v) glucose and appropriate premix amino acid supplements (BD 
Biosciences) at pH 5.8.  SD medium without tryptophan (SD/-Trp) was made with 
0.074 % (w/v) Trp Drop Out (DO) supplement. Similarly, SD/-Leu, SD /-Trp/-Leu, 
and SD/-Trp/Leu/His/Ade media were made with 0.069 % (w/v) Leu, 0.064 % (w/v) 
Trp/Leu and 0.06 % (w/v) Trp/Leu/His/Ade DO supplement, respectively. Whenever 
needed, SD medium was also supplemented with an additional 0.003 % (w/v) adenine 
hemisulfate.  For SD agar, 2 % (w/v) agar (Difco) was added. 
YPD medium was made with 2 % (w/v) peptone, 1 % (w/v) Yeast extract, 2 % 
(w/v) glucose at pH 6.5.  YPDA was prepared by adding 0.003 % (w/v) adenine 
hemisulfate to YPD medium.  For YPD and YPDA agar, 2 % (w/v) agar was added. 
Whenever required, ampicillin and kanamycin were included in the medium or 
agar at concentrations of 100 mg/l and 30 mg/l, respectively, unless otherwise stated.  
For IPTG/X-gal plates, 0.05 % (w/v) IPTG and 0.04 % (w/v) X-gal were included.  
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For X-α-gal plates, 100 μl of a 2 mg/ml stock, which was made by reconstituting the 
powder in dimethylformamide, was spread per plate. 
2.2 Challenging horseshoe crabs with Pseudomonas 
aeruginosa 
2.2.1 Preparation of P. aeruginosa for infection of horseshoe crabs 
A single clone of P. aeruginosa was inoculated into 10 ml of TSB and 
cultured overnight at 37 °C with shaking at 230 rpm. Bacteria was collected by 
centrifugation at 5000 x g for 10 min at 4 °C, washed with 10 ml of saline (0.9 % 
NaCl) and resuspended to the original culture volume in saline. An aliquot of 100 μl 
of this Pseudomonas suspension was serially diluted for enumeration and the rest was 
stored at 4 oC as stock culture for injection of the horseshoe crabs. Aliquots of 100 μl 
of 106, 107, and 108 dilutions were plated on TSA agar and incubated at 37 oC. The 
next day, bacteria was enumerated and the cell density of the 4 oC stock culture was 
calculated accordingly. 
2.2.2 Challenging horseshoe crabs with bacteria 
Horseshoe crabs were infected with P. aeruginosa by intracardial injection. 
Before that, crabs were cleaned and weighed. The septum, which was the site of 
injection was cleaned gently with detergent and disinfected with 70 % ethanol. To 
ensure that the horseshoe crab was free of infection before the treatment, a few drops 
of hemolymph was collected by cardiac puncture prior to bacterial challenge. The 
hemolymph was then plated on TSA plates. Only samples collected from microbial-
free crabs were used for subsequent analysis. A sub-lethal dose, as established by Ng 
(Ng, 2005), of 1.2x106 cfu P. aeruginosa/100 g body weight was used to challenged 
each horseshoe crabs. The volume of bacteria that was administered to each crab was 
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adjusted to 200 µl with saline before injection. Samples collection was performed at 1, 
3, 6, 9, 12, and 24 hour post infection (hpi).  
2.2.3 Collection of amebocytes and other tissues 
Uninfected, which is called naïve hereafter, or infected horseshoe crabs were 
bled for the collection of the amebocytes. The hemolymph was diluted with the same 
volume of anti-coagulation solution (3 % NaCl, 0.125 % N-ethylmaleimide) that was 
prewarmed to 42 oC. The mixture was then incubated at 42 oC for 8 min and 
centrifuged at 150 x g for 10 min. The supernatant was discarded and the amebocytes 
were snap-frozen in liquid nitrogen before storage at -80 oC until use.  
Hepatopancreas, heart, muscle, intestine, and stomach were obtained by 
dissection.  Once removed from the horseshoe crabs, the tissues were immediately 
frozen in liquild nitrogen and stored at - 80 oC until use.   
2.3  Isolation of RNA  
2.3.1 Preparation for RNA purification 
RNA was required for the synthesis of cDNA that was used for cloning 
CrSARM, analysis of tissue distribution and transcript profiling of CrSARM by RT-
PCR. Since RNA is extremely sensitive to RNase contamination, maintenance of 
RNase free condition is very critical for the extraction of good quality RNA. Water 
and solutions were treated with 0.01% of diethylpyrocarbonate (DEPC) overnight at 
37 °C and autoclaved for 2 h to remove residual DEPC. Metal and glass apparatus 
were baked at 200 oC for 4 h. Plastic-wares that were not disposable, were soaked in 3 
% hydrogen peroxide overnight, rinsed thoroughly with DEPC treated water and 
autoclaved for 2 h.  
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2.3.2 Extraction of total RNA 
Tissues were homogenized in Trizol®reagent (Invitrogen) at the ratio of 1 ml 
of Trizol per 100 mg of tissue. Homogenized samples were left at room temperature 
for 5 min so that the nucleoprotein complexes dissociated completely. Chloroform 
(1/5 volume of the homogenate) was then added and the mixture was shaken 
vigorously for 15 s, and incubated at room temperature for 2 min. Next, the mixture 
was centrifuged 1000 x g for 15 min at 4 oC to facilitate phase separation. The top 
colorless aqueous phase, which contained RNA, was carefully transferred to a fresh 
RNase-free tube. RNA was precipitated by incubation with isopropanol (0.5 ml/ 1ml 
of Trizol) for 10 min at room temperature. RNA precipitate was collected by 
centrifugation at 12, 000 x g for 10 min at 4 oC. The gel-like RNA precipitate was 
washed with 75 % ethanol, and pelleted by spinning at 14, 000 x g for 5 min at 4 oC. 
RNA pellet was air-dried for 30 min and stored at – 70 oC.  
The RNA pellet was redissolved in 20 μl of water and pipetted gently for 3 
times and incubated at 60 oC for 10 min. The concentration of the isolated RNA was 
determined by OD reading at 260 nm. To check for protein contamination, RNA 
samples were buffered with 10 mM Tris-HCl (pH 7.0) since stable pH is essential for 
an accurate measurement of A260/A280 ratio. The RNA preparations had acceptable 
quality when the A260/A280 ratio is in the range of 1.9 to 2.1.  
2.3.3 Isolation of messenger RNA 
mRNA was isolated from total RNA using Oligotex®kit (Qiagen). 
Approximately 250 μg of total RNA was used for each preparation. The volume of 
total RNA was adjusted to 250 μl with water. After this, 250 μl of binding buffer (20 
mM Tris-HCl, pH 7.5, 1 M sodium chloride, 2 mM EDTA, 0.2 % SDS) and 15 μl of 
oligotex suspension, which was pre-warmed at 37 °C, were added to the total RNA 
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solution.  The sample was incubated at 70 °C to denature the secondary structure of 
the RNA. mRNAs were then allowed to anneal to the Oligotex beads by incubation at 
room temperature for 10 min. Next, the oligo-dT beads were collected by 
centrifugation for 2 min at 14,000 x g and resuspended in 400 μl of wash buffer (20 
mM Tris-HCl, pH 7.5, 1 M sodium chloride, 2 mM EDTA, and 0.2 % SDS).  The 
suspension was then loaded onto a spin column, which was placed inside a collection 
tube. The solution was removed by centrifugation at 14,000 x g for 1 min. The 
column was transferred to a new collection tube and the beads were washed one more 
time with 400 μl of wash buffer. The column was transferred to another fresh tube for 
elution of the mRNA. Elution was done twice in order to dissociate maximum amount 
of mRNA, which was bound to the oligodT beads. Each time, 50 μl of 70 °C-warmed 
elution buffer (5 mM Tris-HCl, pH 7.5) was added to the column. The beads were 
quickly resuspended by repeated pipetting for four times and the eluted mRNA was 
collected by centrifugation at 14,000 x g for 1 min. The second eluate was collected in 
the same tube with the first one. Since the concentration of mRNA in the eluate was 
low, mRNA was next precipitated with 2.5 volume of 95 % ethanol and 1/10 volume 
of 3M sodium acetate. Precipitation was done at -20 oC overnight. mRNA pellets 
were recovered by centrifugation at 14, 000 x g for 30 min at 4 oC, washed with 500 
μl of 70 % ethanol, and air-dried. mRNA was redissolved in 10 μl of water and stored 
at – 20 °C until use.  
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2.4 Cloning of full-length CrSARM cDNA  
2.4.1 Isolation of expressed sequence tag (EST) that encodes 
CrSARM from the amebocyte subtractive cDNA library 
In order to identify and isolate genes from C. rotundicauda that are 
differentially expressed upon microbial infection, our lab had constructed four 
subtractive cDNA libraries from the two major immune responsive tissues in C. 
rotundicauda: amebocyte and hepatopancreas. These cDNA libraries were generated 
using suppression subtractive cDNA hybridization technique. The experiment was 
performed as described in Ding et al (Ding et al., 2005). Briefly, horseshoe crabs were 
challenged with P. aeruginosa or mock-infected with saline. for three or six hours. 
These time points were chosen based on the report that the acute-phase expression of 
antimicrobial genes occurred in 3-6 hpi in Drosophila (Lemaitre et al., 1997). Tissues 
were isolated from both treatments i.e. Pseudomonas infection and mock-infection. 
For each treatment, samples of the two time points were combined. mRNAs were then 
isolated and used for double stranded cDNA preparation using SMART cDNA 
synthesis kit (Clontech). The double stranded cDNAs were then digested with RsaI, 
which yields blunt-ended cDNA fragments. Next, suppression subtractive cDNA 
hybridization was carried out using PCR-select cDNA subtraction kit (Clontech, 
Figure 2.1). The tester cDNA, which contained differentially expressed transcripts, 
was divided into two equal potions. Each aliquot was ligated to either adaptor-1 or 
adaptor-2, briefly denatured, and separately hybridized with the denatured driver 
cDNA, which serves as the reference for the subtraction, with the ratio of 1 tester : 40 
driver. The two hybridization mixtures were then combined before freshly denatured 
driver cDNA was added to enrich the differential expressed transcripts. Subsequently, 
secondary hybridization mixture was subjected to PCR using primers that are 
complement to adaptor-1 or adaptor-2. Since only the cDNA of the differential 
 34
transcripts harboured different adaptors on each end, they were to selectively amplify, 
and cloned into pGEM-T Easy vector (Promega).  
Using the above principle, genes that were differentially upregulated or 
downregulated in C. rotundicauda amebocyte and hepatopancreas in response to P. 
aeruginosa infection were clustered into amebocyte-/hepatopancreas-forward and 
amebocyte-/hepatopancreas-reverse libraries, respectively. By comparing sequences 
of cDNA clones from these substractive libraries with known gene sequences 
deposited in the GeneBank, a broad spectrum (more than 400 non-redundant ESTs) of 
microbial infection responsive genes from the horseshoe crabs was revealed.  
In this study, an EST clone (AmeR209) that was homologous to human 
SARM (GeneBank accession number: AAR17520), was identified and isolated from 
the amebocyte reverse library. It is henceforth referred to as the C. rotundicauda 
SARM (CrSARM). Conserved Domain Database Blast identified a TIR domain 
within the amino acid squence encoded by AmeR209. The CrSARM TIR domain 
showed high homology to TIR domain located at the C-terminal of SARM homologs 
from other organisms. Subsequently, this EST, which was 617-nucleotide long, was 
used as a probe to screen the phage amebocyte cDNA library and as a template to 
design primer for rapid amplification of cDNA ends (RACE) PCR in order to obtain 




Figure 2.1 Supression subtraction cDNA hybridization  
Figure is adapted from the user manual for PCR-select cDNA subtraction kit (Clontech) 
 
2.4.2 Cloning of 3’ end of CrSARM by phage cDNA library 
screening  
Screening of phage amebocyte cDNA library using EST clone AmeR209 as a 
probe was one approach to clone full-length cDNA of CrSARM. This library was 
constructed using SMART cDNA Library Construction kit (Clontech). The cDNA 
was synthesized from the RNA of the amebocytes collected from the uninfected 
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horseshoe crabs, cloned into λ TriplEx2TM phagemid vector, and packed in λ phages 
using Gigapack® III Gold Packaging Extract (Stratagene). The titer of this library was 




















Figure 2.2 Screening of the phage cDNA library  
 
1. Transfect XL1-Blue E. coli with the phage cDNA library 
2. Plate the cDNA library on LB agar plates for plaque formation 
3. Plaque lifting using positive charge nylon membrane 
4. Hybridize the membrane with [32P]-labeled probes 
5. Detect signal on the membrane by autoradiograph 
6. Pick positive plaques for phage elution
7. For each plaque, repeat the screening cycle (step 1 - 6) until single clone is isolated 
8. Convert λTriplEx2 phagemid to pTriplEx2 plasmid  
9. Sequencing 
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Preparation of [32P]-labeled probe 
AmeR209 was released from pGEM-T Easy plasmid by restriction digest with 
restriction enzyme NotI and EagI. The released fragment was separated from the 
linearised vector by eletrophoresis on 1.2 % agarose gel and purified using QIAquick 
gel extraction kit (Qiagen). The DNA fragment was then used as template to 
synthesize [32P]-labeled probes using Rediprime II Random Prime Labelling system 
(Amersham Biosciences). In brief, 25 ng of DNA was diluted to 45 μl in TE buffer 
(10 mM Tris-HCl, 1 mM EDTA, pH 8.0), denatured for 5 min at 95 oC and cooled on 
ice for 5 min. After this, denatured DNA and 50 μCi of Redivue [32P] dCTP were 
added to the reaction mixure that contained exonuclease free Klenow enzyme, dATP, 
dGTP, dTTP and random primers. The tube was then incubated at 37 oC for 1.5 h. 
When labeling reaction was completed, free nucleotides were removed by Qiaquick 
nucleotide removal kit (Qiagen). The radioactive labeled probe was stored at 4 oC 
until use.  
Screening the phage amebocyte cDNA library  
(a) Preparation of host bacteria 
E. coli XL1-Blue was used as host bacteria to which the phage amebocyte 
cDNA library was transfected. To prepare for transfection, a single colony of E. coli 
XL1-Blue was inoculated into 25 ml of LB-broth containing 0.2 % maltose and 10 
mM MgSO4. The culture was incubated at 37 oC with 200 rpm shaking until OD600 
reached 1.0. Cells were collected by centrifugation at 500 x g for 10 min, resuspended 
in 10 mM MgSO4 to OD600 of 0.5. These cells were stored at 4 oC and used for 
transfection within 2-3 days.  
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(b) Plating the phage amebocyte cDNA library for primary screening 
One million phages were plated on twenty 150 mm LB plates for primary 
screening. Each plate was prepared by incubating 50,000 phages with 600 μl of E. 
coli XL1-Blue at 37 oC for 15 min. Next, 5 ml of the top agarose (LB + 0.07 % 
agarose), which was prewarmed to 50 oC, was added and the tube was inverted 
several times for mixing. The phage/bacteria mixture was then quickly poured onto 37 
oC-pre-warmed LB plate. The plate was swirled gently so that the top agarose spread 
evenly. The plates were incubated at 37 oC until the plaques were visible (around 12 
h), then chilled to 4 oC for 2 h before the plaques were transferred onto nylon filters.  
(c) Plaque lifting 
Colony/Plaque ScreenTM (Perkin-Elmer) membranes, a positively-charged 
nylon filter, were used for plaque lifting. The membrane was carefully overlaid onto 
the plaque surface for 1 min. The position of the membrane was marked by stabbing a 
needle through it and the agar at three asymmetric positions. After that, the membrane 
was removed from the plate. Then, with the plaque side up, the membrane was 
immersed successively in denaturation solution (0.5 N NaOH, 1.5 M NaCl) for 2 min, 
neutralization solution (1.5 M NaCl, 0.5 M Tris, pH 7.4) for 5 min, washed twice, 
each time with 2X SSC (300 mM NaCl, 30 mM Na3-citrate) for 30 s, then dried on 
3MM Whatman paper. Subsequently, the DNA was fixed to the filter by UV-
crosslinking.  
(d) Hybridization of [32P]-labeled probe to the filter 
The membrane was moistened in 2 x SSC for 5 min then placed in the 
hybridization bottle (Hybaid). For prehybridization, the membrane was rotated in 50 
ml of prehybridization buffer (5 x SSC, 1 % SDS, 100 μg/ml calf thymus DNA, 0.1 % 
Ficoll 400, 0.1 % bovine serum albumin (BSA), and 0.1 % polyvinylpyrrolidone) at 
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65 oC for 2 h. The buffer was then replaced by 10 ml of prewarmed, fresh 
prehybridization buffer. Next, [32P]-labeled probe, which was denatured for 10 min at 
100 oC and then snap-chilled on ice for 5 min, was added. Hybridization was carried 
out at 65 oC overnight. The membrane was then subjected to successive stringent 
wash with 2 x SSC, 0.1 % SDS at room temperature for 20 min; 1 x SSC, 0.1 % SDS 
at 37 oC for 20 min; 0.2 x SSC, 0.1 % SDS at 42 oC for 15 min; and 2 x SSC at room 
temperature for 15 min. After washing, the membrane was exposed to X-ray film 
(Fuji) and developed using Kodak X-Omat 3000 RA autoradiographic processor.   
(e) Screening for and procurement of positive plaques 
The location of positive plaques was determined by lining up the film with the 
respective plate. The putative plaques were removed from the plate by using the large 
end of the yellow pipette tip to cut through the agar. Next, the agar piece was placed 
in 1 ml of SM buffer (50 mM Tris-HCl, pH 7.5, 100mM NaCl, 8mM MgSO4, 0.01% 
gelatin) and 20 μl of chloroform, vortexed vigorously, and incubated at 4 oC overnight 
for phage elution.  
(f) Secondary screening 
Due to the high density of plaque forming units on the primary screening 
plates, it was necessary to perform a second round of screening in order to 
authenticate the positive plaques as the single clones.  Phage elution from primary 
screening was diluted 1000 times in SM buffer to ensure the plaques would be well-
separated. An aliquot of 3 μl of the diluted phage was used to infect 600 μl of the host 
bacteria as described before. Secondary screening was carried out similarly as the 
primary screening. Putative plaques were picked using the small end of the yellow 
pipett tip and eluted in 500 μl of SM buffer and 20 μl of chloroform.  
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(g) Conversion of λTriplEx2 phagemid to pTriplEx2 plasmid 
In order to determine the sequence of the cDNA harboring by the putative 
plaques, conversion of λTriplEx2 phagemid to pTriplEx2 plasmid was necessary to 
facilitate the stable propagation in E. coli. This conversion involved in vivo 
recombination of the loxP sites that flanked the pTriplEx2 plasmid, which was 
embedded inside the λTriplEx2 phagemid, resulting in the release of the plasmid.      
E. coli BM25.8 was used as the host bacteria since it expressed Cre recombinase that 
was essential for the recombination event (Figure 2.3). The single clone of E. coli 
BM25.8 was cultured at 31 oC in 10 ml of LB broth with shaking at 150 rpm. When 
the OD600 reached 1.1-1.4, 10 mM of MgCl2 was added to the culture. Next, 150 μl of 
eluted phages were combined with 200 μl of host cell culture. The phage/host mix 
was incubated at 31 oC for 30 min without shaking. Another aliquot of 400 μl of LB 
broth was then added before the mixture was incubated for 1 h at 31 oC with shaking 
at 230 rpm. After that, 10 μl of the infected cell suspension was spread on an LB-
ampicillin (100 μg/ml). The culture was incubated overnight at 31 oC and 
subsequently, a single colony was isolated from the plate, grown overnight in LB-
ampicillin broth, and subjected to plasmid isolation using Wizard plus SV miniprep 
(Promega). The insert cDNA was sequenced using Lamda TriplEx2 sequencing 
primers (Clontech) in BigDye Terminator v3.1 (Applied Biosience) sequencing 
reaction with an ABI Prism 3100A model sequencer. The sequence was analyzed with 
DNAMAN version 4.15 software. Vector sequence was manually removed from the 












Figure 2.3 Conversion of λTriplEx2 phagemid to pTriplEx2 plasmid. 
Figure is adapted from instruction manual for SMART cDNA library construction kit 
(Clontech) 
2.4.3 Cloning of 5’ end cDNA by RACE PCR 
The 5’end of CrSARM was obtained using BD SMART™ RACE cDNA 
amplification kit (Clontech). To generate first strand cDNA for 5’-RACE PCR 
reaction, a 10 μl reaction mixture was set up with 2.0 μg of total amebocyte naive 
RNA, 12 pmols of 5’-CDS primer (5’-(T)25VN-3’), 12 pmols of BD SMART II A 
Oligo (5’-AAGCAGTGGTATCAACGCAGAGTACGCGGG-3’), BD PowerScript 
reverse transcriptase, 2 mM dithiothreitol (DTT) and 1 mM dNTP mix in 1 x First 
strand buffer (50 mM Tris-HCl, pH 8.3, 6 mM MgCl, 75 mM KCl). cDNA synthesis 
was carried out at 42 oC for 1.5 h, followed by 72 oC for 7 min. The reaction mixture 
was then diluted in 50 μl of water and stored at – 20 oC until use.  
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RACE PCR was performed with the gene-specific reverse primer, TIR-5RACE 
(5’-CGGAAGACCAACTGGAAGAGGTCTGTGG-3’), which was complementary 
with the sequence close to the 5’ end of the AmeR209 clone (Figure 3.1-B), and the 
universal primer mix (UPM), which was the mixture of the long (5’-
CTAATACGACTCACTATAGGGCAAGCAGTGGTATCAACGCAGAGT-3’) and 
the short (5’-CTAATACGACTCACTATAGGGC-3’) oligonucleotides. The 
underlined sequence of the long oligonucleotide is complementary to the sequence 
introduced at the 5’-end of the first strand cDNA product by BD SMART II A Oligo 
primer. An aliquot of 50 μl of the 5’-RACE PCR was set up with 2.5 μl of first strand 
cDNA, 1 μl of 10 mM TIR-5RACE primer, 5 μl of 10 x UPM (0.4 mM of long and 
2.0 mM of short oligonucleotide), 0.2 mM dNTP mix, and 1 μl of 50 x BD 
Advantage 2 Polymerase Mix (BD TITANIUM Taq, 1 μg/ml TaqStart Antibody, and 
small amount of proof reading polymerase) in 1 x Advantage 2 PCR Buffer (40 mM 
Tricine-KOH, pH 8.7, 15 mM KOAc, 3.5 mM Mg(OAc)2, 3.75 μg/ml BSA, 0.005% 
Tween 20, 0.005% Nonidet-P40). Standard PCR program of one cycle at 95 °C for 30 
s, followed by 30 cycles of denaturation at 95 °C for 10 s, annealing at 65 °C for 30 s 
and extension at 72 °C for 3 min, and termination with one cycle at 72 °C for 10 min, 
was performed. The PCR product was loaded on a 1.2 % agarose gel. A band at ~ 2.5 
kb was isolated from the gel using QIAquick gel extraction kit (Qiagen). Before being 
cloned into pGEM-T Easy (Promega), the DNA fragment, which was blunt-ended 
due to the presence of proof reading polymerase in the Advantage polymerase mix, 
was subjected to A-tailing. Gel-purified DNA was concentrated to 7 μl using a 
speedvac, then, combined with 0.2 mM dATP, 5 U of Taq DNA polymerase, and 1 x 
Thermopol buffer (NEB) in 10 μl reaction mix. The tube was incubated at 70 oC for 
30 min. Subsequently, 3.0 μl of A-tailing products was cloned into 50 ng of pGEM-T 
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Easy vector using 3 U of T4 DNA ligase and Rapid Ligation buffer (Promega). 
Ligation was carried out at 4 oC, overnight. The ligation mixture was then 
transformed into 100 μl of competent E. coli Top10 and spread on LB-Xgal-IPTG-
ampicillin plates for blue/white colony selection. White colonies were selected for 
colony PCR with T7 and SP6 primers, which are complement to sequences flanking 
the multiple cloning sites of pGEM-T Easy vector. Subsequently, the plasmids were 
isolated from positive clones and sequenced with T7 and SP6 primers. Based on these 
sequences, two internal primers, TIR-17-F1 (5’-CTGAAGTCAGACAGAAG-3’) and 
TIR-17-R1 (5’-GGATCATGACTAGCAAT-3’), were designed to obtain the 
sequence in the middle of the insert. Finally, the sequence of the 5’RACE product 
was determined by multiple alignment of all of these fragmented sequences.  
2.4.4 Reconstitution of full-length cDNA of CrSARM by in silico 
assembly of the partial sequences  
The sequences of clone AmeR209, H3-2.1 and TIR-5RACE#17, which were 
obtained from the characterization of the EST library, phage library screening and 
5’RACE PCR, respectively, were aligned using DNAMAN software. These three 
sequences were combined based on the overlapping regions. The contiguous 
sequence was then conceptionally translated in six reading frames, three for sense and 
three for antisense strand. The full-length open reading frame (ORF) was defined as 
the longest ORF with the poly-adenine tail downstream of its stop codon. There 
should be a stop codon located just upstream from its real start codon. In addition, 
Blastp search was performed to further validate that the amino acid sequence encoded 
by the full length ORF was indeed homologous to SARM homologues from other 
organisms. Next, the domain architecture of the full length CrSARM protein was 
predicted by CDD search and domain boundaries were determined by Globplot 
software.  
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2.5 Phylogenetic analysis of CrSARM 
To investigate the evolutionary relationship between CrSARM and its 
homologues, multiple sequence alignment was performed to compare the degree of 
sequence homology between them. The amino acid sequences were obtained from the 
NCBI database. Their annotations and accession numbers are listed in Table 3.1. 
Whenever the sequences were supported by a publication the annotations were 
according to the published reference. Sequence alignment was performed using 
Clustal X (version 1.81) with the default parameters. Based on the alignments, 
unrooted phylogenetic trees were constructed using neighbor-joining method (Saitou 
and Nei, 1987). Bootstrap tests at 1000 replicates were carried out to examine the 
validity of the branching topologies. The “Correction for multiple substitution” option 
was selected to optimize the calculation of the evolutionary distances.   
2.6 Characterization of tissue distribution of SARM 
CrSARM was initially cloned from the amebocyte. In order to determine 
whether CrSARM is expressed in tissues other than the amebocytes, the presence of 
CrSARM transcript in hepatopancreas, heart, stomach, intestine and muscle was 
studied by RT-PCR. 
2.6.1 Synthesis of first strand cDNA from mRNA 
First strand cDNAs of various tissues were synthesized using SuperScript™ 
First-Strand Synthesis System (Invitrogen).  For each tissue, 20 μl reaction mixture 
was set up with 300 ng of mRNA, 0.5 mM dNTP mix, 500 ng of oligo(dT)12-18 
primers, 5 mM of MgCl2, 10 mM DTT, 40 units of RNaseOUT™ recombinant RNase 
inhibitor and 50 units of SuperScript™ II reverse transcriptase in 1X RT buffer (20 
mM Tris-HCl, pH 8.4, 50 mM KCl). Reverse transcription reaction was carried out 
for 50 min at 42 oC and terminated by incubation at 70 oC for 15 min. Next, RNA was 
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removed by incubation the reaction mixture with 2 units of RNase H at 37 oC for 20 
min. First strand cDNA was stored at - 20 oC until use.  
2.6.2 Analysis of tissue distribution of CrSARM  
Expression of CrSARM in various tissues was assessed by PCR using 
CrSARM gene specific primers, TIR-F1 (5’-AGACGTAGAGAGGCTCGAAGC-3’) 
and TIR-R1 (5’-TGTTCCCAGGGTCTTTCTTGT-3’). For each tissue, 10 μl reaction 
mixture consisting of 0.5 μl of first strand cDNA, 200 nM of dNTP mix, 600 nM of 
each primer, 0.35 units of Taq DNA polymerase (NEB) in 1 X Thermopol buffer 
(20 mM Tris-HCl, pH 8.8, 10 mM (NH4)2SO4, 10 mM KCl, 2 mM MgSO4, 
0.1 % Triton X-100) was set up. PCR was performed under the following conditions: 
initial denaturation at 94 oC for 5 min, followed by 35 cycles of denaturation at 94 oC 
for 30 s, annealing at 60 oC for 30 s, and extension at 72 oC for 1 min. For positive 
control, PCR was done with ribosomal protein L3 (RbL3) specific primers: RiboF (5’-
TGTTTCTTCAGAGGACCCA3’) and RiboR (5’- CACCAAGAAGTTGCCTCG -3’) 
using the same conditions as for CrSARM. PCR products were resolved by 
electroporation on a 1.2 % agarose gel. Amplicons of 540 and 450 bp in size were 
expected for CrSARM and RbL3, respectively.  
2.7 Trascriptional profiling of CrSARM in the amebocyte upon 
Pseudomonas infection  
The identification of CrSARM EST in the amebocyte subtractive cDNA 
library (as described in section 2.4.1) suggested that CrSARM gene was differentially 
regulated in response to pathogen invasion. Monitoring the level of CrSARM 
transcript during infection would reveal the kinetics of this regulation, thus, assisting 
the functional study of this molecule. 
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Changes in the transcription level of CrSARM were studied by semi-
quantitative RT-PCR. RbL3 was used as an internal normalization standard to 
eliminate sample-to-sample variations in the initial cDNA concentrations. Firstly, 
mRNAs were isolated from naïve, 1, 3, 6, 9, 12, 24 hpi amebocytes (section 2.2.3 & 
2.3). For each time point, mRNAs from three individual animals were then pooled 
together before first strand cDNAs were prepared. Pooling was to neutralize the 
individual variation between the crabs. Next, PCR amplification of CrSARM and 
RbL3 were done as described section 2.6 except that the number of PCR cycles was 
reduced to 28 for the former and 23 for the later to avoid the saturation of PCR 
product. PCR products were resolved on 1.2 % agarose gel, stained with ethidium 
bromide. Gel image was acquired and analyzed by Image Master VDS version 2.0 
software (Pharmacia Biotech). Band intensities were quantified and expressed as 
intergrated optical density (IOD). For normalization, ratio between CrSARM and 
RbL3 IODs was calculated for each time point. The change in transcription level 
during the course of infection was depicted as ratio of the infected sample to the naïve 
sample. Three independent experiments were performed. Mean and standard 
deviation were determined after normalization to RbL3.  
2.8 Identification of protein interaction partners of CrSARM 
by yeast two hybrid assay 
Yeast two hybrid assay is a widely used technique for the identification of 
novel interaction partners of a protein. This method overcomes some problems 
associated with the in vitro pull-down assay such as the difficulty of obtaining  cDNA 
encoding the protein interaction partners,  the low abundance of protein involved in 
the interaction, and the lack of glycosylation of recombinant proteins expressed in a 
bacterial system.  
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GAL4-based yeast two hybrid system (BD MatchmakerTM Construction and 
Screening Kit, Clonetech, Figure 2.4) was used to discover interaction partners of 
SARM. GAL4 is a yeast transcription factor consisting of two structurally and 
functionally distinct domains, namely DNA-binding domain (BD) and transcription 
activation domain (AD). For yeast two hybrid assay, the bait gene was cloned in 
frame with the GAL4 BD in pGBKT7 vector and transformed into yeast reporter 
strain Y187. A cDNA library was created in yeast reporter strain AH109 as a 
recombinant construct with pGAD7-Rec vector, which expresses protein as a fusion 
with GAL4 AD. Hybrids formed as a result of the library and the bait mating were 
selected on SD medium that lack of Ade, Trp, His, and Leu (Quadruple Dropout 
Medium or QDO). Only hybrids in which GAL4 DNA-BD and GAL4 AD was 
brought to proximity by the interaction between the bait and the prey grew on QO 
medium due to the activation of reporter genes. Positive clones were further verified 
by streaking on to QDO medium containing X-α-gal (Figure 2.4). Nucleotide 
sequence of the prey was determined by sequencing pGAD7-Rec recombinant 
plasmid rescued from the hybrid. Figure 2.5 is the overview of the yeast two hybrid 
screening process, the detail of which will be described in the following sections.  
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Figure 2.4 Principle of GAL4-based yeast two hybrid system  
(A) Gene encoding the protein of which the interaction partners are unknown is cloned in 
frame with GAL4-DNA binding domain (BD) of the pGBKT7 vector. (B) cDNA library is 
cloned downstream of GAL4-activation domain (AD) of the pGADT7-Rec vector. Screening 
can be performed by either mating or co-transformation. (C) Interaction between the bait (X) 
and the putative prey (Y) brings GAL4-AD and GAL4–BD in close proximity, resulting in 
the activation of the reporter genes, and thus (D) the growing of positive clones on selective 







Figure 2.5 Overview of yeast two hybrid screening assay for identification of putative 
interaction partners of CrSARM 
 
2.8.1 Synthesis of amebocyte 3 hpi double stranded cDNA library 
Double stranded cDNA library for yeast two hybrid was generated from 
mRNA of 3 hpi amebocyte. This source of mRNA was selected since the transcription 
profile showed an upregulation of CrSARM in the amebocyte shortly after 
Pseudomonas infection. This cDNA library was anticipated to harbour a possibility 
for the isolation of interaction partners of CrSARM . 
Construction of cDNA library
Generate different bait constructs 
of in pGBKT7 vector 
Transform into either Y187 or AH109 
S. cerevisiae  
Check for: 
• Expression in yeast by western blot 
• Transactivation activity i.e. 
autoactivation of the reporter genes 
• Toxicity to the yeast host 
Synthesize ds cDNA Ame 3 hpi 
cDNA library 
Construction of CrSARM baits
Co-transform the library and the 
linearized pGADT7-Rec vector into 
AH109 S. cerevisiae 
Havest the yeast library and 
determine the library titer 
Mate pGBKT7-bait/Y187 with pGADT7-cDNA/AH109 
Select for hybrids that grow & turn blue on QDO/X-gal plate 
Identify cDNA sequences of the pultative preys by sequencing 
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Synthesis of first-strand cDNA 
A mixture of 1.0 μg of mRNA and 10 pmols of CDS III oligo (dT) primer (5’-
ATTCTAGAGGCCGAGGCGGCCGACATG-d(T)30VN-3’) was prepared. Then 2.0 
μl of 5X First-Strand Buffer (250 mM Tris, pH 8.3; 30 mM MgCL; 375 mM KCl), 
1.0 μl of 20 mM DTT, 1.0 μl of 10 mM dNTP Mix and 1.0 of Moloney Murine 
Leukemia Virus (MMLV) Reverse Transcriptase were added. The reaction mixture 
was incubated for 10 min at 42 oC before 10 pmol of SMART IIITM Oligonucleotide 
(5’-AAGCAGTGGTATCAACGCAGAGTGGCCATTATGGCCGGG-3’) was added. 
The reaction was then subjected to PCR in a hot-lid thermal cycler (MJ Research) for 
1 hr at 42 oC followed by 15 min at 75 oC. After cooling to room temperature, the 
parental mRNA was removed by incubating the reaction mixture with 2 U of RNase 
H at 37 oC for 20 min. The first-strand cDNA was stored at – 20 oC until use.  
Generation of double-stranded cDNA library  
The second strand of cDNA was synthesized from the first-stranded template 
in two of 100 μl reactions. Each reaction consisted of 2 μl of first-strand cDNA, 1 x 
Advantage 2 PCR Buffer, 0.2 mM dNTP, 0.2 μM of 5’ PCR primer (5’-
TTCCACCCAAGCAGTGGTATCAACGCAGAGTGG-3’), 0.2 μM and 3’ PCR 
primer (5’-GTATCGATGCCCACCCTCTAGAGGCC GAGGCGGCCGACA-3’), 
1X GC-melt solution and  2 μl  of 50 x BD Advantage 2 Polymerase Mix. The 
reaction mixtures were subjected to a PCR program of 1 cycle of 95 °C for 30 s, 21 
cycles of 95 °C for 10 s, 68 °C for 6 min (with additional 5 s added per successive 
cycle), 1 cycle of 68 °C for 5 min.  Upon completion, the PCR product was pooled 
and 7 μl was analyzed on an agarose gel while the rest was stored at – 20 °C until 
purification. 
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Purification of double-stranded cDNA 
The double-stranded cDNA library was purified and size-fractionated using 
BD Chroma SpinTM TE-400 column, which was pre-packed with resins that facilitated 
the selection of DNA molecules longer than 200 bp. The gel matrix in the spin 
column was resuspended thoroughly before the column was centrifuged in a swinging 
bucket centrifuge for 5 min at 700 x g to re-establish the gel bed. Ninety five μl of 
PCR product was carefully applied to the center of each column. The columns were 
then spun at 700 x g for 5 min. The flow-through, which was purified cDNA library, 
was collected and pooled in a single tube for ethanol precipitation with 2.5 volume of 
95 % ethanol (- 20 °C) and 1/10 volume of sodium acetate (3 M; pH 4.8). The cDNA 
was precipitated at - 20 °C overnight and recovered by centrifugation for 20 min at 14, 
000 x g at room temperature. The supernatant was removed and the pellet was air 
dried for 30 min before reconstitution in 20 μl of deionized water. The purified cDNA 
was stored at - 20 °C until being used for in vivo recombination with pGADT7-Rec 
plasmid in the yeast.  
2.8.2 Generation of GAL4 fusion library in Saccharomyces 
cereviseae AH109 strain  
Using strain AH109, an yeast recombinant library was generated by co-
transformation of double-stranded cDNA library and Sma I-linearized pGADT7-Rec 
plasmid. In vivo recombination between homologous sequences at the ends of cDNAs 
and the linear plasmid would yield a functional GAL4 AD expression plasmid.  
Yeast competent cells were prepared using YEASTMAKERTM Yeast 
Transfomation System 2 (Clontech). Three ml of YPDA medium was inoculated with 
one fresh colony of AH109 yeast strain and incubated with shaking at 230 rpm for 8 h 
at 30 °C. Five μl of the overnight culture was transferred to 50 μl of YPDA. The 
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culture was then grown with shaking at 230 rpm at 30 °C until the OD600 reached 0.2 
(~18 h). After that, cells were collected by centrifugation at 700 x g for 5 min at room 
temperature and resuspended in 100 ml of fresh YPDA. Yeast was incubated for 
another 4 h until the OD600 of 0.49. The cells were collected by centrifugation and 
washed with 60 ml of sterile water before resuspension in 3 ml of 1.1 X TE/LiAc 
solution, which was freshly prepared by mixing 1.1 ml of 10 X TE ( 0.1 M Tris-HCl, 
10 mM EDTA, pH 7.5) with 1.1 ml of 1 M LiAc. Next, the cell suspension was 
centrifuged at 14, 000 x g for 15 s. The cell pellets were resuspended in 600 μl of 1.1 
X TE/LiAc solution. Competent yeast was now ready for transformation.  
Cotransformation was performed by combining 20 μl of double stranded 
cDNA, 6 μl of Sma I-linearized pGADT7-Rec plasmid, 20 μl of herring testes carrier 
DNA, which was pre-denatured by heating at 100 oC two times for 5 min each, snap-
chilled, and added to 600 μl of competent cells in a prechilled 15-ml tube. The tube 
was gently vortexed and 2.5 ml of PEG/LiAc solution, which was freshly prepared by 
combining 8 volumes of 50 % PEG with 1 volume of 10 X TE buffer and 1 volume of 
1M LiAc, was added. The mixture was briefly vortexed before incubating at 30 oC for 
45 min with gentle mixing every 15 min. To the mixture, 160 μl of DMSO was added 
and the cells were left in a 42 oC water bath for 20 min with gentle votexing at every 
10 min interval. Cells were collected by centrifugation at 700 x g for 5 min then 
resuspended in 3 ml of YPD Plus liquid medium (Clonetech). Yeast was then 
incubated at 30 oC, 230 rpm for 90 min. After that, the cells were collected by 
centrifugation and resuspended in 30 ml of 0.9 % NaCl. A 150 μl of this suspension 
were plated on each of 150-mm SD/-Leu agar plates for selection of GAL4 fusion 
transformants. The plates were incubated at 30 oC for 5 days and stored at 4 oC for 5 h 
before the transformants were collected.  
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Harvesting of the library was done by adding 5 ml of Freezing Medium (YPD 
medium, 25% (v/v) glycerol) to each of SD/-Leu plate. Yeast was scraped from the 
agar surface by gently shaking the plates with sterile glassbeads. After that, the yeast 
suspensions were collected and combined. Next, the cell density of the yeast library 
was determined by using Neubauer hemacytometer counting chamber to be 1.5 x 108 
cells/ml. One ml aliquots of the library were then prepared for storage at – 80 oC.  
2.8.3 Generation of pGBKT8-bait constructs 
 Cloning of the baits into pGBKT7 vector 
In order to identify protein partners that associated with CrSARM, cDNAs 
encoding the ORF of full length CrSASM and individual domains of CrSARM (ARM, 
SAM and TIR) were sub-cloned into pGBKT7 vector. Since the full length construct 
was failed to expressed in yeast, shorter cDNA sequence encoding for three putative 
domains made of CrSARMs but not 443 residues at the N-terminal, was also cloned 
into pGBKT vector. This construct is, thus, named as CrSARM-AST (Figure 2.6).  
 
Figure 2.6 Schematic diagram of cDNA constructs of the baits  
On the left are the names of the constructs that were cloned in pGBKT7 vector. Drawing is 
not to scale.  
 







Nucleotide sequences encoding for the baits were amplified from first strand 
cDNA that was synthesized from the naïve amebocyte mRNA (section 2.6.1) using 
iProofTM high-fidelity DNA polymerase (Bio-RAD) and primers with appropriate 
restriction enzyme sites (Table 2.1). For each fragment, 20 μl reaction mixture was set 
up with 0.2 mM dNTP, 0.4 U of iProof DNA polymerase, 100 ng of DNA template 
and 0.5 μM of each of the forward and reverse primers in 1 X iProof HF buffer (Bio-
RAD). The standard PCR program of one cycle of 98 oC for 30 s followed with 35 
cycles of denaturing at 98 °C for 10 s, annealing for 30 s and extension at 72 °C (refer 
to Table 2.1 for detail of annealing time and extension time of each fragment) and 
final extension at 72 °C for 5 min was ran. The PCR products were resolved on 
agarose gel and the band of interest was extracted from the gel by QIAquick gel 
extraction kit (Qiagen). After gel purification, PCR products were cloned into 
pGEMT-Easy vector before they were digested with appropriate restriction enzymes 
and cloned into pGBKT vector. Due to the presence of proof reading enzyme in 
iProof polymerase mix, possible blunt-ended PCR products were subjected to A-
tailing procedure, followed by TA cloning into pGEM-T Easy vector and 
transformation into E. coli Top10. The DNA sequence of the insert was confirmed as 
describe before (2.4.3). Next, the excision of the inserts from pGEM-T Easy vector 
was performed by restriction enzyme digestion with NdeI and BamHI or NdeI and 
EcoRI to isolate CrSARM-ORF, CrSARM-AST, ARM and TIR, respectively. SAM 
was released by simultaneous digestion with BamHI and EcoRI. pGBKT7 vector was 
also linearized with the compatible enzymes in order to received the respective insert. 
After restriction digestion, the linearized inserts and vectors were gel-purified and 
ligated at 4 oC, overnight using T4 DNA ligase (Roche). The ligation reactions were 
set up with the insert : vector molar ratio of 8 : 1 for CrSARM-ORF; 5 : 1 for 
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CrSARM-AST, SAM and TIR; 3 : 1 for ARM. Subsequently, the ligation mixtures 
were transformed into E. coli Top10 and plated onto LB-Kanamycin (30 μg/ml) for 
selection of positive clone. Colony PCR and sequencing were performed to confirm 
the success of the ligation. 
Table 2.1 PCR amplification for cloning of bait fragments to pGBKT7 














(aa. 444 to 
1039) 
Sense: ARM-F-Nde 






(aa 444 to 570) 
Sense: ARM-F-Nde 
(5’-CATATGAATAGAGCTTACGTTGTGGA-3’)   
Antisense: ARM-R-Bam 




(aa 570 to 846) 
Sense: SAM-F-Eco 
(5’-GAATTCAACAAAGAGATAGAATTTGCAG-3’)   
Antisense: SAM-R-Bam 




(aa 847 to 988) 
Sense: TIR-F-Nde 





Restriction sites are underlined. 
Checking the baits for the expression in yeast, transcriptional activation 
and potential toxicity  
Before proceeding with the yeast two-hybrid library screening, one must 
ensure that that the baits were expressed properly in the yeast and their expression 
does not hamper the growth of the host strain, which is Y187. In addition, it is 
important to check that baits themselves are not able to activate the expression of 
ADE3 and HIS2 reporter genes since the putative interactions are isolated based on 
the transcription activation of these nutrient markers.  
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Firstly, pGBKT7-CrSARM, -AST, -ARM, -SAM, -TIR and the pGBKT7 
vector backbone as a negative control for transcriptional activation test, were 
transformed into strain Y187 and AH109 using small-scale transformation protocol. 
This was done by incubating 50 μl competent yeast cells with 1.0 μg of either empty 
pGBKT7 or recombinant pGBKT7 plasmids, 50 μg of denatured herring testes carrier 
DNA and 100 μl of PEG/LiAc solution at 30 oC for 30 min with gentle vortexing 
every 10 min. 20 μl of DMSO was added into each sample before the cells were heat-
shocked at 42 oC for 15 min. The cells were collected by centrifugation at 14, 000 x g 
for 15 s, resuspended in 1.0 ml of YPD Plus liquid medium (Clontech), and incubated 
at 30 oC with 230 rpm shaking for 90 min and spun down and resuspended in 1.0 ml 
of 0.9 % NaCl. The transformants were selected on SD minimal medium lacking of 
tryptophan (SD/-Trp) agar plates. 
The expression of the baits in Y187 was detected by western blotting. To 
prepare for the yeast cell lysate, a single colony of Y187 transformant was picked 
from SD/-Trp plate and inoculated 5 ml of SD/-Trp broth. The cultures were grown at 
30 oC with shaking at 250 rpm until the OD600 reached 1.0. The cells were collected 
by centrifugation at 10 000 x g for 5 min, washed with 5 ml of water and transferred 
to an eppendorf tube. Cell pellets were resuspended in 1 volume of lysis buffer (20 
mM MOPS, pH 7.3, 0.1 mM EDTA, 1 mM PMSF, 1 x cocktail protease inhibitor 
(Roche) and 1 volume of glass beads. Cell lysis were achieved by vortexing the 
mixtures six times for 30 s each. The tubes were chilled on ice for 30 s in between 
each vortexing.  
The crude cell lysates were used for western blotting. One volume of 2 x SDS 
loading buffer was added to the cell lysates. The mixtures were boiled for 5 min, 
centrifuged for 10 min at 14 000 x g. The supernatants were resolved on 12 % SDS-
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PAGE. After the eletrophoresis, the proteins were transferred to PDVF membrane 
(GE Healthcare) by electro-transferred. The membrane was prewet in methanol before 
putting on top of the gel. The transfer was done in a Trans-Blot Electrophoretic 
Transfer Cell (BioRad) at a constant voltage of 70 V for 1 h with the transfer buffer 
containing 25 mM Tris-base, 192 mM glycine, 20 % methanol.  After transfer, the 
membranes were blocked with the blocking buffer( 3 % w/v skimmed milk in 0.1% 
Tween 20 in Phosphate buffer saline, pH 7.2 (PBST)) for 1 h, followed by overnight 
incubation with mouse monoclonal anti-myc antibody (Invitrogen), which was diluted 
5000 times in blocking buffer. The membrane was then washed four times with PBST 
for 15 min each, incubated with HRP-conjugated rabbit anti-mouse IgG (1:10,000 
dilution with blocking buffer), for 1 h  at room tem incubation, and again washed for 
times like before.  The blot was developed with SuperSignal® West Pico 
Chemiluminescent Substrate (Pierce) and exposed to Fuji Super RX film.  
To test for transcriptional activation of the baits, 15 well-isolated colonies of 
each transformation were restreacked to fresh SD/-Trp plates, then replicated on SD 
minimal medium lacking of histidine and tryptophan (SD/-His/-Trp), and adenine and 
tryptophan (SD/-Ade/-Trp) agar plates. All plates were incubated at 30 oC for 4 days. 
Growth on different selection media was then recorded. 
 Once it was confirmed that the yeast transformants only grew on SD/-Trp but 
not SD/-His/-Trp and SD/-Ade/-Trp agar plates, the baits was further tested for their 
toxicity. This can be done by comparing the growth rate of Y187 cells transformed 
with the pGBKT7-bait plasmid with that transformed with pGBKT7 empty vector in 
liquid culture. Cultures of 50 ml of SD/-Trp/Kanamycin (20 μg/ml) liquid medium 
inoculated with one fresh colony of Y187 transformant were set up and grown at 30 
oC, 250 rpm for 24 h. After that, OD600 of the cultures were measured and compared. 
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If OD600 of Y187 transformed with the baits were higher or equal to 0.8 and not 
significantly different from that of the empty pGBKT7, the baits were considered as 
not toxic. Cells were then collected from the culture by centrifugation at 600 x g for 5 
min. Cells pellets were resuspended in 5 ml of SD/-Trp/Kanamycin (20 μg/ml) broth 
and cell count was performed using the Neubauer hemacytometer. These cells were 
then used for mating with the amebocyte 3 hpi library if the cell density was ≥ 1 x 109 
cells/ml.  
2.8.4 Screening of two-hybrid Ame 3 hpi cDNA library by yeast 
mating  
Y187 baits and AH109 library mating 
In order to identify interaction partners of CrSARM, the Y187 clones 
harboring pGBKT-baits constructs were mated with the amebocyte 3 hpi cDNA 
library/AH109. For each mating, 5 ml of Y187 bait cells collected by the end of 
toxicity test were combined with 1 ml of the Ame 3 hpi AH109 library and 45 ml of 2 
X YPDA/Kanamycin (50 μg/ml) liquid medium in a 3-L culture flask. Vial that held 
the library was rinsed twice, each time with 1.0 ml of 2 X YPDA/Kanamycin (50 
μg/ml). The rinsing solutions were also added into the mating flask, which then was 
incubated at 30 oC with gentle shaking at 40 rpm. After incubation for 20 hr, the 
mating culture was checked under microscope for the presence of the three-lobed 
shaped zygotes. If zygotes were observed, mating was continued for another 4 hr 
before cells were collected by 10 min centrifugation at 100 x g. Mating flask was 
rinsed with two aliquots of 50 ml of 0.5 X YPDA/ Kanamycin (50 μg/ml). The rinsed 
solutions were combined to resuspend the cell pellets. Centrifugation was repeated 
and this time the cell pellets was resuspended in 10 ml of 0.5 X YPDA/ Kanamycin 
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(50 μg/ml). The total volume of this cell suspension was recorded in order to estimate 
the number of hybrids that had been screened.  
Screening for positive hybrids 
SD/-Ade/-His/-Leu/-Trp (Quadruple Dropout Medium-QDO) medium was 
used to select for yeast diploid expressed interaction partners of CrSARM.  The 
absence of the four amino acid supplements made the selection highly stringent. 
Aliquots of 200 μl of the mating mixture were spread on QDO agar plates. In addition, 
serial dilution of the mating mixture was done and 100 μl aliquots of 1:10, 1:100, 
1:1000, and 1:10000 dilutions were plated on SD/-Leu, SD/-Trp and SD/-Leu/-Trp 
agar for determination of mating efficiency. All plates were incubated at 30 oC until 
the colonies appeared.  
Hybrids that grew on QDO plates were further selected for the activation of 
MEL1 reporter gene, which encodes for α-galactosidase, by restreaking on fresh QDO 
containing X-α-Gal. Only clones that grew and turned blue on this agar medium were 
further analyzed for protein interaction partners.  
2.8.5 Identification of cDNA sequences of the putative preys 
Sequencing of the pGAD recombinant plasmids harboring in the positive yeast 
diploids would allow the identification of the cDNA library inserts that encoded the 
interacting proteins. 
 Firstly, pGAD plasmids were isolated from the positive hybrid. For each 
hybrid, 2 ml of QDO/Kanamycin (30 μg/ml) inoculated with one fresh yeast colony 
was cultured overnight at 30 oC, 230 rpm. Cells were collected by centrifugation at 
18,000 x g for 5 min. Most of supernatant were poured off and cell pellets were 
resuspended in left-over liquid. Next, the yeast cell wall was disrupted by incubating 
the cells with 100 U of zymolyase (Seikagaku) at 37 oC with shaking at 230 rpm for 
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1.5 h. Subsequently, the cell membrane was broken by vigorously vortexing the cells 
with 20 μl of 20 % SDS followed by one freeze (at – 20 oC)/thaw cycle. The volume 
of the cell lysate was then adjusted to 400 μl using TE buffer pH 7.0. After that, 
phenol/choloroform extraction was performed to isolate the DNA by vortexing the 
cell lysate vigorously for 5 min with 400 μl of phenol : chloroform : isoamyl alcohol 
(25:24:1) mixture. Next, phase separation was facilitated by centrifugation at 14, 000 
x g for 10 min. After that, the aqueous phase was carefully transferred to a fresh tube 
and 400 μl of chloroform : isoamyl alcohol (24:1) was added into each tube and the 
same procedure was followed to remove the residual phenol from the DNA extract. 
Next, ethanol precipitation of the plasmid DNA was done by incubating the DNA 
extract with 2.5 volume of 95 % ethanol and 1/25 volume of 10 M ammonium acetate 
for 1 h at – 80oC. DNA precipitates were collected by centrifuging the tube at 14, 000 
x g for 30 min at 4 oC and washed with 500 μl of 70 % ethanol. After drying by 
speedvac, the DNA pellet was dissolved in 20 μl of water.  
Plasmid DNA isolated from the positive yeast diploid is a mixture of 
pGBKT7-bait and pGAD-prey plasmids. Hence, to segregate them, 10 μl of the 
isolated plasmids were transformed into 100 μl of E. coli Top10 and the transformants 
were divided into two equal aliquots, which were plated on either LB/Ampicilin (100 
μg/ml) or LB/Kanamycin (30 μg/ml) agar medium for the selection of pGAD-prey 
and pGBKT7-bait transformants, respectively. Plasmids isolated from clones grown 
on LB selection media were sequenced using T7 primer in order to identify the gene 
encoding the prey and to verify the sequence of the bait.  
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2.9 Verification of novel protein-protein interactions identified 
by yeast two hybrid screening  
 
Although multiple selection markers are included, they may not totally 
eliminate the occurrence of false positive yeast diploids. It was therefore essential to 
retest the interactions identified by yeast two hybrid screening by using other 
experimental approaches. Co-transformation of the bait and the prey into AH109 S. 
cereviseae is one of the methods to confirm that the protein-protein interactions 
identified by yeast two hybrid screening were not an artifact but a reproducible event.  
AH109 yeast competent cells were prepared as described before (section 
2.8.2). Cotransformation of 1.0 μg of pGBKT-bait and 1.0 μg of pGAD-prey plasmid 
into 50 μl of competent AH109 cells were done using small scale transformation 
protocol (section 2.8.4). At the same time, cotransformation of pGBKT-bait and 
pGADT7-Rec empty vector and of pGBKT7 empty vector with pGADT7-prey 
plasmid were included as negative controls. The transformants were selected on QDO 
agar plates, which were incubated at 30 oC until the colonies appeared.  
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Chapter 3 Results 
3.  
3.1 An EST clone encoding CrSARM was identified from the 
reverse amebocyte substractive cDNA library 
Extensive investigation on the innate immune system of the horseshoe crab in 
the last two decades has revealed a large number of proteins essential for host 
protection against microbial infection. Coordination of the immune related genes and 
proteins is critical for the successful control of pathogen invasion. Therefore, in 
collaboration with other lab members, the first part of this project was aimed to 
investigate how genes were differentially regulated in the amebocyte and 
hepatopancreas of C. rotundicauda, in response to P. aeruginosa infection. Using 
suppression subtractive cDNA hybridization technique, up- and down-regulated genes 
in each tissue were selectively cloned into forward- and reverse-cDNA library, 
respectively. Sequencing of 776 randomly selected clones from these libraries 
resulted in the characterization of 447 non-redundant ESTs allowing the discovery of 
many novel immune related proteins from the horseshoe crab (Ding et al., 2005). 
Of particular interest is the finding for the first time of a homolog of the 
mammalian SARM in the C. rotundicauda species of horseshoe crab, which was, thus, 
named as CrSARM. Indeed, EST AmeR209 (dbEST accession: CK086823) isolated 
from the amebocyte reverse cDNA library showed significant BLASTx match to 
SARM from human, mouse and SARM homologs in Drosophila and C. elegans 
(Figure 3.1 A). Conserved Domain Database Blast identified a TIR domain and a 








CG7915-PA & CG7915-PB Drosophila melanogaster AAF50491 & 
AAN12011 
1e-74 
SARM  Mus musculus NP_766383 1e-60 
SARM  Homo sapiens NP_055892 4e-60 




1         GTACACCTACATTATGCTCCAGGCTGGACTGTCCAGAGACGTCTTTCCCTTTCTGACGGA 
1           Y  T  Y  I  M  L  Q  A  G  L  S  R  D  V  F  P  F  L  T  E  
 
61        AGACCAACTGGAAGAGGTCTGTGGTATCAGTAACAGTATTCACAGACGAAGAATTTGGCA 
21          D  Q  L  E  E  V  C  G  I  S  N  S  I  H  R  R  R  I  W  Q  
 
121       AGCACTACTAGGTTCTACCCATTCATACACCAGTTGCGATGGTGATATTAGTTGCAACAA 
41          A  L  L  G  S  T  H  S  Y  T  S  C  D  G  D  I  S  C  N  K  
 
181       AACATTAGATGTCTTCATCAGTTATCGTAGGCCAACTGGCTCTCAGCTTGCTAGCCTTCT 
61          T  L  D  V  F  I  S  Y  R  R  P  T  G  S  Q  L  A  S  L  L  
 
241       GAAGGTTCACCTCCAACTTCGAGGCTTTTCAGTTTTTATAGACGTAGAGAGGCTCGAAGC 
81          K  V  H  L  Q  L  R  G  F  S  V  F  I  D  V  E  R  L  E  A  
 
301       TGGAAAATTTGACAATAATCTCGTCAACAGCATACACCAAGCAAAACATTTTATTTTAGT 
101         G  K  F  D  N  N  L  V  N  S  I  H  Q  A  K  H  F  I  L  V  
 
361       TCTAACGTCAGACGCTCTCGCTCGTTGCATACGGGACACTGAATGCAAAGATTGGGTGCA 
121         L  T  S  D  A  L  A  R  C  I  R  D  T  E  C  K  D  W  V  H  
 
421       CAAGGAAATAGTGGAAGCACTCCAAAGCCAGTGTAACATCATTCCAATTCTTGACAATTT 
141         K  E  I  V  E  A  L  Q  S  Q  C  N  I  I  P  I  L  D  N  F  
 
481       TCAATGGCCTGAGCCTGAAAGTTTACCAGAAGATATGAGGGCAGTGTGTTACTTTAATGG 
161         Q  W  P  E  P  E  S  L  P  E  D  M  R  A  V  C  Y  F  N  G  
 
541       TGTGAGATGGATTCACGACTACCAAGACGCCTGCGTCGACAAGCTCGAGAGGTTCATGCG 
181         V  R  W  I  H  D  Y  Q  D  A  C  V  D  K  L  E  R  F  M  R  
 
601       CGGGGAGCTGAACGTAC 
201         G  E  L  N  V   
 
Figure 3.1 EST clone AmeR209 is homologous to SARMs from other organisms 
(A) BLASTx search showed significant match (E-value ≤ 10-3) between EST AmeR209 
(dbEST accession: CK086823) with human, mouse SARM and CG7915 and TIR-1 (Toll and 
interleukin 1 receptor domain protein), which are homologs of mammalian in Drosophila, C. 
elegans. (B) Nucleotide sequence of EST AmeR209 and the correspondent amino acid 
sequence, which was generated by conceptional translation. Regions that show homology to 
TIR domain and SAM motif are shaded and underlined, respectively. Nucleotide sequence 
complementary to TIR-5RACE primer is in bold.  
 
Although, the function of SARM is largely unknown, the presense of TIR 
domain in its structure strongly suggests its potential function as a signaling molecule 
of the TLR signaling pathways, the key component of the the innate immunity. 
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Studying of CrSARM, hence, would provide insights into the signaling events leading 
to the generation of potent immune responses against microbial infection in the 
horseshoe crab. Moreover, since SARM is an evolutionary conserved protein, 
understanding of CrSARM would help to uncover the significance of this immune-
related molecule in host defense in higher organisms, particularly in human. Those 
were the reasons accounting for the selection of CrSARM as a molecule of research 
interest.  
Alignment of the AmeR209 sequence with full length SARM homologs from 
other organisms indicated that CrSARM aligns with the sequence near the C-terminal 
of those molecules. Screening of phage amebocyte cDNA library, was, thus, 
performed to isolate the full length CrSARM. 
3.2 The 3’-end of CrSARM cDNA was isolated from the 
phagemid library 
AmeR209, which codes for CrSARM, was used as a probe to screen phage amebocyte 
cDNA library. Forty seven putative clones, which gave rise to clear but not very sharp 
dots on X-ray film (Figure 3.2 A), were isolated after two rounds of screening of one 
million phage clones. Sequencing showed that 40 out of 47 clones harbored DNA 
fragments whose 5’-ends overlapped with the 3’-end of the probe. Other clones, 
however, contained irrelevant sequences, which had been isolated due to unspecific 
hybridization. All of the 40 positive clones contained the poly-adenine sequence at 
their 3’-terminal, though varied in length, indicating that the 3’-end of CrSARM 
cDNA was successfully isolated. The sequence of the longest fragment, which was 
1150 bp in size, harbored in clone H3-2.1 is shown in Figure 3.2 B. None of the 
positive clones, however, extended beyond the 5’end of AmeR209. Therefore, 




1      ACACCAAGCA AAACATTTTA TTTTAGTTCT AACGTCAGAC GCTCTCGCTC GTTGCATACG 
61     GGACACTGAA TGCAAAGATT GGGTGCACAA GGAAATAGTG GAAGCACTCC AAAGCCAGTG 
121    TAACATCATT CCAATTCTTG ACAATTTTCA ATGGCCTGAG CCTGAAAGTT TACCAGAAGA 
181    TATGAGGGCA GTGTGTTACT TTAATGGTGT GAGATGGATT CACGACTACC AAGACGCCTG 
241    CGTCGACAAG CTCGAGAGGT TCATGCGCGG GGAGCTGAAC GTACGGCCGG ATGGTCCCCT 
301    TGGACGACAC ATCGGAATGG GGGGACCTGG AACACCTGGA ACCCCCAGTA CACTTAGTGG 
361    ACGTCAGTTG TTCCAAAGAA GCTCGAGTTA CGACAGTGCT AAGGGAAGTT CTTGTTCGGT 
421    GGAACTTTAA CGTCTAATTT TAAGGACACG TCTTTTGTGA TGTTAACAAG AAAGACCCTG 
481    GGAACACGGT AGCGTAGACT CATGGTCTTC GTCTCTCTAT TAAGGCCTAG TACCTGATCT 
541    ATGAATAAGC AAAGTCGAGT TTAGGTTTTT ATATTTCCAC GAACTTGTAA GACAACGTGC 
601    GGTAGTAACG GTTCAGACAC GCGCTCATCA CTGTCTTTAT CATGTAACAC ATTGTATAAC 
661    AATCGCAACC TGGTGTTTTG TTTGGTTTTT TTATTTAGGT TTGGTCTCTC TTAAATATTT 
721    TTACGTATCA CATGAAATCT CCAGTCATTG AGAAGTTTAG GTTGTCCTAA CCATCAGTAA 
781    ATCGCAGTCA TTTTCATTAG TAAATATATT TAGCGCTCTT AATCCCGAAT TACGTAAAAA 
841    CTAAGCAGAA GGTCCTTTCA GCAGGCACTT TATTGTTAGA GNGAAATAAA AATTACGAGA 
901    AAATAATAAT TTCTGATTTG CTAGCTTCAA AGTTTACGAA TTTGAATTAA TTGCATATTT 
961    TAATGAAAAG GCTTAAGTTT AATATAACAG CATTTTACTG CGAAGCAGAC GTCAAGTTAT 
1021   TTGTACGCAA TGATATTGAA TTCCGATAGG TTTCATTTCC ATGTTTTATC TATGAACCTT 
1081   TTATCGATCA GTAATATAAT TAAATATCAA TCAAGGCCGC AAAAAAAAAA AAAAAAAAAA 
1141   AAAAAAAAAA 
Figure 3.2 3’end of CrSARM was obtained from phage cDNA library screening 
(A) E. coli XL1-Blue was transfected with phage amebocyte cDNA library and plated on LB 
agar for plaque formation. The plaques were transferred to positive-charged nylon membrane 
and hybridized with [32P]-labeled probe. The membrane was subjected to autoradiography. 
Dots with fuzzy edges, which are marked with arrows, on the X-ray film indicate position of 
putative clones. Sharp dots were created by the tips of forceps/needle used to handle/mark the 
membrane. (B) Nucleotide sequence of clone H3-2.1, the longest clone that was isolated from 
the screening of phage amebocyte cDNA library using AmeR209 cDNA as a probe. Poly-
adenine tail that marked the extreme 3’-end of CrSARM cDNA is underlined. Sequence 





3.3 5’-end of CrSARM was obtained by 5’-RACE 
First strand cDNA, which was synthesized from the mRNA of naïve 
amebocyte, was used as a template for 5’-RACE.  Before isolation of the mRNA, the 
quality of the total RNA was checked on agarose gel. 18S and 28S ribosomal RNAs 
were clearly seen indicating that the total RNA was intact (Figure 3.3 A). A single 
band of ~ 2.5 kb was obtained by 5’RACE PCR (Figure 3.3 B). This fragment was 
cloned into pGEM-T Easy vector to facilitate its sequencing. Three positive pGEM-T 
Easy transformants, TIR-5RACE#17, 46, 59 and 60 were selected after colony PCR. 
Sequencing of these clones showed that they all contained an identical fragment of 
2563 nucleotides and their 3’-end aligned with the 5’-end of AmeR209 (Figure 3.3 C 
& D). Hence, TIR-5RACE#17 was used for analysis hereafter.  
CDD Blast identified an Armadillo/Heat motif (ARM) and two consecutive 
SAM domains at the 5’- and 3’-ends of TIR-5RACE#17, respectively. In addition, a 
putative start codon that was preceded by a stop codon (TAG) was found upstream of 
ARM (Figure 3.3 D). Indeed, this arrangement was similar to the sequence at the 5’-
end of SARM homologs from other organisms. It therefore can be said that the 5’-




























1      GGAAGGCAGTGGTTTCAACGCAGAGTACGCGGGGACTTCTTAGAGTGACTGTTGGCGGACGTTCACTCAT 
71     TCACGATGATCTAGACGTCTGCAAGGCGTAGTGTTTTGTTACAGGATTCATGGAAAATGGATTCGCCCCC 
141    CCCCCCCTGGTTCCTGATTTTTCAGAAGATTATAGCCAGAAGACTAACTCCGATACTAACATCTTGATCC 
211    AAAGTTTCGATAACAATCCTTCTTTAAATGGTAAAATGAAGAACAACGCATCTTCAAAGACCAAAGGAAC 
281    AAATATAACTGCTAGGTATCATGCTACGAAGTCAGCCGATAATGCCACCACCGCCACATCATCAACGTCG 
351    GCTATATGCAAGAAGTCAGAGGTCAAAGTTTGTCAGAAGCTCAAGCAGGAACAAAATGAAAGTTTCCAAG 
421    AAAAACAAAACTTTTCCAGAAGTTTTAGCGTATCTTCGAGCGCAGGCAGTAATACCAAAACGAAACTGAA 
491    GTCAGACAGAAGAGGAAACTCCCTCGACACTGTTCTGGACACCACAAAAACTCCCCACCAGAGAGATTTC 
561    ACTTTTGAACAGAAACAAGTAATGTCTTCTTCCCAAACCAAAACCACCACAGATAGTTTTTCCTGCGAAA 
631    AAGCCAAGATAGATAACAAAGAATTGAAGGAGCTCCAAACAGAAGAGCTGAGTTATGCTGAAAAACATTC 
701    TTCTTCAATAGTCAATGCTCGACTAAAAGCTGATGACTTCTCTGCTGAGAAGACAAACGTTATTAATAAA 
771    GATCAGGTACAGTTGAAGTGTGAAGAAACTATCCATCAACAGCAAAGGGTTGCTACGACCACTTCTCAAC 
841    GAGTAGCAACAGAAAAATTTACAACAGAAAAAATATCCACGACAGCTCAAGAAGAACGTCATACTTTTTC 
911    CCAATCATCGCTCCAACAAGAAACAAACGTTTCCTCCAAGCTAAAGATTTCCAATAATAAGATGACTTCC 
981    ATTCTCAGTGGTCATGACTTCCATGAACTAGATATTGGAGGACTGATGTCGCCATCGGGTGGAAGTCCAA 
1051   TCATTACTTTTCCCGAGGAAGAAGTGTTTCACCAAAGACGTCAAAATCAAGATTTAGCTATCACCGAAGG 
1121   CATTCAAGATGACATACAACTTCTGCAGTCGCATACCTCATCTTCTGAAGTGGATAAAACGATTACCAGG 
1191   TATTGTTCTAGAATGGAAAACTGTATAAACCGTTTGAAGACATCTTCAACTCCGCAGGCTGTAGAACTGT 
1261   TGTCTCTTATGGCAGATATGATAATAAAAGCTTGGTCTTTATCATCTCATGGGCATGAACTTGGTCAAAA 
1331   ATTATGTGAAACCATCCACAATAAAGGCGGACTCGACATTCTCATAAGTAACTGTGCAACGACAGACAAT 
1401   GACCTGCAGTTCGCCAGCGCTAAACTTCTAGAACATTGCCTCAACGATAACAATAGAGCTTACGTTGTGG 
1471   AAAGAGGTCTGATGAATATCGTGACGATGGCGTGTTCCTTCAGCAAAGCGAATTCTGTGTGTCATTCCAG 
1541   GACTGGAACAGCAATACTGGAAAATCTCTTCAGACACTCAGAGAAGACATGCAGTGACGTTGTTAGGCTT 
1611   GGAGGACTAAAATCAATTCTCTATGACTGCAGACACATAGACGTACGAACTCTTCGTCACTGTGCTATAG 
1681   CTTTGGCGAATCTCTCTCTTTATGGTGGTCCTGAGAACCAGCAAGCTATGATCAAGGAAAAAGTTCCGGT 
1751   CTGGCTGTTTCCGCTAGCTTTTAGCCAGGATGACATCATTAAGTACTTCGCCTGCTTGGCTATCACTACT 
1821   TTAGTAGCTAACAAAGAGATAGAATTTGCAGTCTTGCGCTCTGGAACCTTGGACCTTGTTGAACCATTTA 
1891   TTGCTAGTCATGATCCAGAAGAGTTTGCCAGCAAAGCTCCAGCTCATATCCACAGACAATCCAAAGAATG 
1961   GCTTTTGAGACTGGTTCCTGTCTTAGACAGTAACAGGGAAGAAGCTAGAAGCTTAGCAGCTTTTCACTTC 
2031   GCCCTAGAGGCCAGCATAAAAAAAAAACTTGGAAACACAGAGATATTTCACGACATCGGTGCAATAGAAG 
2101   TCTTGAAGAGAGTTGCCAGTTCTCCAAATGCCATTGCATCAAAGTACGCCGCTCAAGCTCTCCAGCTGAT 
2171   TGGTGAAGAGATACCACACAAACTCTCTCAACAAGTTCCGCTGTGGAGTGCGGAAGACGTCACACAGTGG 
2241   GTTAAACAGATAGGGTTTTCGACTTACTGTCAAGAATTTATGAATAGCCGGGTGGACGGAGACTTACTGC 
2311   TACAGCTCAATGAAGATACCTTAAAAAATGATATTGGTATCAGTAATGGTATTCTGAGGAAAAGGTTTCT 
2381   TCGAGAACTGGTCCAACTAAAACGTCTTGCTGATTACTCGTCTTGCGACACAATCTCTCTTAACATGATA 
2451   CTACAAGAACTGGGTTCAGAATATAGCCAGTACACCTACATTATGCTCCAGGCTGGACTGTCCAGAGACG 
2521   TCTTTCCCTTTCTGACGGAAGACCAACTGGAAGAGGTCTGTGG 
 
Figure 3.3 Cloning of 5’-end cDNA of CrSARM 
(A) Total RNA from naïve amebocyte showed 18S and 28S ribosomal RNA bands. mRNA 
was isolated from total RNA and used for synthesizing cDNA, which in turn served as 
template for (B) 5’RACE  PCR. ~ 2.5 kb fragment was gel purified and cloned into pGEM-T 
Easy vector. (C) Colony PCR using T7 and SP6 primers was performed to screen the pGEM 
transformant. Clones TIR-5RACE#17, 46, 59 & 60 have inserts with the correct size 
(indicated by the blue arrow). M = 100bp DNA ladder plus marker (Fermentas). (D) TIR-
5RACE#17 contains 2562 nucleotides. It encodes for a putative ARM motif and two SAM 
motifs, which are written in blue and red, respectively. Putative start codon (ATG) and its 
preceding stop codon (TAG) are circled. The sequence overlapping with that of AmeR209 is 










3.4 In silico assembly of full length CrSARM cDNA sequence  
Full length CrSARM (GeneBank accession number: DQ295792), which was 
determined by careful assembling of AmeR209, H3-2.1 and TIR-5RACE#17 
sequences using DNAMAN software, encompassed a total of 3936 nucleotides with a 
poly-adenine tail at the extreme 3’-end. This is the first horseshoe crab SARM 
deposited to the GenBank. Horseshoe crab SARM has a single ORF of 3123 
nucleotides encoding for a polypeptide of 1040 amino-acid residues containing 720 
bp 3’ untranslated region. Conserved domain search revealed a mammalian SARM-
characteristic modular architecture of CrSARM which contains two central SAM 
domains (SAM1 aa 696-763 and SAM2 aa 766-835) that are flanked by an N-terminal 
ARM motif from aa 441-570) and an extreme C-terminal TIR domain (aa 849 - 987) 
(Figure 3.4 & Figure 3.5).  
 
Figure 3.4 CrSARM has a standard modular structure of the vertebrate SARM  
The schematic domain arrangement of CrSARM as shown by conserved domain search at 
http://www.ncbi.nlm.nih.gov.libproxy1.nus.edu.sg/Structure/cdd/wrpsb.cgi. Conserved 
domain database references: ARM (cd00020), Armadillo/beta-catenin-like repeat; SAM 
(smart00454, cd00166), sterile-alpha motif; TIR (smart00255), Toll/interleukin-1 receptor 
domain. 
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3.5 CrSARM is evolutionarily conserved 
Searching the database with full length amino acid sequence of CrSARM led 
to the retrieval of its homologs from worm, insects, bird and mammals. High 
homology between SARM sequences from different organism (Figure 3.5), especially 
at the C-terminal region where ARM, TIR and SAM are located, indicates that the 
unique combination of these three domains bears critical significance to the function 
of this protein. Sequence at the N-terminus of the invertebrates homologs, however, 
are significantly longer than those of the vertebrates homologs (Figure 3.5 and 
Appendix A).  
Phylogenetic study showed that CrSARM is grouped of with other SARM 
homologs of insects like Drosophila and Anopheles whereas the vertebrate SARMs 
and the homolog of vertebrate SARM in C. elegans, TIR-1, form separate groups 
(Figure 3.6).  
Table 3.1 SARM homologs that were used for phylogenetic analysis  
Protein Organisms Accession number 
Toll and interleukin 1 
receptor domain protein 
isoform a (TIR-1a)  
Caenorhabditis elegans AAV91312 
Toll and interleukin 1 
receptor domain protein 
isoform c (TIR-1c) 
Caenorhabditis elegans AAV91313 
Drosophila  Ect4 isoform a Drosophila melanogaster NP_648173 
Drosophila  Ect4 isoform b Drosophila melanogaster NP_729327 
Cow SARM Bos taurus XP_616381 
Dog SARM Canis familiaris XP_548285 
Horseshoe crab SARM Carcinoscopius rotundicauda DQ295792 
Human SARM Homo sapiens NP_055892  







CrSARM    1 MENGFAPPPLVPDFSEDYSQKTNSDTNILIQSFDNNPSLNGKMKNNASSKTKGTNITARYHATKSADNATTATSSTSAICKKSEVKVCQK 
DmEtc4    1 -------MKAAEIKRDLTNIQKSMSEINDLAKERITGGPGSISTTSASAITAPSTMSQTTTSRLAPKLTSAHPSIDDLRGLSRQDKITQL 
HsSARM      ------------------------------------------------------------------------------------------ 
CeTIR1      ------------------------------------------------------------------------------------------ 
 
CrSARM   91 LKQEQNESFQEKQNFSRSFSVSSSAGSNTKTKLKSDRRGNSLDTVLDTTKTPHQRDFTFEQKQVMSSSQTKTTTDSFSCEKAKIDNKELK 
DmEtc4   84 QKKIRASFENLVDHDDSNVIVTLPDDDDCPHNHFGSGLNLTHPTAAQLSASGLSGSSKTIDTIKFQEKSMKTESKTKVVTDGFSSEQATS 
HsSARM      ------------------------------------------------------------------------------------------ 
CeTIR1    1 --------------------------------------------------MGEEILTERNQLSRQDASCFRSPRSPLGRTDDAFFELDDD 
 
 
CrSARM  181 ELQTEELSYAEKHSSSIVNARLKADDFSAEKTNVINKDQVQLKCEETIHQQQRVATTTSQRVATEKFTTEKISTTAQEERHTFSQSSLQQ 
DmEtc4  174 NSAEMKRLQAGDIDYQESKGASAMRNRLEVDGVKTEENAAVIKEALSLRTGDITQQASNNVAASSITVQSENFSADKKAISQSQQSQTMT 
HsSARM      ------------------------------------------------------------------------------------------ 
CeTIR1   41 DDLSSPSVPGSPVDPPSISVPLPPKSAPPCPTQPAPLTNGDLYPTILSNGTPIPNGRITPALSTVSVSLIHEARLQQSLSTPCNGSEEEM 
 
 
CrSARM  271 ETNVSSKLKISNNKMTSILSGHDFHELDIGGLMSPSGGSPIITFPEEEVFHQRRQNQDLAITEGIQDDIQLLQSHTSSSEVDKTITRYCS 
DmEtc4  264 SNGIISQEKHVSSASQANYSMSHKGVSSTGSSMITSSSQMSAMNGQMLKLADLKLDDLKSLTAGSGQQEIEQTINKYSNMLTSIVSSLQE 
HsSARM    1 -----------------------------------------------------MGAVARAHGGLRVARARESVAGGRHRGAGRPGARAAG 
CeTIR1  131 HNGQVRKESEYRRFKSEGSTAGASLPAAEKTHMDELSPVDQRSTSGTARFLIQQDSVVNPSTKMSNTEQVAMMHTLKTKLSKYQAMMDKA 
 
  
CrSARM  361 RMENCINRLKTSSTPQAVELLSLMADMIIKAWSLSSHGHELGQKLCETIHNKGGLDILISNCATTDNDLQFASAKLLEHCLNDNNRAYVV 
DmEtc4  354 DERGGSAITVHDVGGKKSQYLEKINEVIRRAWAVPTHGHELGYSLCNSLRQSGGLDLLMKNCVKP--DLQFSSAQLLEQCLTTENRKHVV 
HsSARM   38 AAAGLVRAEAGGRRAGRGRRPGRGLPTGGGGLAAAAVGREVAQGLCDAIRLDGGLDLLLRLLQAPELETRVQAARLLEQILVAENRDRVA 
CeTIR1  221 FEEIAKVEDANIIEGCTIVRKLMRKVWNTPKVSADLANALCDYLRDRDYFDKLIKMFISPNTAACDQVRMECGKVLEECTSSANLEYIVN 
 
 
CrSARM  451 ERGLMNIVTMACSFSKANSVCHSRTGTAILENLFRHSEKTCSDVVRLGGLKSILYDCRHIDVRTLRHCAIALANLSLYGGPENQQAMIKE 
DmEtc4  442 DNGLDKVVNVACVCTKNSNMEHSRVGTGILEHLFKHSEGTCSDVIRLGGLDAVLFECRTSDLETLRHCASALANLSLYGGAENQEEMILR 
HsSARM  128 RIGLGVILNLAKEREPVELARSVAG---ILEHMFKHSEETCQRLVAAGGLDAVLYWCRRTDPALLRHCALALGNCALHGGQAVQRRMVEK 
CeTIR1  311 KSYTKKIMIVAMKLNKTPDQQRLSLSLIGNLFKHSNAVSLSLIETDVIDHIILTFKRAPECPDILRHAALALANILLYTCFEGKKKIIQK 
 
 
CrSARM  541 KVPVWLFPLAFSQDDIIKYF-ACLAITTLVANKEIEFAVLRSGTLDLVEPFIASHDPEEFASKAPAHIHRQSKEWLL---RLVPVLDSNR 
DmEtc4  532 KVPMWLFPLAFHNDDNIKYY-ACLAIAVLVANKEIEAEVLKSGCLDLVEPFVTSHDPSAFARSNLAHAHGQSKHWLK---RLVPVLSSNR 
HsSARM  215 RAAEWLFPLAFSKEDELLRLHACLAVAVLATNKEVEREVERSGTLALVEPLVASLDPGRFARCLVDASDTSQGRGPDDLQRLVPLLDSNR 
CeTIR1  401 KIPEWLFFLASQADDVTRYYACIAVCTIVSVKEFEPLVRKSDTMKLVEPFLQVHDPATFARDYHKYAQGNTKEWLERLLPMLQPSRRR-- 
 
 
CrSARM  627 EEARSLAAFHFALEASIKKKLGNTEIFHDIGAIEVLKRVASSPNAIASKYAAQALQLI-GEEIPHKLSQQVPLWSAEDVTQWVKQIGFST 
DmEtc4  618 EEARNLAAFHFCMEAGIKREQGNTDIFREINAIEALKNVASCPNAIASKFAAQALRLI-GETVPHKLSQQVPLWSVEDVQEWVKQIGFND 
HsSARM  305 LEAQCIGAFYLCAEAAIKSLQGKTKVFSDIGAIQSLKRLVSYSTNGTKSALAKRALRLLGEEVPRPILPSVPSWKEAEVQTWLQQIGFSK 
CeTIR1  489 -EARSVAAFHFTLEATIKKEQNKLDVFQEIGAIQALKEVASSPDEVAAKFASEALTVIGEEVPYKLAQQVPGWTCADVQYWVKKIGFEEY 
 
 
CrSARM  716 YCQEFMNSRVDGDLLLQLNEDTLKNDIGISNGILRKRFLRELVQLKRLADYSSCDTISLNMILQELGSEYSQYTYIMLQAGLSRDVFPFL 
DmEtc4  707 YIDKFNESQVDGDLLLKLNQDNLRADIGIGNGILLKRFERELQNLKRMADYSSKDTAKMHQFLSEIGTDYCTYTYAMLNAGIDKCALPHV 
HsSARM  395 YCESFREQQVDGDLLLRLTEEELQTDLGMKSGITRKRFFRELTELKTFANYSTCDRSNLADWLGSLDPRFRQYTYGLVSCGLDRSLLHRV 
CeTIR1  578 VEKFAKQMVDGDLLLQLTENDLKHDVGMISGLHRKRFLRELQTLKVAADYSSVDESNLDNFLMGLSPELSVYTYQMLTNGVNRSLLSSLT 
 
 
CrSARM  806 TEDQLEEVCGISNSIHRRRIWQALLGSTHSYTSCDGDISCNKTLDVFISYRRSTGSQLASLLKVHLQLRGFSVFIDVERLEAGKFDNNLV 
DmEtc4  797 NEDMLMTECGIHNSIHRLRILNAVKNLENSLPSSSEENMA-KTLDVFVSYRRSNGSQLASLLKVHLQLRGFSVFIDVERLEAGKFDNGLL 
HsSARM  485 SEQQLLEDCGIHLGVHRARILTAAREMLHSPLPCTGGKPSGDTPDVFISYRRNSGSQLASLLKVHLQLHGFSVFIDVEKLEAGKFEDKLI 
CeTIR1  668 DEMMQNACGITNPIHRLKLTQAFETAKHPDDVEVAMLSKQI---DVFISYRRSTGNQLASLIKVLLQLRGYRVFIDVDKLYAGKFDSSLL 
 
 
CrSARM  896 NSIHQAKHFILVLTSDALARCIRDTECKDWVHKEIVEALQSQCNIIPILDNFQ-WPEPESLPEDMRAVCYF-NGVRWIHDYQDACVDKLE 
DmEtc4  886 NSIRQAKNFVLVLTPDALHRCINDEDCKDWVHREIVAALNSNCNIIPIIDQQFDWPEVERLPEDMRSVAHF-NGVNWIHDYQDACIDKLE 
HsSARM  575 QSVMGARNFVLVLSPGALDKCMQDHDCKDWVHKEIVTALSCGKNIVPIIDGFEWPEPQVLPEDMQAVLTFN-GIKWSHEYQEATIEKIIR 
CeTIR1  755 KNIQAAKHFILVLTPNSLDRLLNDDNCEDWVHKELKCAFEHQKNIIPIFDTAFEFPTKEDQIPNDIRMITKYNGVKWVHDYQDACMAKVV 
 
 
CrSARM  984 RFMRGELNVRPDGPLGRHIGMGGPGTPGTPSTLSGRQLFQRSSSYDSAKGSSCSVEL--------------------------------- 
DmEtc4  975 RFLRGEKNIDRIAAMVPGTPGSVSYQRMHSNDSDYQSGGAGAGSGAGTGGGGGGGVTGSVVDGLMVAANGSGQGGPTSTTSTTSSTPNSN 
HsSARM  664 FLQGRSSRDSSAGSDTSLEGAAPMGPT--------------------------------------------------------------- 
CeTIR1  845 RFITGELNRTTPTTKEMPSISRKTTQQRWQTTNTVSRTGPSRSIGGPRMEPPTPTFFSVTPTGSQERATSTRRKIQPSASTTSDRN---- 
 
 
CrSARM      -------------- 
DmEtc4 1065 SSSSSNQSPPAAPA 
HsSARM      -------------- 
CeTIR1      -------------- 
 
Figure 3.5 CrSARM has high homology to the orthologs 
CrSARM amino acid sequence was aligned with the SARM homologs from C. elegans (CeTIR1), D. 
melanogaster (DmEtc4), and human (HsSARM). GeneBank accession numbers for these proteins are 
listed in Table 3.1. ARM repeat motif, SAM motifs, and TIR domain of CrSARM are indicated by the 
line above the alignment. The three conserved boxes (B-1, B-2 & B-3), which are important for the 
dimerization of TIR domains, are double underline. 
ARM
SAM-1 SAM-2 
























Figure 3.6 Phylogenetic tree of CrSARM and SARM from other  
Selected proteins and the corresponding source of origin of the organisms are listed in Table 
3.1. AgEAA11071, mosquitoes EAA11071; BtSARM, cow SARM; CeTIR-1a & CeTIR-1c, 
C. elegans TIR1 isoform a and c; CfSARM, dog SARM, CrSARM, horseshoe crab SARM, 
DmCG7915a/b, Drosophila Etc4 isoform a and b; HsSARM, human SARM; MmSARM, 
mouse SARM. The un-rooted tree was constructed using neighbor-joining method based on 
the multiple sequence alignment produced using ClustalX (1.81) (Appendix A).The scale bar 
corresponds to 0.1 estimated amino-acid substitutions per site. The confidence scores (in %) 
of a bootstrap test of 1000 replicates are indicated for major branching nodes.  
 
3.6 CrSARM shows tissue specific expression 
 Tissue distribution of CrSARM was studied by RT-PCR using CrSARM gene 
specific primers. The result showed that this protein is not ubiquitously expressed. 
CrSARM transcripts were detected in the two immune related tissues, hepatopancreas 
and amebocyte, muscle and heart but not in intestine and stomach (Figure 3.7). Unlike 
CrSARM, human SARM was found exclusively in the liver and kidney due to the 
presence of a liver- and kidney- specific nuclear factor binding sequences upstream of 
SARM gene (Mink et al., 2001). The difference in tissue expression is another 
indication that this signaling molecule may perform different roles in invertebrates 
and vertebrates.  
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Figure 3.7 Expression of CrSARM in different tissues 
RT-PCR detection of CrSARM mRNA from various tissues. Amplifications of CrSARM 
cDNA fragments were performed using equal number of PCR cycles. The horseshoe crab 
ribosomal protein L3 (RpL3) was used as the control.  
 
3.7 Infection with P. aeruginosa up-regulated CrSARM gene  
The EST encoding CrSARM was isolated from the 3+6 hpi amebocyte reverse 
library indicating its expression was differentially regulated by Pseudomonas 
infection (Ding et al., 2005). Studying the kinetics of this regulation was essential for 
uncovering the function of this novel signaling molecule. Transcription profiling was 
performed by semi-quantitative PCR. The relative transcriptional level of CrSARM at 
different time points post infection was compared to that of the naïve (uninfected) 
sample after normalization against RpL3. The bar-chart in Figure 3.8 shows that the 
amount of CrSARM transcript was almost double at 3 hpi. After that, however, the 
transcription was repressed significantly before gradually returning to the basal level 
after 12 hpi.  The increase at 3 hpi was unexpected since CrSARM was found in a 
reversed amebocyte cDNA library. However, this contradiction can be explained by 
the fact that the drastic reduction at 6 hpi had compensated the increase at 3 hpi, 
leading to the net repression effect when the cDNAs of these two time points were 
combined for the preparation of the amebocyte subtractive cDNA library  
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Figure 3.8 Transcription profile of CrSARM upon Pseudomonas infection 
Horseshoe crabs were infected with sub-lethal dosage of P. aeruginosa. Amebocytes 
were collected at certain time points after infection (0, 1, 3, 6, 9, 12, and 24 hpi) and 
used for mRNA isolation. RT-PCR was performed with gene specific primers for 
CrSARM or RbL3. cDNAs were resolved on 1.2 % agarose gel, quantified as 
intergrated optical density (IOD) by Image Master VDS version 2.0 software. For 
normalization, the ratio of CrSARM to RpL3 was calculated for each time point. 
Relative transcription level was determined by comparing the infected sample with 
the naïve sample.   
3.8 Putative interaction partners of CrSARM were isolated by 
yeast two hybrid screening 
As previously mentioned, all of the three domains that made up SARM are 
well known for their ability to mediate protein-protein interaction (section 1.2.2 e). 
The unique combination of these domains in SARM highly suggests that this 
intracellular signaling molecule may function as an adaptor protein. By assembling on 
this adaptor, signaling molecules of TLR or a novel signaling pathway may be 
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occur. Identification of proteins that interact with CrSARM is hence a feasible 
approach to test this hypothesis.  
Yeast two hybrid was a method of choice for identification interaction of 
partners of CrSARM since it has several advantages over other techniques that can 
also be used for studying protein-protein interaction, for example, GST pull-down. 
Indeed, post-transcriptional modification of recombinant proteins, which may be 
essential for the interaction, is possible in an eukaryotic expression system like yeast. 
Moreover, low expression level of target proteins (typically that of signaling proteins) 
does not pose a hindrance for the detection of potential interaction protein partners 
since expression of both bait and preys are constitutively expressed under the control 
of a strong promoter (PADH1).  
 The cDNA library for yeast two hybrid screening was prepared from mRNA 
of 3 hpi amebocytes because amebocytes are immune-responsive and the expression 
of CrSARM as well as many signaling proteins were found to be upregulated in  the 
first few hours post infection (Figure 3.8 and Ding et al., 2005)). Double-stranded 
cDNA were generated from mRNA. Salts and molecules smaller than 200 bp were 
removed by passing the cDNA through TE column. The size of the purified cDNAs 
was in the range of 300 bp, which was good enough for downstream works (Figure 












                                                
Figure 3.9 The synthesis of double stranded cDNA for the yeast library construction 
(A) Double stranded cDNA was synthesized by PCR amplification of single stranded cDNA. 
7 μl of PCR product was checked on agarose gel, the remainder, 193 μl, was loaded into two 
TE columns for size selection and salt removal. Purified cDNA was concentrated by ethanol 
precipitation to 20 μl and (B) 1 μl was analyzed on agarose gel. Positive control was prepared 
with human placenta mRNA provided by the manufacturer using the same protocol. M, 
marker with molecular mass in bp; Ame, amebocyte cDNA; Pl, human placenta cDNA as 
control.  
 
Double stranded cDNAs and the linearized pGAD-Rec vector were co-
transformed into S. cereviseae strain AH109. Circular recombinant plasmids were 
generated as a result of in vivo recombination. Transformation efficiency was 
determined to be 4.8 x 106 cfu/3μg of vector, which was higher than that of the 
positive control, SV40 DNA fragment provided by the manufacturer. In addition, 
transformation of the linearized vector alone did not yield any transformant, 
indicating that the vector was not able to re-circularized by itself in vivo (Table 3.2). 
Hence, there were sufficient representations of different cDNAs in the amebocyte 3 
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Table 3.2 Transformation efficiency of the yeast amebocyte 3 hpi cDNA library  
Double stranded DNA Vector Efficiency (cfu/3 μg of vector) 
Ame 3 hpi cDNA Linearized pGAD-Rec 4.8 x 106 
SV40 Linearized pGAD-Rec 3.4 x 106 
None Linearized pGAD-Rec 0 
AH109 was transformed with circular pGAD-Rec or co-transformed with double stranded 
cDNA and linearized pGAD-Rec. Serial dilution was carried out and the transformants were 
selected on SD/-Leu agar. Transformation efficiency was determined as number of colonies 
grew on selective medium per 3 μg of vector transformed.  
 
 
The transformed yeasts were plated on SD/-Leu agar and harvested from 
nearly 200 plates. The cDNA library titer was determined to be 1.2 x 108 cfu/ml. For 
an effective screening, a cell density higher than 107 cfu/ml is required. The 
amebocyte 3 hpi cDNA library, therefore, harbors a satisfactory titer.  
3.8.1 Potential interaction partners of CrSARM were retrieved from 
yeast two hybrid screening of 3 hpi amebocyte cDNA library  
Construction of the baits 
For screening of the yeast library, five constructs of baits were sub-cloned into 
pGBKT7 vector. They are the full-length CrSARM; individual domain of CrSARM: 
ARM, SAM, and TIR; and the C-terminal sequence (CrSARM-AST) encoding for all 
three domains of CrSARMs (aa 444-1039) (Figure 2.6). These baits were PCR 
amplified from single stranded cDNA that was synthesized from naïve amebocyte 
mRNA. The PCR products with the expected sizes (Table 3.3) were obtained as 
shown in Figure 3.10. The PCR fragments were cloned into pGEMT-Easy vector and 
sequenced to ensure that they were free of mutation. After that, the inserts were 
released from pGEMT-Easy vector by digestion with the respective restriction 
enzymes and cloned into pGBKT7 vectors. Sequencing of recombinant pGBKT7 
vectors were performed to make sure that the inserts were in-frame with cDNA 
sequence encoding for GAL4-BD domain, and thus c-myc epitope tag in pGBKT7. 
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Bait constructs were then transformed into both yeast strain AH109 and Y187. 
Transformants that grew on SD/-Trp agar were selected for toxicity and 
transcriptional activation tests. 
Table 3.3 pGBKT7-bait constructs 
Clone ID Size of cDNA 
insert (bp) 
Expected size of BD-fusion 
protein (kDa) * 
pGBKT7-CrSARM 3123 135.6 
pGBKT7-CrSARM-AST 1791 86.2 
pGBKT7-ARM 378 33.2 
pGBKT7-SAM 831 50.5 
pGBKT7-TIR 426 35.7 
* Molecular of GAL4-BD is ~ 20 kDa 
 
Figure 3.10 PCR amplification of cDNAs encoding the baits 
Full-length CrSARM, its C-terminal fragment (CrSARM-AST), ARM, SAM and TIR domain 
(referred to Figure 2.6 schematic diagram of each fragment) were amplified by PCR and 
cloned into pGBKT7 vector. Expected size of each fragment can be found in Table 3.3. 100 
bp DNA Ladder Plus (Fermentas) was used as molecular marker. 
Testing of the baits for the expression, toxicity and transcriptional activation 
The expression of BD-fusion proteins in Y187, which was later used for 
mating with the cDNA library in AH109, was verified before proceeding with the 
screening process. This was achieved by Western blotting using anti-myc antibody, 
which recognized the c-myc epitope tag in the fusion proteins, to detect the presence 
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of the fusion proteins in the crude yeast cell extract. Bands of expected sizes were 
observed in all of the bait constructs except for the full length CrSARM (Figure 3.11) 
indicating that the BD-bait fusions except the full length CrSARM were properly 
expressed. It was unable to detect BD-CrSARM protein even though the Western 
blotting was repeated with higher amount of cell lysate. Due to this problem, 
pGBKT7-CrSARM was not included in subsequent experiments.  
 
Figure 3.11 Expression of BD-bait fusion proteins in Y187 yeast 
pGBKT7-bait/Y187 and the non-transformed Y187 clones were cultured overnight in SD/-
Trp and YPD liquid media, respectively. Crude cell lysates were prepared and resolved on 
SDS-PAGE. Proteins were transfer to PDVF membrane for Western blotting with anti-myc 
antibody. Lysate from non-transformed Y187 S. cerevisiae was used as the negative control. 
Arrows indicate bands with the expected sizes for the BD-bait fusions as shown in Table 3.3. 
Fainter bands below the BD-SAM, BD-ARM and BD-TIR bands are degradation products.  
 
Before mating with the library, it was also important to make sure that the BD-
bait fusion proteins were not toxic to the yeast and do not activate the expression of 
marker gene ADE2, HIS3 and lacZ. To check for toxicity, the growth of Y187 
transformed with the bait constructs in SD/-Trp broth was compared with those 
transformed with empty pGBKT7 vector. Table 3.4 showed that expression of the 
baits did not hamper the growth of Y187 yeast. The transcriptional activity of the 
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baits was tested by streaking AH109 and Y187 transformed with the bait constructs 
on SD/-Ade/-Trp and SD/-His/-Trip agar. The typical transcriptional activity test for 
one of the baits is shown in Figure 3.12. All of the baits did not grow on medium 
lacking adenine or histidine. However, AH109 transformed with GBKT7-ARM and 
pGBKT7-CrSARM-AST showed weak growth on SD/-His/-Trp. Nevertheless, the 
interference of the low background growth on the –His medium was eliminated by 
using minimal medium lacking both adenine and histidine (SD/-Ade/-His/-Leu/-Trp 
or QDO) to select for the positive hybrids. Therefore, pGBKT7-CrSARM-AST, -




Figure 3.12 Checking for transcriptional activity of pGBKT7-ARM 
S. cereviseae Y187 and AH109 were transformed with pGBKT7-ARM plasmid. The 
transformed cells were selected on SD/-Trp agar. For each yeast strain, 15 clones were 
selected for transcriptional activity test. Those clones were firstly streaked to SD/-Trp agar 
plates then replicated to SD/-Ade/-Trp and SD/-His/-Trp agar plates. Y187 and AH109 
transformed with pGBKT7-53 provided by the manufacturer were included as positive 
controls (+). Negative controls (-) were the non-transformed Y187 or AH109. All plates were 
incubated for 4 days at 30 oC.  
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Table 3.4 Testing the baits for toxicity 






An aliquot of 50 ml of SD/-Trp/Kan (20 μg/ml) liquid medium was inoculated with one 
colony of Y187 transformed with empty pGBKT7 or different pGBKT7-bait constructs. The 
culture was incubated at 30oC with 250 rpm shaking for 24 h before OD600 was measured.  
Screening of the amebocyte 3 hpi cDNA library by yeast mating 
The amebocyte 3 hpi cDNA/AH109 library was screened with the CrSARM-
AST, ARM, SAM and TIR baits using the yeast mating method. To obtain an 
effective screening, at least 5 x 109 bait clones were used in each mating with 1.2 x 
108 clones of preys (Table 3.5). In all of the mating, the three-lobed shaped zygotes 
(Figure 3.13 A) were observed after 20 h of incubation, indicating that the budding 
diploid cell had not detached from the two haploid parental cells. Yeast mating was 
hence carried out for another 4 h. A small aliquot of the mating mixture was used for 
determination of mating efficiency, the rest was spreaded on SD/-Ade/-His/-Leu/-Trp 
(QDO) agar plates for the selection of positive hybrids. Table 3.5 shows the mating 
efficiencies of the four baits. Although the mating efficiencies of SAM and TIR baits 
were not very high, they were in the acceptable range for a successful identification of 
novel protein-protein interaction. Indeed, the mating efficiencies of 6 % and above 
gave more than 7 x 106 diploids for the selection of positive hybrids considering 1.2 x 
108 library clones were screened.  The mating efficiency of CrSARM-AST and ARM 
baits, however, were much lower though comparable amount of baits were used for 
each mating.  In addition, the efficiency did not improved when the mating was 
repeated with ten times higher amount of ARM bait. Low mating efficiencies of these 
two baits were therefore not due to either the toxicity of the BD-bait fusion proteins 
(Table 3.4) or the insufficient number of the bait clones. This leaves the possibility 
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that the ARM domain, which was present in both of the baits, interferes with the 
mating process. This hindrance may be overcome if library screening is done by 
transforming the pGBKT7-bait plasmids into the cDNA library in AH109 cells. The 
transformants in which the bait and the prey interact can be selected on QDO medium 
similarly to the selection for the positive hybrids. This could be a future approach to 
solve this problem.  
Table 3.5 Screening of amebocyte 3 hpi cDNA library by the yeast mating method 
Bait clone Cell count of baits as 
determined using the 














1.2 x 109 2.6 22 0 
pGBKT7-ARM 1.4 x 109 0.75 18 2 
pGBKT7-SAM 1.3 x 109 6.0 31 16 
pGBKT7-TIR 1.7 x 109 6.9 85 43 
pGBKT7-bait/Y187 clone was cultured in 50 ml of  SD/-Trp/Kan (20 μg/ml) liquid medium 
for 24 h at 30 oC with 250 rpm shaking. Cells were collected and resuspended in 5 ml of 2 x 
YPDA/Kan (50 μg/ml) broth. Cell count was performed with the hemocytometer. The bait 
suspension was combined with 1 ml of the amebocyte 3 hpi cDNA library for mating for 24 h 
at 30 oC. Viabilities (cfu/ml) of the bait, the library and the diploids were determined by 
spreading the mating mixture on SD/-Trp, SD/-Leu and SD/-Leu/-Trp agar, respectively. 
Mating efficiency was calculated as the percentage of the diploid’s viability to the limiting 
partner’s viability, which was the library in this case. Putative hybrids were first selected on 
QDO plates, and further validated by restreaking to QDO-Xgal plates.  
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Figure 3.13 Screening of the amebocyte 3 hpi cDNA library by yeast mating 
(A) The zygote with the tri-lobe shape is indicated by the arrow. (B) Checking the diploids on 
QDO-Xgal plates. Positive diploid should turn blue due to the activation of LacZ reporter 
gene. (C) Colony PCR of E. coli clones transformed with DNA isolated from the positive 
hybrids of SAM bait using primers flanking cDNA inserts in the pGADT7 vector.  
 
The numbers of diploid cells that grew on QDO plates were consistent with the 
mating efficiencies (Table 3.5). Approximately half of the diploids isolated from the 
screenings with TIR and SAM baits grew to the diameter of > 1 mm within 14 days of 
incubation at 30 oC; the rest and all the diploids of the screenings with CrSARM-AST 
and ARM baits took at least 16 days to grow to > 1 mm in diameter. Most of the slow 
growing colonies were actually the false positives since they did not grow or grew but 
did not turn blue when being restreaked to fresh QDO agar plates containing X-α-gal 




pGADT7-cDNA plasmids were rescued from the positive diploids, which 
were 43 for the TIR-bait, 16 for the SAM bait, and 2 for the ARM bait, and 
transformed into E. coli Top10. Two bacterial clones were randomly selected from 
each transformation for colony PCR with the primers flanking the respective cDNA 
insert. Results showed that clones transformed with DNA from the same yeast colony 
have inserts of the same size while those transformed with DNA from different yeast 
colonies have inserts of different sizes (Figure 3.13 C), indicating that each yeast 
hybrid seemed to harbor one type of pGADT7-cDNA plasmid and each bait may have 
more than one putative interaction partner. 
The isolated preys were identified by sequencing followed by blast search. 
The result is summarized in Table 3.6. Since some of the preys were expressed in 
more than one hybrid, the numbers of non-redundant potential interaction candidates 
of TIR, SAM, and ARM domains were 26, 11 and 2, respectively. Although the yeast 
two hybrid system with three reporter genes (Ade1, His3 and LacZ) should have given 
lower number of false positives than the older system with only one reporter gene, the 
isolation of false positives is still the major problem associated with this application. 
The next step after obtaining the sequencing data of the preys was therefore to 
identify the interactions of potential interest for subsequent analysis of interaction 
specificity (Van Criekinge and Beyaert, 1999). Putative interaction partners of each 
bait were categorized into two groups: the ones of potential interests and the others 
(Table 3.6). Genes that are included in the later group are those encoding commonly 
found false positives reported in literature such as ribosomal proteins (Van Criekinge 
and Beyaert, 1999); those repeatedly isolated by our lab from the yeast two hybrid 
screening using unrelated baits (cathepsin-L, coagulogen, ring finger proteins 36); 
those encoding biologically irrelevant proteins such as proteins involved in 
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metabolism (fumarylacetoacetate hydrolase, quinine reductase, alcohol 
dehydrogenase) or proteins of different localization from CrSARM such as 
glycoprotein hormone alpha 2 and factor C, which are secretory proteins. In addition, 
genes that were not inframe with the AD domain or gave no significant match were 
also omitted from further analysis. Therefore, further characterization was performed 
with the clones belong to the “Potential interest” group to verify the specificity of the 
interactions. 
3.8.2 Yeast co-transformation confirms the interaction partners of 
CrSARM and eliminates the false positives  
The putative interactions were further verified by co-transformation. 
Individual pGADT7-prey was co-transformed with the correspondent pGBKT7-bait 
into AH109 yeast to accessed the reproducibility of check whether the interaction. At 
the same time, the specificity of the interaction was analyzed by co-transformations of 
the pGADT7-prey with the empty pGBKT7 vector, and the pGBKT7-baits with the 
empty pGADT7 vector. Analysis shows that co-transformation allowed the 
identification of some false positives among the potential interaction candidates. 
Indeed, co-transformation of some preys with their correspondent baits did not result 
in the transformants that could grow on the QDO plate (Table 3.6) although the 
presence of the two plasmids in those transformants was ensured by  the growth of 
yeast on SD/-Leu/-Trp agar before transferring to the QDO plates (Figure 3.14). Other 
group of false positives was the ones that activated the expression of reporter genes in 
the absence of the baits as shown by the growth of yeast harboring the prey and the 
empty pGBKT7 plasmids on QDO medium (Figure 3.14 & Table 3.6). In Table 3.6, 
the interactions that can be re-established and shown to be specific by co-
transformation are those with all of the three last columns shaded. 
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Figure 3.14 Analysis of interaction specificity by yeast co-transformation 
The pGADT7-cDNA plasmids that were isolate from the putative diploids of the TIR baits. 
were co-transformed with either pGBKT7-TIR or the pGBKT7 vector backbone. into AH109 
yeast. Co-transformations of pGBKT7-TIR and pGADT7 vector backbone, and pGBKT7-p53 
and pGADT7-SV40 (provided by the manufacturer) were set up as the negative and positive 
controls, respectively. The transformants were selected on SD/-Leu/-Trp for the expression of 
Leu2 and Trp1 genes, which are the reporter genes harbored on pGADT7 and pGBKT7 
vectors, respectively. Three transformants were then restreaked to fresh SD/-Leu/-Trp and 
QDO plate for testing of interaction specificity. The plates were incubated at 30 oC for four 
days before the growth of yeast were recorded. Result of co-transformation assay is 
summarized in Table 3.6 
 
Result of the co-transformation analysis (Table 3.6) showed that only six 
“preys” were found to interact specifically with TIR domain. One of them was HS1-
associated protein X-1 (HAX1). Hax1 got its name from the interaction with HS-1, 
which is expressed exclusively in the cells of heamatopoetic lineage and potentially 
functions in signal transduction from the antigen receptors in B cells (Suzuki et al., 
1997). Though the exact function is unknown, it was speculated that HAX1 could 
involved in the regulation of apoptosis since it was found to interact with the anti-
apototic proteins such as Bcl2 and the viral homolog of Bcl2: BHRF1 (Matsuda et al., 
2003). In addition, HAX1 may play a role in cytoskeleton remodeling as suggested by 
its interaction with cortactin, which is an F-actin-associated protein that is closely 
related to HS1 (Gallagher et al., 2000). Another interesting putative interaction 
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partner of TIR domain is SUMO-1, which was shown to regulate wide variety of 
cellular processes by covalent attachment to the lysine residue of the target proteins or 
physical interaction with the target proteins. SUMO-1 modification, which is also 
known as sumoylation, very often results in the repression of the cellular process due 
to the alteration in the molecular interaction properties and/or the subcellular 
localization of the target proteins. Though, majority of proteins regulated by 
sumoylation is transcription factors, sumoylation of signal transducing molecules such 
as Fas, tumor necrosis factor receptor 1, apoptosis signal regulated kinase (ASK1) had 
been reported (Lee et al., 2005). Proteasome alpha subunit and heat shock protein 40 
(Hsp40), which are structural components of the proteasome and chaperone 
machinery, respectively, are also amogst the putative interaction partners of the TIR 
domain. This may suggest the potential roles of CrSARM in protein degradation and 
modification. In addition, two out of six proteins showed specific interaction with TIR 
domain are hypothetical proteins. Further study is needed to clarify the identities as 
well as the functions of these proteins.  
 Amogst nine positive clones isolated from yeast two hybrid screening with 
the SARM domain bait, only calcium/calmodulin-dependent protein kinase I (CaMKI) 
showed specific interaction with SAM domain in the co-transformation test. Proteins 
of CaMK family are activated in response to the change in intracellular Ca2+ 
concentration as a result of the activation of Ca2+-binding proteins such as 
Ca2+/calmodulin. With a broad range of substrates, CaMKs can mediate signal 
transduction leading to the activation of a wide variety of cellular processes (Fujisawa, 
2001). The fact that infection by some pathogens leads to the change of cytosolic Ca2+ 
concentration (Brunet et al., 2000; Haque et al., 1998; Low et al., 1992) suggests the 
potential function of CaMKs in host defense. Indeed, recently, Verploegen et al 
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reported that CKliK, a novel CaMKI exclusively found in the granulocytes 
(Verploegen et al., 2000), plays a critical role in cytokine-responsive functions of the 
granulocytes such as phagocytosis, cell migration and adhesion (Verploegen et al., 
2005). 
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 Potential interest      
3, 2, 9, 18 Proteasome alpha subunit [Ornithodoros moubata] 7e-37 AAS01024 √ X X 
4 HS1-associated  protein X-1 (HAX1) [Homo sapiens]  5e-7 AAB51196 √ X X 
37 Small ubiquitin-like modifier, SUMO-1 (aa.7-44/98) [Apis mellifera]  7e-10 XP_392826 √ X X 
10, 16, 17, 38,42 DnaJ (Hsp40) homolog, subfamily A, member 1 [Homo Sapiens]  4e-117 NP_001530 √ X X 
21 Hypothetical protein [Drosophila pseudoobscura]  0.066    EAL32171 √ X X 
30 Hypothetical protein [Yarrowia lipolytica]  0.67 XP_502158 √ X X 
8 Tyrosine kinase-interacting protein [Saimiriine herpesvirus 2]   0.04 CAC84292 √ √ X 
28, 48 Adenylate cyclase-associated protein 1[Danio rerio]  5e-41 NP_956203 √ √ X 
49 Activated protein kinase C receptor; RACK1 [Xenopus laevis]  2e-108 AAD42045 √ √ X 
11 Novel ubiquitin-like protein [Danio rerio]  4e-17 CAD60858 √ √ X 
20, 24, 36 Hypothetical protein [Strongylocentrotus purpuratus]  1e-27 XP_800816 √ √ X 
40 Similar to protein tyrosine phosphatase [Danio rerio]  0.003 XP_698134 X X X 
13 Hypothetical protein LOC68201 [Mus musculus]  9e-7 NP_080889 X X X 
 Others      
50 Zinc finger protein 36 [Rattus norvegicus]  0.13 NP_001031703    
15 U2 small nuclear ribonucleoprotein B [Gallus gallus]  3e-38 XP_419331    
3,19, 46, 52 46 Ribosomal protein S20 [Crassostrea gigas] 3e-32 CAD91428    
14 Glycoprotein hormone alpha 2 [Drosophila melanogaster] 8e-30  AAX38184    
1 Flocculin-like protein [Candida albicans] 0.018 XP_712591    
29 Methionine sulfoxide reductase B2b [Schistosoma mansoni]  3e-40 AAT77264    
44 Cystallin, zeta (quinine reductase) [Xenopus tropicalis]  2e-51 NP_00100568    
27 Fumarylacetoacetate hydrolase domain containing [Mus musculus]  2e-29 XP_547188    
31 Cathepsin-L [Strongylocentrotus purpuratus] 2e-67  XP_801784    
25 Coagulogen type II [Tachypleus tridentatus]  3e-51 CAA27780    
34 Alcohol dehydrogenase [Gryllotalpa orientalis]  4e-23 AAR84629    
43, 45, 54,55 No ORF found in frame with AD domain      










 Potential interest      
3 Calcium/calmodulin-dependent protein kinase 1D [Rattus 
norvegicus]  
8e-5 XP_225567 √ X X 
4, 5, 9 Hypothetical protein [Burkholderia cenocepacia]  4e-7 ZP_00464021 √ √ X 
16 Hypothetical protein LOC496712 [Xenopus tropicalis]  7e-28 AAH88681 X X X 
11 Sulfatase domain protein 3 [Caenorhabditis elegans]  1e-24 AAA79198 X X X 
 Others      
1, 15  Coagulogen type II [Tachypleus tridentatus]  3e-97 CAA27780    
17 Factor C [Carcinoscorpius rotundicauda]  8e-40 AAB34362    
2 Bahma associated protein 60 kDa [Drosophila melanogaster]. 1e-132 AAC28455    
13 Mitochondria ribosomal protein L50 [Homo sapiens]  4e-15 CAI14610    
7, 12,14 Zinc finger protein 36 [Rattus norvegicus]  0.13 NP_001031703    
8 ribosomal protein S16 [Heteropneustes fossilis]   6e-37 AAK11731    










2 8.6 kDa Transglutaminase substrate  
[Tachypleus tridentatus] 
7e-41 AAB24710 X X X 
1 Zinc finger protein 36 [Rattus norvegicus]  0.14 NP_001031703    
 
The preys isolated by the yeast two hybrid screening of TIR domain (A), SAM domain (B) and ARM motif (C) were sequenced. ORFs that were inframe with 
the AD domain encoding by pGADT7 vector were used for protein-protein blast (Blastp) search to identify the homologous proteins. The preys were divided 
into two categories, namely “the potential interest” and “the others” based on the criteria that described in pages 83-84. Potentially biological relevant 
interactions were further confirmed and validated for interaction specificity by co-transformation with either the correspondent pGBKT7-bait plasmid or 
empty pGBKT7 vector into AH109 yeast. Co-transformation of the bait with empty pGADT7 vector was included as another negative control. The co-
transformation yeasts were first selected on SD/-Leu/-Trp agar. Three colonies were then replicated on fresh SD/-Leu/-Trp and QDO plates. All plates were 
incubated for 4 days at 30 oC before the growth on QDO plates were recorded. (√): growth; (X): no growth; gray shading: expected outcome if the interaction 
is specific.  
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Chapter 4 Discussion 
4.  
4.1 CrSARM – a signaling molecule responsive to P. 
aeruginosa infection  
SARM was first identified in human and its homologs were found in mouse, 
Drosophila and C. elegans (Mink et al., 2001). Since then, SARM quickly became a 
molecule of research interest because of its unique domain structure composing three 
domains: ARM, SAM and TIR, all of which are well-known for their ability to 
mediate protein interaction. In addition, in SARM due to the presence of TIR domain, 
which is present exclusively in molecules involved in IL-1 and TLR signaling 
pathways, it is believed that SARM may be a novel immune-related signaling protein 
(McGettrick and O'Neill, 2004; O'Neill et al., 2003). Indeed, Liberati et al (Liberati et 
al., 2004) and Couillault et al. (Couillault et al., 2004) showed the involvement of C. 
elegans SARM homolog, TIR-1, in immune response against bacterial and fungal 
infections in the worm. Nevertheless, the potential role that SARM plays in 
embryonic development was also reported (Chuang and Bargmann, 2005).  
Our work further confirms the participation of this novel signaling molecule in 
the innate immune response. Indeed, the horseshoe crab SARM was identified as one 
of the signaling molecules whose expressions were differentially regulated in 
response to Pseudomonas infection (Ding et al., 2005). The kinetics of this regulation, 
which was studied by RT-PCR, reveals that the transcription of CrSARM was 
induced during the first 3 h after Pseudomonas infection, followed by a suppression 
for the next 6 h before returning to the basal level at 12 hpi (Figure 3.8). On the 
contrary, Meijer et al reported that the zebra fish SARM (zSARM) transcription level 
did not change upon the infection with Mycobacterium marinum, a gram positive 
 91
bacteria that is closely related to M. tuberculosis (Meijer et al., 2004). This deviation 
may be due to either of the following reasons. Firstly, the transcript level of zSARM 
may revert to the basal level at the eighth day after infection, which was the time 
point reported by Meijer et al (Meijer et al., 2004). Other possibility could be that 
SARM may not be involved in immune response against gram positive bacteria, but is 
only restricted to host defense against gram negative bacteria and fungi as shown by 
Couillault et al (Couillault et al., 2004) and our work. Biological significance of the 
change in transcription level of CrSARM upon Pseudomonas infection will be 
elaborated further in sections 4.4.1 and 4.4.2.  
4.2 What can be derived from the comparison of sequence 
homology between CrSARM and SARM homologs of 
other organisms? 
Multiple sequence alignment shows that the invertebrate SARMs, including 
CrSARM, share high homology with the vertebrate homologs (Figure 3.5). In addition, 
all SARM homologs that have been identified so far harbour the same modular 
structure: a combination of an N-terminal ARM motif and a C-terminal TIR domain 
that flanks the two consecutive SAM motifs (Jault et al., 2004; Liberati et al., 2004; 
Meijer et al., 2004; Mink et al., 2001). The conservations of protein sequence and 
domain architecture of SARM homologs across the animal kingdom strongly 
indicates that some if not all the functions of SARM have been retained through 
evolution, justifying the extrapolation of the findings in the ancient invertebrate like 
the horseshoe crab to the mammals.  
Interestingly, the invertebrate SARM homologs harbour the N-terminal 
sequences that are missing in their vertebrate counterparts. Indeed, the N-terminal 
sequences of CrSARM and the Drosophila SARM homolog, Ect4, are almost 200 
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amino acid longer than that of human and mouse SARMs. TIR-1, SARM homolog in 
the C. elegans, also has around 50 residues extra at its N-terminus (Figure 3.5). 
Consistently, the phylogenetic analysis shows that SARM protein family can be 
divided into three subgroups: the ones from the C. elegans, the ones from other 
invertebrates other than C. elegans, and those from the vertebrates (Figure 3.6). The 
significance of the N-terminal sequences, which do not encode any functional domain, 
in the invertebrate SARMs is unknown. However, based on the above observations, 
one can speculate that the invertebrate SARMs may have additional function besides 
that conserved from worm to mammals. An example of proteins that are involved in 
more functions in the invertebrates than in the vertebrates is the Toll like receptors 
(TLR). The Drosophila Toll functions in both embryonic dorso-ventral patterning 
process (Morisato and Anderson, 1995) and in the immune responses against bacterial 
and fungal infection (Lemaitre et al., 1996; Rutschmann et al., 2002). Its homolog in 
vertebrates, however, exclusively involved in host defense (reviewed in Akira and 
Takeda, 2004; Takeda and Akira, 2005) 
4.3 Difference in tissue specific expression may reflect 
differences in function between the invertebrate and 
vertebrate SARM homologs 
Expression of the horseshoe crab SARM analyzed by RT-PCR was restricted 
to the hepatopancreas, amebocyte, muscle and heart (Figure 3.7). Human SARM, 
however, was detected only in the kidney and liver, which is equivalent to the 
hepatopancreas of the horseshoe crab. The lack of expression of human SARM in 
other tissues such as the brain and some cancer cell lines is possibly due to the 
silencing effect caused by the antisense RNA of SARM detected at high level in these 
tissues (Mink et al., 2001). It is likely that a similar mechanism of repression regulates 
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the expression of CrSARM in different tissues of the horseshoe crab. In C. elegans, 
SARM homolog was found in the embryo and the hypodermis, where it involved in 
the regulation of the differentiation of olfactory neurons (Chuang and Bargmann, 
2005) and the expression of antimicrobial peptides (Couillault et al., 2004), 
respectively. It can be seen that the expression of SARM in immune-responsive 
tissues has been conserved from the worm to human, suggesting that the immune-
related function of this protein has been maintained through evolution. Whether 
SARM functions in the embryogenesis in organisms higher than C. elegans and why 
it is expressed in the horseshoe crab’s muscle and heart remain to be solved.  
4.4 SARM, a distinct TIR domain containing adaptor 
SARM is the newest member of the TIR domain-containing adaptor proteins. 
The presence of TIR domain in this protein suggests its potential role in the TLR 
signaling. However, until now, the link between SARM and the TLR signaling 
pathways has not been established. Studies in C. elegans showed that TIR-1, the 
mammalian SARM homolog, regulates the expression of antimicrobial peptides in  
Tol-1 independently manner although TIR-1 and Tol-1 are the only two TIR domain-
containing proteins predicted to be present in C. elegans (Couillault et al., 2004; 
Liberati et al., 2004). However, while Tol-1 does not exhibit immune-related function 
(Couillault et al., 2004), Drosophila Toll and TLRs in higher organisms do. Therefore, 
it is a worthwhile effort to verify the potential role of SARM in TLR signaling in 
higher organisms.  
The very unique domain architecture of SARM with three protein-interaction 
domains (ARM, SAM and TIR) strongly suggests that SARM is a component of 
novel signaling pathways. Indeed, this is reflected from our study of CrSARM. A 
spectrum of potential protein interaction partners of CrSARM was isolated by yeast 
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two hybrid screening. Subsequently, co-transformation confirmed that only 
calcium/calmodulin dependent protein kinase I (CaMKI), HS1-associated protein X-1 
(HAX1), small ubiquitin-like modifier (SUMO-1), Hsp40, proteasome alpha-subunit, 
and two hypothetical proteins interact specifically with CrSARM (Table 3.6). The 
diverse cellular functions of these SARM-interaction protein partners suggest that 
CrSARM may mediate signal transductions within more than one signaling pathway. 
The following sections will discuss the potential biological significance of these 
interactions based on our current understanding of SARM; the biological functions of 
the interaction partners; as well as the innate immune response of the horseshoe crab.  
4.4.1 CrSARM may be involved in Ca2+-dependent regulation of p38 
MAPK  
Chuang and Bargmann (Chuang and Bargmann, 2005) reported that during 
embryonic development in C. elegans, TIR-1, the SARM homolog of C. elegans, 
provides surface for the signaling complex downstream of a voltage-gated calcium 
channel to assemble and to regulate the expression of the odorant receptor, thus, 
establishing the asymmetry of the olfactory AWC neurons. UNC-43, a homolog of 
CaMKII, and NSY-1, a homolog of human ASK1, were found to belong to the 
complex. However, physical interaction was only confirmed between TIR-1 and 
UNC-43 though the co-localization of TIR-1, UNC-43 and NSY-1 to the post-
synaptic regions was observed (Chuang and Bargmann, 2005). Since ASK1 is a 
mitogen-activated protein kinase (MAPK) kinase kinase that can activate both JNK 
and p38 MAPK signaling pathways, it was thought that TIR-1 is involved in the 
regulation of the odorant receptor expression via the UNC-43/NSY-1/p38 or JNK 
cascade. Consistent with Chuang and Bargmann (Chuang and Bargmann, 2005),   
Leberati et al (Liberati et al., 2004) reported that the suppression of TIR-1 expression 
 95
by RNA interference repressed the activation of p38 MAPK, reducing resistance of C. 
elegans to pathogen infection.  
In the yeast two hybrid screening of the amebocyte 3 hpi cDNA library using 
the SAM domain of CrSARM as the bait, we isolated calcium/calmodulin 
dependent protein kinase I (CaMKI) (B). Although the C. elegans SARM homolog, 
TIR-1, was shown to interact with CaMKII to modulate the expression of olfactory 
receptors in neuronal cells (Chuang and Bargmann, 2005), there are data in support of 
the interaction between CrSARM and CaMKI. Indeed, while CaMKII is mainly 
expressed in the brain, CaMKI is found in the cytosol of a wide variety of tissues 
(Tobimatsu and Fujisawa, 1989). Moreover, a CaMKI-like kinase expressed 
exclusively in human granulocytes, which are the functional equivalence of the 
horseshoe crab amebocytes, was isolated several years ago (Verploegen et al., 2000). 
It is therefore likely that in non-neuronal cells including the amebocytes, interaction 
between CrSARM and CaMKI would mediate various cellular functions in response 
to the change in intracellular Ca2+ level. It has been known that infection can trigger 
the alteration in free cytosolic Ca2+  concentration, resulting in the attenuation of a 
variety of immune-related processes including degranulation, phagocytosis, and 
cytoskeleton remodeling (Brunet et al., 2000; Haque et al., 1998; Low et al., 1992). 
Nevertheless, further study is required to determine how CrSARM-CaMKI complex 
may contribute to the immune responses against bacterial infection.  
Although, the downstream target of the horseshoe crab CaMKI remains 
unknown, the finding of Chuang and Bargmann (Chuang and Bargmann, 2005) 
suggests that ASK1 could be a potential candidate. Interestingly, SUMO-1, one of the 
potential interaction partners of the TIR domain of CrSARM (Table 3.6 A), was 
shown in a recent research to physically interact with ASK1 and inhibit its activation 
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(Lee et al., 2005). Interaction between SUMO-1 and CrSARM, therefore, would be 
essential to down-regulate the Ca2+/CaMKI/ASK1/p38 or JNK signaling cascade to 
prevent the damage of the host tissue and the wasting of cellular resources due to the 
overwhelming immune responses activated by this signaling cascade. Besides SUMO-
1 mediated down-regulation of the downstream signaling, suppression of CrSARM 
expression at the later stage of infection (Figure 3.8) could be an additional 
mechanism to suppress this signaling pathway. The presence of two negative check-
points would assure that the downstream signaling is repressed quickly and efficiently. 
Taken together, we speculate that upon infection, CrSARM may function as a scaffold 
protein supporting the assembly and signal transduction through the 
CaMKI/ASK1/(p38/JNK) cascade, ultimately resulting in the activation of immune 
related genes that are under the control of AP-1 transcription factor, which is the 
downstream target of p38 MAPK. When the invading pathogen is under control, 
down-regulation of this signaling would be achieved by the recruitment of SUMO-1, 
a negative regulator of ASK1, to the TIR-domain of CrSARM and the inhibition of 
CrSARM expression itself. This hypothesis is schematically illustrated in (Figure 4.1). 
This speculation can be validated by further investigation: (a) to confirm the link 
between ASK1 with CaMKI and SUMO-1; (b) to determine whether the binding of 
CaMKI, SUMO-1 and possibly ASK1 to CrSARM is constitutive or temporally 
regulated; (c) to define the signaling that controls the switching between activation 
and repression decision; and (d) to identify the ultimate immune responses mediated 













   
 
 
Figure 4.1 CrSARM regulates Ca2+-dependent activation of p38/JNK kinases in 
response to pathogen infection via the interactions with CaMKI and SUMO-1  
(A) Infection causes the influx of extracellular Ca2+ into the cell via the ion channels and 
simultaneously activation of TLR or an unknown PRR upstream of CrSARM, promoting the 
interaction between CrSARM with CaMKI and ASK1. At the same time, the increase in 
intracellular Ca2+ concentration leads to the activation of CaMKI, which in turn activates 
ASK1, an upstream component of p38 and JNK kinase signaling cascades. As a result, p38 
and/or JNK are phosphorylated and translocate into the nucleus to activate the transcription 
factor AP1, resulting in the expression of AP1 dependent immune-related genes. (B) To avoid 
tissue damage and exhaustion of cellular resources due to overwhelming immune response, 
the signaling cascade is repressed by two mechanisms: (1) downregulation of CrSARM 
expression, and (2) inhibition of ASK1 activation by SUMO-1, which was shown to interact 
with the TIR domain of CrSARM. Solid arrows represent processes that are confirmed 
experimentally. Dotted arrows and dotted line represent interactions and processes that 




































4.4.2 Does CrSARM play a role in the regulation of apoptosis or 
remodeling of cytoskeleton? 
We identified HAX1 amongst putative interaction partners of CrSARM TIR 
domain. As mentioned previously, HAX1 was thought to be involved in the regulation 
of apoptosis and cytoskeleton remodeling signaling. This is based on its ability to 
interact with a prosurvival protein, Bcl2, and the F-actin associated protein cortactin, 
respectively (Gallagher et al., 2000; Matsuda et al., 2003). Both apoptosis and 
cytoskeleton remodeling highly relate to pathogenesis as well as host defense.  
CrSARM-HAX1 interaction may be essential for the host resistance against 
pathogen-induced apoptosis  
 Apoptosis of the host cells that are infected by pathogens is a sacrificial 
immune response to protect the non-infected cells from pathogen invasion (DosReis 
and Barcinski, 2001; Koyama et al., 1998). Host induced apoptosis is particularly 
important for an effective control of viral and obligate intracellular parasite infection. 
However, several pathogens including P. aeruginosa exploit the host signaling 
pathways to induce the death of immune related cells, and thus impair the host 
defense. Indeed, researchers have shown that several proteins produced by P. 
aeruginosa such as quorum sensing molecule N-3-oxododecanoyl homoserine lactone, 
pyocyanin and exotoxin A toxin, are able to induce apoptosis of macrophages and/or 
neutrophils (Allen et al., 2005; Jenkins et al., 2004; Tateda et al., 2003). Exotoxin A 
was shown to trigger a caspase dependent signaling pathway, which can be 
suppressed by Bcl-2, whereas molecular mechanisms associated with proapoptotic 
activity of the two former Pseudomonas proteins remain unclear. 
 In the horseshoe crabs, the amebocytes play a very active role in the clearance 
of the infected pathogen (Ding et al., 2005; Ng et al., 2004). Hence, induction of the 
 99
amebocyte cell death would favor the survival of the P. aeruginosa inside the 
horseshoe crab. It is thus tempting to speculate that CrSARM/HAX1 complex, 
through the interaction with Bcl2, would inhibit the cell death signaling initiated in 
the amebocytes by the Pseudomonas. In this context, CrSARM would serve as an 
adaptor to couple the undefined upstream signaling pathway, which is triggered by the 
pathogen, with the downstream anti-apototic signaling cascade.  In line with this 
hypothesis, we found that the change in the transcript level of CrSARM in response to 
Pseudomonas infection (Figure 3.8) synchronizes with the profile of bacterial 
clearance from the infected horseshoe crabs, which was shown in the previous study 
in the lab (Ng et al., 2004), and Figure 1.8). It seems that the upregulation of 
CrSARM during the first three hours of infection occured to protect of the cells from 
apoptosis induced by the great burden of the invading bacteria. After 3 hpi, the 
majority of the pathogens was cleared from the infected horseshoe crabs, thus lifting 
the proapoptosis driving force, and hence the anti-apoptotic activity is no longer 
required. This is coincident with the rapid reduction in transcription level of CrSARM, 
which would allow the level of CrSARM protein return to the basal level.  
The potential role of CrSARM in cytoskeleton remodeling 
We should not rule out the possibility that the interaction between CrSARM 
and HAX1 may play a role in the remodeling of actin cytoskeleton due to the possible 
interaction between the latter with cortactin, which is an F-actin binding protein. The 
expression of CrSARM in tissues with actin-based contractile capacity like muscle 
and heart (Figure 3.7) and the presence of cortactin in human skeletal and cardiac 
muscles as shown by Wu and Montone (Wu and Montone, 1998) support this 
argument. In addition to muscle contraction, actin dynamics play a significant role in 
many cellular processes including cell migration, membrane dynamics, and cellular 
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transport. If the interaction between CrSARM, HAX1, and cortactin truly happens in 
vivo, CrSARM would serve as a bridge to link the upstream signaling, which can be a 
physiological and/or immune-related, to the regulation of actin cytoskeleton, which 
would effect various actin-dependent cellular processes.  
Among the essential host defense responses, phagocytosis and receptor-
mediated endocytosis are the two processes that are tightly associated with 
cytoskeleton remodeling. The phagocytosis-related function of CrSARM is supported 
by the following lines of evidence. A recent research has revealed that activation of 
TLR may enhance the antigen-endocytosis of dendritic cells via the modulation of 
podosome turn-over. Podosome is an F-actin rich structure associated with the 
invasive potential of the cells (West et al., 2004). The formation of podosome was 
reported to be regulated by cortactin (Kaverina et al., 2003). Therefore, through the 
interaction with HAX1, which is a cortactin binding protein, CrSARM may play a 
role in TLR signal transduction leading to the phagocytosis of the pathogen. Proof of 
this hypothesis will shed light on the molecular mechanism of the phagocytosis of 
bacterial pathogen by the amebocytes that was reported previously by Zhu et al (Zhu 
et al., 2005). Alternatively, CrSARM/HAX1/cortactin complex may participate in the 
receptor-mediated endocytosis, which is essential for the downregulation of some 
signaling cascades. Indeed, cortactin was shown to be involved in the endocytosis of 
the activated epidermal growth factor receptors, a process required for the 
downregulation of EGF signaling (Daly, 2004; van Rossum et al., 2005). Other TIR 
domain-containing adaptor molecule that was found to act as a negative regulator of 
the TLR signaling pathways is Triad3A, although the downregulation of signaling is 
achieved by ubiquitination-dependent degradation of the activated TLRs.  
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In order to determine the biological significance of CrSARM/HAX1 
interaction, future work should focus on the identification of signaling cascades up- 
and down-stream of CrSARM/HAX1 complex.  
 4.4.3 Implication of other potential interactions  
  Effort should be taken to evaluate the validity and the implication of the 
interactions between TIR domain of CrSARM with proteasome alpha-subunit, 
Hsp40, which are structural components of proteasome and chaperone machineries, 
respectively, and the two hypothetical proteins (Table 3.6). Though there is no 
definite indication how such interactions are essential for the cells, interactions 
between proteasome alpha subunit, a structural component of proteasome, with 
nonubiquitinated proteins and between heat shock proteins that compose of the 
chaperone machinery with the signaling proteins were documented (Cho et al., 2001; 
Dong et al., 2004; Pratt and Toft, 2003). Indeed, it was speculated that the recruitment 
of proteasome subunit to unubiquitinated proteins would direct the proteins to the 
ubiquitin-independent proteasomal degradation pathway (Cho et al., 2001; Dong et al., 
2004). In the interaction between the signaling molecules with the chaperon 
machinery, it is possible that the latter might severe as a temporary carrier to shuttle 
the former to the site of action in the cells. Alternatively, by interaction with the 
chaperon, signaling molecules could acquire the conformational change that favors its 
interaction with the ligand or other signaling molecules. An example is the binding of 
the glucocorticoid receptor to the hsp90/hsp70 chaperone machinery converts steroid-
binding cleft on the receptor from the closed to open conformation, allowing the 
access of the steroid (Pratt and Toft, 2003). It is thus worthwhile to investigate the 
biological functions of the interactions between CrSARM and the components of 
proteasome and chaperone machinery.  
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Chapter 5 Conclusion and Future Perspectives 
5.  
Differential usage of TIR domain-containing adaptors by TLRs tailors the 
innate immune responses to match the nature of the immune challenges. As this class 
of signaling molecule is expanding, the more we understand of the functions of these 
adaptor proteins, the greater is our appreciation of the sophisticated contribution of 
TLR signaling in the ancient host defense component of immunity. Among the TIR 
domain-containing adaptor proteins, SARM is the newest to be described and, thus, 
also the least to be functionally characterized. Research on this signaling molecule is 
hence, constrained by the limitation of literature support. However, any new findings 
will more than offset the challenge of the lack of information, which will offer 
significant insights into not only TLR signaling but also innate immunity, a field that 
is still rudimentary compared with adaptive immunity.  
We have successfully obtained the full-length cDNA of C. rotundicauda 
SARM and showed that the expression of CrSARM is responsive to P. aeruginosa 
infection, confirming the immune-related function of this protein. The search for 
interaction partners of CrSARM led to our identification of CaMKI, SUMO-1, HAX-
1, proteasome-α subunit, Hsp40 and two hypothetical proteins, thus revealing the 
potential signaling events that CrSARM may participate in. Based on our results and 
the scientific literature on the C. elegans SARM homolog, we propose that this TIR 
domain-containing adaptor may promote and regulate signal transduction leading to 
the activation of p38 MAPK through the interaction with CaMKI, SUMO-1 and 
ASK1. The interaction between CrSARM with HAX1, on the other hand, indicates 
the potential role of CrSARM as an adaptor protein coupling the upstream signaling, 
which is possibly TLR-related, to the downstream signaling that either results in anti-
apoptotic activity or actin remodeling.  Thus, SARM may be regarded as a 
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cytoplasmic bridging molecule for the upstream TLR signaling to the downstream 
p38 MAPK pathways. Although more work is needed to fully decipher and confirm 
this hypothesis, the interaction between CrSARM and proteasome-α subunit and 
Hsp40 suggests the possible connections between CrSARM with proteasome 
degradation and chaperone-mediated protein modification, respectively. Needless to 
say, the activation of p38 MAPK, the induction of anti-apoptosis, actin remodeling, 
proteasome degradation, and protein folding by the chaperone machinery have been 
known to play essential roles in various physiological as well as immune related 
functions such as the regulation of antimicrobial peptide expression, promotion of 
host cell survival upon pathogen infection, pathogen clearance by phagocytosis, and 
down-regulation of signal transduction by endocytosis of activated receptors 
 Future study should firstly aim to validate of the interaction of CrSARM with 
its putative partners using different approaches such as immunoprecipitation and/or 
GST pull-down assays. The functional study of each individual interaction may be 
performed to uncover the biological relevance of these interactions in the context of 
global intracellular signaling in response to pathogen invasion. In addition, 
experiments could be designed to investigate whether CrSARM functions 
downstream of CrTLR that is currently being isolated by our lab. Last but not least, 
further work should also address the following questions: (1) what receptors/ligands 
activate the signaling cascades through CrSARM; (2) how CrSARM co-ordinates 
with various signaling pathways; and (3) what is the significance of that co-ordination 
under naïve physiological conditions and during infection.  
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Appendix A 
DmCG7915a    1 --------------------------MKAAEIKRDLTNIQKSMSEINDLAKERITGGPGS 
DmCG7915b    1 --------------------------MSNQAPWPVRKGIFRSSGQS-DFTPTRSP----- 
AgSARM       1 PIACCEPVSVHLQLLNSRSSSSKSSKLSSSTSSTTTKHVEKSSSSTQRMSSLTSSSSSSS 
CrSARM       1 --------------------------MENGFAPPPLVPDFSEDYSQKTNSDTNILIQSFD 
CfSARM       1 ------------------------------------------------------------ 
MmSARM       1 ------------------------------------------------------------ 
BtSARM       1 ------------------------------------------------------------ 
HsSARM       1 ------------------------------------------------------------ 
CeTIR1a      1 ------------------------------------------------------------ 
CeTIR1c      1 ------------------------------------------------------------ 
 
 
DmCG7915a   35 ISTTSASAITA-----------------PSTMSQTTTSRLAPKLTSAHPSIDDLRGLSR- 
DmCG7915b   29 -SPIVEMPLSP-----------------PPVATPSNRFGINSPLSPPPQPIQVVAGSTT- 
AgSARM      61 -STTSAAAVKQGLGEMQNSIAEMKNMMGHSTSSSSSSTSQNLSTTTSTSSIKSSALSNHR 
CrSARM      35 NNPSLNGKMKN------------------NASSKTKGTNITARYHATKSADNATTATSST 
CfSARM       1 ------------------------------------------------------------ 
MmSARM       1 ------------------------------------------------------------ 
BtSARM       1 ------------------------------------------------------------ 
HsSARM       1 ------------------------------------------------------------ 
CeTIR1a      1 ---------------------------------------MGEEILTERNQLSRQDASCFR 
CeTIR1c      1 ---------------------MLPNRKPPRPSPSFQSLNNNNQRFPLRRSLKIAQAHSLP 
 
 
DmCG7915a   77 --QDKITQLQKKIRASFENLVDHDDSNVIVTLPDDDDCPHNHFGSGLNL----------- 
DmCG7915b   70 --ATTMS------TASAARVSGAAAS----TSSSSSSSSSSQCSSQTSS----------- 
AgSARM     120 KMSSKINDIKSRLRSSMDSLDDPQGADPLVTFPDSETDDDHLSGMASSLKPLGANSGGSG 
CrSARM      77 SAICKKSEVKVCQKLKQEQNESFQEKQNFSRSFSVSSSAGSNTKTKLKS----------- 
CfSARM       1 ------------------------------------------------------------ 
MmSARM       1 ------------------------------------------------------------ 
BtSARM       1 ------------------------------------------------------------ 
HsSARM       1 ------------------------------------------------------------ 
CeTIR1a     22 SPRSPLGR---------------------------------------------------- 
CeTIR1c     40 TVPSEDAKDDDLITPELSTDFDFREIQHRYLMALQNEQDGETT----------------- 
 
 
DmCG7915a  124 -------THPTAAQLSASGLSGSSKTIDTIKFQEKSMKTESKTKVVTDGFSSEQATSNSA 
DmCG7915b  107 -------SSSSHTRVRKS-SNPPPQPITSCPLSPPPPPPPQQQQQLPQQLPPPTPINNTN 
AgSARM     180 GILVPNGTNHHHHQALMNGCAAAGTTVDTVKFEQKKMTSESKTKVTTDGFSSEQATINSA 
CrSARM     126 --------DRRGNSLDTVLDTTKTPHQRDFTFEQKQVMSSSQTKTTTDSFSCEKAKIDNK 
CfSARM       1 ------------------------------------------------------------ 
MmSARM       1 ------------------------------------------------------------ 
BtSARM       1 --------------MGSGGGGTREEELPFLLLCLLHLQPSPQWALRPHPNLFVQDPALTL 
HsSARM       1 ------------------------------------------------------------ 
CeTIR1a     30 ---------TDDAFFELDDDDDLSSPSVPGSPVDPPSISVPLPPKSAPPCPTQPAPLTNG 
CeTIR1c     83 --------STDDAFFELDDDDDLSSPSVPGSPVDPPSISVPLPPKSAPPCPTQPAPLTNG 
 
 
DmCG7915a  177 EMKRLQAGDIDYQESKGASAMRNRLEVDGVKTEENAAVIKEALSLRTGDITQQASNNVAA 
DmCG7915b  159 HSAITTP---NHNNNHNCNQMRNVREIP-IEVEQ----SKEALSLRTGDITQQASNNVAA 
AgSARM     240 ESKKLQAGDLQYQEQAALAATSSRMEVDGVTAEEKGAILKEARSLKMGDFQQAEANNIAA 
CrSARM     178 ELKELQTEELSYAEKHSSSIVNARLKADDFSAEKTNVINKDQVQLKCEETIHQQQRVATT 
CfSARM       1 --------------------------------------------------------MVLT 
MmSARM       1 --------------------------------------------------------MVLT 
BtSARM      47 SPNFCSVPLPGPLPSTLPPVSSSPAVRSRILLFPSSGSLRPAPPLQTGDVPRSPAPMVLT 
HsSARM       1 --------------------------------------------------------MGAV 
CeTIR1a     81 DLYPTILSNGTPIPNGRITPALSTVSVSLIHEARLQQSLSTPCNGSEEEMHNGQVRKESE 
CeTIR1c    135 DLYPTILSNGTPIPNGRITPALSTVSVSLIHEARLQQSLSTPCNGSEEEMHNGQVRKESE 
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DmCG7915a  237 SSITVQSENFSADKKAISQSQQSQTMTSNGIISQEKHVSSASQANYSMSHKG-------- 
DmCG7915b  211 SSITVQSENFSADKKAISQSQQSQTMTSNGIISQEKHVSSASQANYSMSHKG-------- 
AgSARM     300 HSRKVHSDHFSAENKAISQAQQKQTVSASGIFNQEKHVSSTTQSTFTMSNTS-------- 
CrSARM     238 TSQRVATEKFTTEKISTTAQEERHTFSQSSLQQETNVSSKLKISNNKMTSILSGHDFHEL 
CfSARM       5 LL--------------LSAYKLCSFFTMSGPRPGAERLAVPWPDGGGGAGPW-------- 
MmSARM       5 LL--------------FSAYKLCRFFTMSGPRPGADRLTVPGPDRSGGASPW-------- 
BtSARM     107 LL--------------LSAYKLCRFFAMSGPRPDAERLAVPGPDGGGGASQW-------- 
HsSARM       5 AR------------------------AHGGLRVARARESVAGGRHRG------------- 
CeTIR1a    141 YRRFK------SEGSTAGASLPAAEKTHMDELSPVDQRSTSGTARFLIQQDS-------- 
CeTIR1c    195 YRRFK------SEGSTAGASLPAAEKTHMDELSPVDQRSTSGTARFLIQQDS-------- 
 
 
DmCG7915a  289 ------VSSTGSSMITSSSQ---MSAMNGQMLKLADLKLDDLKSLTAGSGQQEIEQTINK 
DmCG7915b  263 ------VSSTGSSMITSSSQ---MSAMNGQMLKLADLKLDDLKSLTAGSGQQEIEQTINK 
AgSARM     352 ------TISSSSQMSTLSSS---SSAALGDDFP----SFEDFERL--GNTPEEIDSTIMK 
CrSARM     298 DIGGLMSPSGGSPIITFPEEEVFHQRRQNQDLAITEGIQDDIQLLQSHTSSSEVDKTITR 
CfSARM      43 -------WSAGGRG----------------------------PREVSPGAAAEVQGALER 
MmSARM      43 -------WAAGGRG----------------------------SREVSPGVGTEVQGALER 
BtSARM     145 -------WVAGSRR----------------------------PRELSPGASTEVQGALER 
HsSARM      28 ---------AGRPG----------------------------ARAAGAAAG------LVR 
CeTIR1a    187 ------VVNPSTKMS----------------------------NTEQVAMMHTLKTKLSK 
CeTIR1c    241 ------VVNPSTKMS----------------------------NTEQVAMMHTLKTKLSK 
 
 
DmCG7915a  340 YSNMLTSIVSSLQEDERGGSAITVHDVGGKKSQYLEKINEVIRRAWAVPTHGHELGYSLC 
DmCG7915b  314 YSNMLTSIVSSLQEDERGGSAITVHDVGGKKSQYLEKINEVIRRAWAVPTHGHELGYSLC 
AgSARM     397 YSKHLANYVQNLQQTEQLK----------KAPTLLNHMNEIIRRAWAVPTHGHELGASLC 
CrSARM     358 YCSRMENCINRLKTSSTPQ-----------AVELLSLMADMIIKAWSLSSHGHELGQKLC 
CfSARM      68 AMPELQQALSALKQAGGAR----------AVGAGLAEVFQLVEEAWLLPAVGREVAQGLC 
MmSARM      68 SLPELQQALSELKQASAAR----------AVGAGLAEVFQLVEEAWLLPAVGREVAQGLC 
BtSARM     170 ALPELQQALSALKQAVSVR----------ALGAGLTEVFQLVEEAWLLPAMGREVAQGLC 
HsSARM      45 AEAGGRRAGRGRRPGRGLP----------TGGGGLAAA-----------AVGREVAQGLC 
CeTIR1a    213 YQAMMDKAFEEIAKVEDAN-----------IIEGCTIVRKLMRKVWNTPKVSADLANALC 
CeTIR1c    267 YQAMMDKAFEEIAKVEDAN-----------IIEGCTIVRKLMRKVWNTPKVSADLANALC 
 
 
DmCG7915a  400 NSLRQSGGLDLLMKNCVKPD------LQFSSAQLLEQCLTTENRKHVVDNGLDKVVNVAC 
DmCG7915b  374 NSLRQSGGLDLLMKNCVKPD------LQFSSAQLLEQCLTTENRKHVVDNGLDKVVNVAC 
AgSARM     447 DTLRNTGGLDILMRNCVDNDS----EVQFSSARLLEQCLTTENRTHVVKNGLDKVVNVAC 
CrSARM     407 ETIHNKGGLDILISNCATTDN----DLQFASAKLLEHCLNDNNRAYVVERGLMNIVTMAC 
CfSARM     118 DAIRLDGGLDLLLRLLQAPEL----ETRVQAARLLEQILVAENRDRVARIGLGVILNLAK 
MmSARM     118 DAIRLDGGLDLLLRLLQAPEL----ETRVQAARLLEQILVAENRDRVARIGLGVILNLAK 
BtSARM     220 DAIRLDGGLDLLLRLLQAPEL----ETRVQAARLLEQILVAENRDRVARIGLGVILNLAK 
HsSARM      84 DAIRLDGGLDLLLRLLQAPEL----ETRVQAARLLEQILVAENRDRVARIGLGVILNLAK 
CeTIR1a    262 DYLRDRDYFDKLIKMFISPNTAACDQVRMECGKVLEECTSSANLEYIVNKSYTKKIMIVA 
CeTIR1c    316 DYLRDRDYFDKLIKMFISPNTAACDQVRMECGKVLEECTSSANLEYIVNKSYTKKIMIVA 
 
 
DmCG7915a  454 VCTKNSNMEHSRVGTGILEHLFKHSEGTCSDVIRLGGLDAVLFECRTS--DLETLRHCAS 
DmCG7915b  428 VCTKNSNMEHSRVGTGILEHLFKHSEGTCSDVIRLGGLDAVLFECRTS--DLETLRHCAS 
AgSARM     503 VCTRNNATDHSRVGTGILEHLFKHSEDTCSNVIRLGGLDAVLFECRKN--DVETLRHCAG 
CrSARM     463 SFSKANSVCHSRTGTAILENLFRHSEKTCSDVVRLGGLKSILYDCRHI--DVRTLRHCAI 
CfSARM     174 ---EREPVELARSVAGILEHMFKHSEETCQRLVSAGGLDAVLYWCRRT--DPALLRHCAL 
MmSARM     174 ---EREPVELARSVAGILEHMFKHSEETCQRLVAAGGLDAVLYWCRRT--DPALLRHCAL 
BtSARM     276 ---EREPVELARSVAGILEHMFKHSEETCQKLVTAGGLDAVLYWCRRT--DQALLRHCAL 
HsSARM     140 ---EREPVELARSVAGILEHMFKHSEETCQRLVAAGGLDAVLYWCRRT--DPALLRHCAL 
CeTIR1a    322 MK-LNKTPDQQRLSLSLIGNLFKHSNAVSLSLIETDVIDHIILTFKRAPECPDILRHAAL 





DmCG7915a  512 ALANLSLYGGAENQEEMILRKVPMWLFPLAFH-NDDNIKYYACLAIAVLVANKEIEAEVL 
DmCG7915b  486 ALANLSLYGGAENQEEMILRKVPMWLFPLAFH-NDDNIKYYACLAIAVLVANKEIEAEVL 
AgSARM     561 ALANLSLYGGSENQEAMINRKVPSWLFPLAFH-NDENIKYYACLAIVVLVANKEIEAEVI 
CrSARM     521 ALANLSLYGGPENQQAMIKEKVPVWLFPLAFS-QDDIIKYFACLAITTLVANKEIEFAVL 
CfSARM     229 ALGNCALHGGQAAQRRMVEKRAAEWLFPLAFSKEDELLRLHACLAVAVLATNKEVEREVE 
MmSARM     229 ALANCALHGGQTVQRCMVEKRAAEWLFPLAFSKEDELLRLHACLAVAVLATNKEVEREVE 
BtSARM     331 ALANCALHGGQAAQRRMVEKRAAEWLFPLAFSKEDELLRLHACLAVAVLATNKEVEREVE 
HsSARM     195 ALGNCALHGGQAVQRRMVEKRAAEWLFPLAFSKEDELLRLHACLAVAVLATNKEVEREVE 
CeTIR1a    381 ALANILLYTCFEGKKKIIQKKIPEWLFFLASQ-ADDVTRYYACIAVCTIVSVKEFEPLVR 
CeTIR1c    435 ALANILLYTCFEGKKKIIQKKIPEWLFFLASQ-ADDVTRYYACIAVCTIVSVKEFEPLVR 
 
 
DmCG7915a  571 KSGCLDLVEPFVTSHDPSAFAR---SNLAHAHGQSKHWLKRLVPVLS-SNREEARNLAAF 
DmCG7915b  545 KSGCLDLVEPFVTSHDPSAFAR---SNLAHAHGQSKHWLKRLVPVLS-SNREEARNLAAF 
AgSARM     620 KSGTLNLVEPFVTTHNPSEFAK---SNLAHAHGQSKHWLQRLVPVLS-SKREEARNLAAF 
CrSARM     580 RSGTLDLVEPFIASHDPEEFAS---KAPAHIHRQSKEWLLRLVPVLD-SNREEARSLAAF 
CfSARM     289 RSGTLALVEPLVASLDPGRFARCLVDASDTRQGRGPDDLQRLVPLLD-SSRMEAQCIGAF 
MmSARM     289 HSGTLALVEPLVASLDPGRFARCLVDASDTSQGRGPDDLQSLVLLLD-SSRLEAQCIGAF 
BtSARM     391 RSGTLDLVEPLVASLDPGRFARCMVDASDTSQGRAPDDLQRLVPLLD-SSRLEAQCIGAF 
HsSARM     255 RSGTLALVEPLVASLDPGRFARCLVDASDTSQGRGPDDLQRLVPLLD-SNRLEAQCIGAF 
CeTIR1a    440 KSDTMKLVEPFLQVHDPATFAR---DYHKYAQGNTKEWLERLLPMLQPSRRREARSVAAF 
CeTIR1c    494 KSDTMKLVEPFLQVHDPATFAR---DYHKYAQGNTKEWLERLLPMLQPSRRREARSVAAF 
 
 
DmCG7915a  627 HFCMEAGIKREQGNTDIFREINAIEALKNVAS-CPNAIASKFAAQALRLIGETVPHKLSQ 
DmCG7915b  601 HFCMEAGIKREQGNTDIFREINAIEALKNVAS-CPNAIASKFAAQALRLIGETVPHKLSQ 
AgSARM     676 HFCMEAGIKKEQGNTNIFKEIGAIEPLIRVAS-SPNAIASKFAAQALRLIGEEVPHKLSQ 
CrSARM     636 HFALEASIKKKLGNTEIFHDIGAIEVLKRVAS-SPNAIASKYAAQALQLIGEEIPHKLSQ 
CfSARM     348 YLCAEAAIKSLQGKTKVFSDIGAIQSLKRLVSYSTNGTTSALAKRALRLLGEEVPRPILP 
MmSARM     348 YLCAEAAIKSLQGKTKVFSDIGAIQSLKRLVSYSTNGTTSALAKRALRLLGEEVPRRILP 
BtSARM     450 YLCAEAAIKSLQGKTKVFSDIGAIQSLKRLVSYSTNGTTSALAKRALRLLGEEVPRRILP 
HsSARM     314 YLCAEAAIKSLQGKTKVFSDIGAIQSLKRLVSYSTNGTKSALAKRALRLLGEEVPRPILP 
CeTIR1a    497 HFTLEATIKKEQNKLDVFQEIGAIQALKEVAS-SPDEVAAKFASEALTVIGEEVPYKLAQ 
CeTIR1c    551 HFTLEATIKKEQNKLDVFQEIGAIQALKEVAS-SPDEVAAKFASEALTVIGEEVPYKLAQ 
 
 
DmCG7915a  686 QVPLWSVEDVQEWVKQIGFNDYIDKFNESQVDGDLLLKLNQDNLRADIGIGNGILLKRFE 
DmCG7915b  660 QVPLWSVEDVQEWVKQIGFNDYIDKFNESQVDGDLLLKLNQDNLRADIGIGNGILLKRFE 
AgSARM     735 QVPLWSTEDVREWVKQIGFGEYEQSFYDSKVDGDLLLQMQDHNLCDDIGMKNGILRIRFL 
CrSARM     695 QVPLWSAEDVTQWVKQIGFSTYCQEFMNSRVDGDLLLQLNEDTLKNDIGISNGILRKRFL 
CfSARM     408 CVASWKEAEVQTWLQQIGFSHYCESFREQQVDGDLLLRLTEEELQTDLGMKSGITRKRFF 
MmSARM     408 CVASWKEAEVQTWLQQIGFSQYCENFREQQVDGDLLLRLTDEELQTDLGMKSSITRKRFF 
BtSARM     510 SVPSWKEAEVQTWLQQIGFSQYCENFR------------------TDLGMKSGIIRKRFL 
HsSARM     374 SVPSWKEAEVQTWLQQIGFSKYCESFREQQVDGDLLLRLTEEELQTDLGMKSGITRKRFF 
CeTIR1a    556 QVPGWTCADVQYWVKKIGFEEYVEKFAKQMVDGDLLLQLTENDLKHDVGMISGLHRKRFL 
CeTIR1c    610 QVPGWTCADVQYWVKKIGFEEYVEKFAKQMVDGDLLLQLTENDLKHDVGMISGLHRKRFL 
 
DmCG7915a  746 RELQNLKRMADYSSKDTAKMHQFLSEIGTDYCTYTYAMLNAGIDKCALPHVNEDMLMTEC 
DmCG7915b  720 RELQNLKRMADYSSKDTAKMHQFLSEIGTDYCTYTYAMLNAGIDKCALPHVNEDMLMTEC 
AgSARM     795 RELQNLKKMADYSSRDTDGLHAFLSRIGPEYTIYTYTMLNAGVDIESLRTLDEDQLTATC 
CrSARM     755 RELVQLKRLADYSSCDTISLNMILQELGSEYSQYTYIMLQAGLSRDVFPFLTEDQLEEVC 
CfSARM     468 RELTELKTFASYATCDRSNLADWLGSLDPRFRQYTYGLVSCGLDRSLLHRVSEQQLLEDC 
MmSARM     468 RELTELKTFASYATCDRSNLADWLGSLDPRFRQYTYGLVSCGLDRSLLHRVSEQQLLEDC 
BtSARM     552 RELTELKTFANYATCDRSNLADWLGSLDPRFRQYTYGLVSCGLDRSLLHRVSEQQLLEDC 
HsSARM     434 RELTELKTFANYSTCDRSNLADWLGSLDPRFRQYTYGLVSCGLDRSLLHRVSEQQLLEDC 
CeTIR1a    616 RELQTLKVAADYSSVDESNLDNFLMGLSPELSVYTYQMLTNGVNRSLLSSLTDEMMQNAC 






DmCG7915a  806 GIHNSIHRLRILNAVKNLENSLPSS-SEENMAKTLDVFVSYRRSNGSQLASLLKVHLQLR 
DmCG7915b  780 GIHNSIHRLRILNAVKNLENSLPSS-SEENMAKTLDVFVSYRRSNGSQLASLLKVHLQLR 
AgSARM     855 GITNAIHRSRILQVIK-LNESIPSFRSEQSAEKNLDVFVSYRRSNGSQLASLLKVHLELR 
CrSARM     815 GISNSIHRRRIWQALLGSTHSYTSCDGDISCNKTLDVFISYRRPTGSQLASLLKVHLQLR 
CfSARM     528 GIRLGVHRARILSAAREMLHSPLPCTGCKPSGDIPDVFISYRRNSGSQLASLLKVHLQLH 
MmSARM     528 GIRLGVHRTRILSAAREMLHSPLPCTGGKLSGDTPDVFISYRRNSGSQLASLLKVHLQLH 
BtSARM     612 GICLGVHRARILTAAREMLHSPLPCTGGKPSGDAPDVFISYRRNTGSQLASLLKVHLQLH 
HsSARM     494 GIHLGVHRARILTAAREMLHSPLPCTGGKPSGDTPDVFISYRRNSGSQLASLLKVHLQLH 
CeTIR1a    676 GITNPIHRLKLTQAFETAKHP--DDVEVAMLSKQIDVFISYRRSTGNQLASLIKVLLQLR 
CeTIR1c    730 GITNPIHRLKLTQAFETAKHP--DDVEVAMLSKQIDVFISYRRSTGNQLASLIKVLLQLR 
 
 
DmCG7915a  865 GFSVFIDVERLEAGKFDNGLLNSIRQAKNFVLVLTPDALHRCINDEDCKDWVHREIVAAL 
DmCG7915b  839 GFSVFIDVERLEAGKFDNGLLNSIRQAKNFVLVLTPDALHRCINDEDCKDWVHREIVAAL 
AgSARM     914 GFSVFIDVERLEAGKFDNNLLQSIRHARHFLLVLTPDALNRCIDDVDCKDWVHREIVAAL 
CrSARM     875 GFSVFIDVERLEAGKFDNNLVNSIHQAKHFILVLTSDALARCIRDTECKDWVHKEIVEAL 
CfSARM     588 GFSVFIDVEKLEAGKFEDKLIQSVMGARNFVLVLSAGALDKCKQDHDCKDWVHKEIVTAL 
MmSARM     588 GFSVFIDVEKLEAGKFEDKLIQSVIAARNFVLVLSAGALDKCMQDHDCKDWVHKEIVTAL 
BtSARM     672 GFSVFIDVEKLEAGKFEDKLIQSIMSARNFVLVLSAGALDKCMQDHDCKDWVHKEIVTAL 
HsSARM     554 GFSVFIDVEKLEAGKFEDKLIQSVMGARNFVLVLSPGALDKCMQDHDCKDWVHKEIVTAL 
CeTIR1a    734 GYRVFIDVDKLYAGKFDSSLLKNIQAAKHFILVLTPNSLDRLLNDDNCEDWVHKELKCAF 
CeTIR1c    788 GYRVFIDVDKLYAGKFDSSLLKNIQAAKHFILVLTPNSLDRLLNDDNCEDWVHKELKCAF 
 
 
DmCG7915a  925 NSNCNIIPIIDQQFDWPEVE-RLPEDMRSVAHFNGVNWIHDYQDACIDKLERFLRGEKNI 
DmCG7915b  899 NSNCNIIPIIDQQFDWPEVE-RLPEDMRSVAHFNGVNWIHDYQDACIDKLERFLRGEKNI 
AgSARM     974 NSECNIIPIIDN-FQWPEPE-KLPEDMRGVCHFNGIRWIHDYQDACVDKVERFMRAEMN- 
CrSARM     935 QSQCNIIPILDN-FQWPEPE-SLPEDMRAVCYFNGVRWIHDYQDACVDKLERFMRGELN- 
CfSARM     648 SCGKNIVPVIDG-FEWPEPE-DLPEDMQAVLTFNGIKWSHEYQEATIEKIIRFLQGRSS- 
MmSARM     648 SCGKNIVPIIDG-FEWPEPQ-ALPEDMQAVLTFNGIKWSHEYQEATIEKIIRFLQGRPS- 
BtSARM     732 SCGKNIVPVIDG-FKWPEPQ-ALPEDMQAVLTFNGIKWSHEYQEATIEKIIRFLQGRSS- 
HsSARM     614 SCGKNIVPIIDG-FEWPEPQ-VLPEDMQAVLTFNGIKWSHEYQEATIEKIIRFLQGRSS- 
CeTIR1a    794 EHQKNIIPIFDTAFEFPTKEDQIPNDIRMITKYNGVKWVHDYQDACMAKVVRFITGELN- 
CeTIR1c    848 EHQKNIIPIFDTAFEFPTKEDQIPNDIRMITKYNGVKWVHDYQDACMAKVVRFITGELN- 
 
 
DmCG7915a  984 DRIAAMVPGTPGSVSYQRMHSNDSDYQSGGAGAGSGAGTGGGGGGGVTGSVVDGLMVAAN 
DmCG7915b  958 DRIAAMVPGTPGSVSYQRMHSNDSDYQSGGAGAGSGAGTGGGGGGGVTGSVVDGLMVAAN 
AgSARM    1031 -------------------------------------GRGG------CGLLDHGSRLLSR 
CrSARM     992 ----------------------------------------------VRPDGPLGRHIGMG 
CfSARM     705 ------------------------------------------------RDSSAGSDTSLE 
MmSARM     705 ------------------------------------------------QDSSAGSDTSLE 
BtSARM     789 ------------------------------------------------RDSSAGSDTSLE 
HsSARM     671 ------------------------------------------------RDSSAGSDTSLE 
CeTIR1a    853 -----------------------RTTPTTKEMPSISRKTTQQRWQTTNTVSRTGPSRSIG 




DmCG7915a 1044 GSGQGGPTSTTSTTSSTPNSNSSSSSNQSPPAAPA------ 
DmCG7915b 1018 GSGQGGPTSTTSTTSSTPNSNSSSSSNQSPPAAPA------ 
AgSARM    1048 QPGDATPTSAIYQRMHSNDS--------------------- 
CrSARM    1006 GPGTPGTPSTLSGRQLFQRSSSYDSAKGSSCSVEL------ 
CfSARM     717 GAVLMGPT--------------------------------- 
MmSARM     717 GATPMGLP--------------------------------- 
BtSARM     801 SAAPPGPHLTSP----------------------------- 
HsSARM     683 GAAPMGPT--------------------------------- 
CeTIR1a    890 GPRMEPPTPTFFSVTPTGSQERATSTRRKIQPSASTTSDRN 
CeTIR1c    944 GPRMEPPTPTFFSVTPTGSQERATSTRRKIQPSASTTSDRN
 
